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1.1 The diagnosis of brain tumors 
The occurrence of brain tumors is one of the leading causes of cancer 
death in young adults and the second fastest growing cause of cancer death 
among people over age 65 1. Persons with a brain tumor often have symptoms 
like gradual loss of movement or sensation in an arm or leg, loss of vision or 
speech difficulty. In hospital, a radiological investigation may demonstrate an 
abnormality in the brain. Since the symptoms of the patient can easily be 
confused with other disorders of the brain, e.g. infarct or abces, the first step 
is to identify the disorder as being a tumor. If a brain tumor has been 
diagnosed, the next very important step is to identify the type of tumor and 
possibly the tumor grade. The tumor type is dependent on the type of cell the 
tumor originates from. In this thesis the focus is on three types of tumors: 
oligodendroglioma, astrocytoma and meningioma. The first two tumor types 
arise from the brains supportive tissue, and are collectively called gliomas. 
Meningiomas are tumors that arise from the leptomeninges (tissue that serves 
as the lining of the brain). The tumor grade indicates the level of tumor 
malignancy. Tumors are graded on their growth rate, vascularity (blood 
supply), presence of a necrotic center, invasive potential (border distinctness) 
and similarity to normal cells. Malignant tumors may contain several grades of 
cells. The most malignant grade of cell found determines the grade for the 
entire tumor, even if most of the tumor is a lower grade. 
It is rarely possible to decide upon the tumor type and grade with absolute 
certainty from the clinical history and radiological investigations. There are a 
number of specialized tests to diagnose brain tumors. A neurological 
examination checks: eye movement, sensory-motoric and muscular responses, 
reflexes, hearing, tactile and sensory sensation, movement, balance and co-
ordination. Next, special imaging techniques and laboratory tests can be used, 
that detect the presence of a tumor and provide clues about its location. The 
most commonly used techniques for diagnosing brain tumors are1: 
a) Computed Tomography (CT), which uses X-ray radiation to create a 
detailed image of the body's tissues and structure; 
b) Magnetic Resonance Imaging (MRI), which uses a magnetic field 
rather than X-rays to create an image, and can often distinguish more 
accurately between healthy and abnormal tissue; 
 Introduction 
 11 
c) Positron Emission Tomography (PET), which provides a picture of 
brain activity rather than structure by measuring local levels of injected 
compounds, such as glucose or methionine, that have been labeled with a 
radioactive tracer; 
d) Biopsy and characterization by a pathologist is a final step in confirming 
the diagnosis of a brain tumor. A biopsy is a surgical procedure in which a 
small sample of tissue is taken from the suspected tumor. Then, a more 
precise diagnosis, revealing the type and grade of the tumor can be 
obtained by histopathology. 
In spite of the quality of the aforementioned noninvasive radiological tools, 
often a biopsy is still required before a treatment plan can be developed. Brain 
biopsy is an invasive surgical procedure and has a significant risk of mortality. 
Biopsy does not always provide the correct answer, since it is difficult to 
collect the tissue sample from the exact location. Often, the tissue sample is 
heterogeneous, which complicates the identification of the tumor type by the 
pathologist. Furthermore, a biopsy provides only local information from the 
tumor, while tumors are known to be heterogeneous and infiltrative. 
Therefore it is very important to develop new, noninvasive, radiological tools 
that can aid in the diagnosis of tumor type and grade. 
1.2 Can MR spectroscopy assist in tumor diagnosis? 
A new technique, that is not commonly used yet in the clinic is Magnetic 
Resonance Spectroscopy (MRS). MRS provides completely different infor-
mation as compared to MRI, but can be obtained with most 1.5 Tesla MRI 
instruments used for routine radiology. During MRS, spectra are obtained that 
contain information about the concentrations and chemical properties of an 
extended set of metabolites. Two techniques are commonly applied for this 
purpose2. First, the MR spectra can be obtained from a specific selected region 
(volume element or voxel) in the brain. This is called single voxel spectroscopy 
(SVS). In brain tumor diagnosis, the voxel normally includes the tumorous 
area. Next to SVS, also multiple voxels can be measured simultaneously. 
Normally, this implies the acquisition of spectra from a two- (or three-) 
dimensional grid. Each voxel contains an MR spectrum, that provides 
metabolic information about the volume it is measured from. The method is 
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normally referred to as magnetic resonance spectroscopic imaging (MRSI) or 
chemical shift imaging (figure 1.1). MRSI can be especially helpful in the 
identification of heterogeneity in the tumorous part of the brain, since changes 
in the tissue structure can be assessed on a metabolic level. 
 
Figure 1.1. Example of the information obtained by MRI and MRSI. MR 
images with different contrasts are commonly obtained for diagnosing brain tumors. Examples of a 
T1-weighted, T2-weighted, proton density weighted and T1-weighted MR image after administration 
of a Gadolinium-DTPA tracer are given in figure a to d. A grid is displayed over the images. From 
each location in the grid, one complete proton MR spectrum is obtained during MRSI. An example 
of such a proton MR spectrum is given in figure e.  
 
MRS can be performed with several MR sensitive nuclei. Next to the 
proton nucleus (1H), other potentially useful nuclei for biomedical applications 
include 31P, 19F and 13C. The use of 31P-MRS has been found important in 
studies of energy metabolism, as the content of ATP, phosphocreatine and 
inorganic phosphate during exercise can be followed3. It can also be used to 
calculate intracellular pH4, which is an important parameter in the study of 
tumors. Also the signals of phosphomonoesters in tumors can be measured by 
31P-MRS. These signals are found to be raised in tumors compared with 
normal tissue. 
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The metabolic information obtained by 1H-MRS has proven to be 
important in the investigation of brain tumors5, 6. Several metabolite concen-
trations have been found to be lowered or increased in tumors compared with 
normal tissue. This change in concentration can be used for specific tumor 
determination. The proton nucleus has a high MR sensitivity and its natural 
abundance is high. A large number of (brain) metabolites contain protons, that 
generate signals at specific frequencies in the MR signal. The number of 
signals is so high that these actually crowd the MR spectrum and the overlap 
of signals is manifest. 
To influence the presence of signals from metabolites in the proton MR 
spectrum, acquisition protocols can be used that use different acquisition 
parameters. One of these parameters, the echo-time, has a direct influence on 
the signal of metabolites in the MR spectrum. If the echo-time is long, the 
number of signals from metabolites is lower and the baseline of the spectrum 
is often flat. Proton MR spectra acquired with a short echo-time contain more 
signals but can have a distorted baseline due to metabolic components that 
resonate in a large range of the spectrum. Short echo-time spectra contain 
more information, but the extraction of this information might be difficult 
compared with long echo-time spectra. 
In principle, the data from proton MR spectroscopy can assist in the 
noninvasive clinical diagnosis of brain tumors directly. The spectral pattern of 
spectra obtained from tumors if different from spectra obtained form healthy 
brain tissue. Also the patterns of spectra obtained from different tumor types 
and tumor grades are dissimilar. A well trained clinician could use the 
information of the patterns to substantiate the diagnosis. However, the 
appearance of spectroscopic data is very different compared to imaging data. 
Clinicians are used to diagnose patients on basis of imagers, not spectra. 
Furthermore, the amount of data generated, especially during MRSI, hampers 
the diagnosis by clinicians. Going through all the data would simply be too 
time consuming. Therefore, there is a need for the development of statistical 
models that condense the data and that provide an output that is easily 
interpreted by the radiologists and other clinicians. Optimally, the output 
should be some kind of a brain image in order to map the most malignant 
tumor part as well as the tumor boundaries and to compare the results with 
the conventionally obtained MR images. The main goal of the development of 
statistical models would be to aid the clinician in the diagnosis of brain 
tumors, by improving the accessibility of the information within the MR 
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spectra. Ultimately, the statistical interpretation of noninvasively obtained data 
from multiple methodologies could lead to a situation in which the surgical 
procedure, the biopsy, is not necessary anymore. This would be very beneficial 
to the patient, clinician and insurance, since a biopsy is tremendously stressful 
for the patient, time-consuming, expensive, and to some extent error-prone 
regarding the final clinical diagnosis. 
1.3 The information content of MRI and MRS  
MRI has become one of the most important noninvasive aids in clinical 
diagnosis of brain tumors, because it enables the radiologist to assess the 
anatomical location, morphology and size of the tumor tissue with a relatively 
high spatial resolution. Stacked images are recorded throughout the total 
volume of the brain in order to localize the tumor optimally. Also MR images 
with different contrasts are recorded, as the acquisition of only one type of 
image may not show the desired information. The contrasts are normally 
obtained by the acquisition of T1-weighted, T2-weighted and proton density 
weighted images. This is often followed by a T1-weighted image after 
intravenous administration of Gadolinium-DTPA, to assess the blood brain 
barrier viability (figure 1.1). Next to this, also more modern MRI methods 
may be used, like diffusion-weighted imaging and functional MRI. During 
diffusion-weighted imaging, the water movement within the brain tissue is 
analyzed at the molecular level. An abnormality can be detected and visualized 
on diffusion-weighted images, since the normal water movement is restricted. 
With functional MRI it is possible to visualize which specific brain structure 
participates in a specific function, and is therefore important in the assessment 
of the function of the brain tissue surrounding a tumor. 
The proton MR spectra obtained by MRS contain information from 
important brain metabolites like glutamate, myo-inositol, choline, creatine, 
N-acetyl aspartate (NAA), lactate and fatty acids7. NAA is considered to be a 
neuronal marker of which the levels are decreased in brain tumors. The 
choline resonance arises from a group of compounds that are involved in 
membrane synthesis and degradation. Increased choline is often a marker of 
tumor aggressiveness. The creatine signal reflects compounds involved in 
energy metabolism and may be decreased in brain tumors. Lactate is normally 
below detection limit, but it is often increased in brain tumors. The function 
of myo-inositol is largely unknown, but its signal appears to be altered in brain 
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tumors. The signals from fatty acids are known to be increased in several brain 
tumors, especially high grades, and are an indicator for necrosis (cell death). 
Glutamate is an important neurotransmitter in brain and may be elevated in 
oligodendrogliomas8 and other tumors. 
The classical way to use the metabolic information stored in the spectral 
pattern for the diagnosis of brain tumors is to quantitate the intensity of 
several signals in the MR spectra. The most simple methodologies integrate 
spectral regions of interest, based on the assumption that the underlying 
points are highly (lorentzian or gaussian) correlated and contain information 
from one single metabolite. More specialized routines fit the spectrum in the 
spectral domain using a basis set of experimental model spectra9. Also fitting 
in the time domain, using a priori knowledge is used10. A significant statistical 
change in one of the quantitated metabolite levels is often used as a marker for 
malignancy of the tumor. However, in most cases merely univariate methods 
are used, while the availability of information is highly suited for a multivariate 
approach. 
1.4 Extracting information from spectroscopic data 
using chemometrics 
Another, fundamentally different way of collecting information from 
spectra is to use chemometrics11. Chemometrics is a discipline, that has the 
goal to obtain information and knowledge from data in the field of chemistry. 
It explores chemical data with the use of mathematics, statistics and formal 
logic12. Chemometric models are used to mine information from multivariate 
imaging13, 14, spectroscopic data15, 16, and are applicable to a broad gamut of 
chemical and physical problems. These models can be applied to data obtained 
from MRI and MRS also, since these methods acquire data using the same 
basic methodology as methods in for example high-resolution NMR in 
biochemistry. 
Several investigators have used chemometric approaches on MRI17 data or 
MRSI data to diagnose or, less difficult, localize brain tumors5, 18-26. Howells27, 28 
has been one of the first who used chemometric methods on MR data to 
discriminate between tumors. She prepared chemical extracts from tumor 
tissue, which were analyzed with high resolution NMR. Several chemometric 
methods were used to analyze the data. Preul5 has introduced chemometrics in 
the classification of brain tumors using noninvasive methods. He used MRSI 
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data in combination with a linear discriminant analysis technique to 
discriminate between the five most common types of brain tumors in adults. 
MRSI was used to measure the spatial distribution of the (relative) concen- 
trations of several metabolic compounds, resulting in so-called metabolic 
maps or images (figure 1.2). Then, the multivariate data were used to classify 
the tumors. Metabolic maps have also been used to assess the heterogeneity of 
tumors29, 30, since it is important to know the heterogeneity in the tumor and 
surrounding tissue for clinical diagnosis and evaluation of disease.   
In order to increase the accuracy of classification, several classification 
approaches have been developed. A hierarchical tree-like decision system31 
uses multiple binary classifiers, each optimized for a specific decision (e.g. 
healthy vs. abnormal, or malignant vs. benign). Another approach is to use 
consensus diagnosis20, in which several independent classifiers work in parallel. 
If the majority of the classifiers yield the same classification result, then this 
consensus is accepted as being the true class with a high accuracy. 
 
Figure 1.2. Metabolic maps  constructed from MRSI data. The MR image shows 
a tumor in the lower right of the brain (a). To investigate the metabolic changes in the brain, 
metabolic maps of choline (b), creatine (c) and N-acetyl aspartate (d) are constructed from the MRSI 
data. Bright colors represent a high intensity, and thus a high concentration of metabolic compound. 
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1.5 The challenges for chemometrics to improve 
tumor classification 
Four stages can be defined in the strategy of tumor classification using 
chemometrics in combination with MRI and MRS data. Each will be described 
shortly, followed by the challenges for chemometrics. 
The first stage comprises of a selection of training samples for specific 
tumor classes to be classified. Preferably, these samples are selected from a 
database of samples that are acquired in the same unique way. The training set 
has to contain sufficient samples for each tumor class. Ideally, for each class 
also an independent test set should be available, in order to test the accuracy 
of the classifier. To obtain enough samples from a large number of tumors, 
databases have to be developed32 that not only contain MR imaging and 
spectroscopic data, but also clinical information. All data should be easily 
accessible to the researcher, and should be validated. Although this seems to 
have nothing in common with chemometrics, it does! The selection of data by 
the researcher is important for the final classification result. Therefore, 
software has to be developed that guides the researcher through the large 
amount of data in the databases. Methods have to be developed that deal with 
missing or corrupted data, and which perform automated quality control. Only 
then it can be thoroughly investigated whether for example the contribution 
of image and clinical data to spectroscopic data has a positive effect on tumor 
classification. 
The second step consists of all kinds of preprocessing on the data33. This 
may involve several steps. The most common classic methods in the 
processing of 1H-MRS data are; a) Eddy current correction34, b) residual water 
signal removal (water filtering)35, c) Fourier transformation, d) first order 
phase correction,  and e) normalization. 
Preprocessing of the MRS data is a very important issue, especially since 
signals with a low signal to noise ratio are important in tumor diagnosis. The 
challenges for chemometrics in this area are the development of fully 
automated procedures that exhibit robustness and that can identify outliers. 
This is important, because the user in the clinic will probably not have 
expertise in data processing. It is also important in a statistical sense, since 
several pre-processing steps have to be executed in a cascade and error 
propagation has to be kept to a minimum. Furthermore, methods have to be 
developed that prepare data from several sources, e.g. MRS, MRI, CT, PET 
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18 
and clinical information. This will facilitate the combination of data from 
different radiological methods into one input data set. One of the most 
difficult problems in this field that needs investigation, deals with the best 
matching of the differences in spatial resolution between MRI and MRSI data. 
Also the matching between images from different modalities is a difficult 
problem, since pixels from images with the same pixel location should contain 
information from the same spatial location. 
The third step in the strategy of tumor classification involves feature 
reduction of the highly dimensional spectroscopic data. During feature 
reduction, variables are selected from the data that are meaningful for the 
classification. This is especially important if spectroscopic data is used in the 
classification of brain tumors, since in this case the number of variables often 
exceeds the number of objects. Feature reduction should be performed in 
such a way that the information that optimally discriminates the tumor classes 
is kept. Unfortunately, this is not always a straightforward task. As mentioned, 
one can use classic quantitative procedures based on a priori information or 
use chemometrics to perform feature reduction. There is a major challenge 
foreseen for chemometrics in this part of tumor classification, since a lot of 
methods are available that have proven to be very successful. One can think of 
methods like principal components analysis, factor analysis and genetic 
algorithms28, 36-38. Each of these methods has its advantages and disadvantages. 
Probably, for each classification problem the best feature reduction algorithm 
needs to be found separately.  
The last step involves the actual classifier. If the feature reduction has been 
sufficient and retained much of the class discriminating information, then the 
direct distance to the class centers (centroids) or the k-nearest neighbors 
method can be used. The data can also be used as input for methods that 
further reduce the dimensionality by finding optimal separable directions (e.g. 
linear discriminant analysis or quadratic discriminant analysis). Furthermore, 
density functions, neural networks, genetic algorithms, factor analysis and 
support vector machines can be used to construct the classifier. The number 
of methods is steadily growing19, 20, 23, 28, 39, 40, and selection of the best one is 
becoming a major task. If data from imaging modalities is used (this also 
includes MRSI), the newly developed classification method also needs to deal 
with the spatial distribution. Chemometrics has been used to develop 
classifiers which take the classification result of neighboring voxels into 
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account. The tumor is normally located in one specific region of the brain, so 
this could improve classification. 
Since the clinician is interested as much in the reliability of classification as 
in the classification itself, the methods developed should also be able to 
generate probabilities of classification. With the use of chemometrics it is 
possible to calculate these probabilities. It should be investigated whether it is 
possible to generate robust reliability estimates, parallel to the classification. If 
this is indeed the case, then chemometrics can play an important part in the 
acceptance of automated brain tumor classification in the clinic.  
1.6 Outline of the thesis 
In this thesis, chemometric methods are investigated that are used on 
proton MRSI data and MRI data, in order to develop a reliable and 
noninvasive brain tumor diagnosis model. As discussed in Chapter 1.5, there 
are challenges for chemometrics in all stages of the strategy of automated 
brain tumor classification using MRSI and MRI data. To find out what the 
most important challenges to solve were, the methods normally used during 
each stage of brain tumor classification were investigated. Brain tumor 
classification is a very difficult issue. A good classification result can only be 
obtained if each stage in the strategy is thoroughly investigated and dealt with. 
As a result, new methods were developed for the preprocessing, feature 
reduction and classification procedures used in brain tumor classification. 
With respect to the classification, a model was developed that also provides 
probabilities of classification. Probabilities of classification give insight into 
the reliability of the classification. This is important, since the clinicians who 
will use the system have to be convinced that the classification results are 
meaningful. Hopefully, the developed methods described in this thesis will be 
of help in better understanding tumor morphology, type and grade and may be 
of help in finding the best treatment and follow-up of patients with a brain 
tumor.  
In order to test all investigated chemometric approaches, a semi-automated 
classification system has been developed that uses information obtained from 
MRSI data as well as MRI data. At the beginning of this study no automated 
preprocessing procedures were available. A lot of time has been invested in 
the development of such procedures to preprocess the data in the best 
possible way. This has been followed by the development of a segmentation 
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and classification strategy. It was investigated whether the segmentation had 
additional value in obtaining a more reliable classification result. The 
classification strategy was developed such that it calculated a probability of 
classification for each classification result. These probabilities were presented 
image like, to facilitate an easy interpretation in the clinic. Both, the results of 
classification and the results of the probability maps have been evaluated. 
Finally, several feature selection approaches have been tested in their ability to 
condense the data, so as to have the best input for the classification strategy. 
MRI and MRSI basics are presented in Chapter 2, focusing on the role they 
play in the diagnosis of brain tumors. Some processing techniques for MR 
images and MR spectroscopic images are also addressed in this section. In 
Chapter 3, a new preprocessing technique is described based on a standard 
preprocessing method (eddy current correction34), to improve the automated 
preprocessing of MRSI spectra. The application of a semi-automatic unsuper-
vised clustering technique (mclust41) to in vivo MRI and MRSI data of patients 
with a brain tumor is investigated and described in Chapter 4. This clustering 
technique is used to segment the brain. The segments are classified using a 
new classification algorithm. This algorithm, described in Chapter 5, also 
calculates the probability of classification for each segment. Besides, the 
classification and probability of classification of each individual voxel are 
calculated. The two classification images, one from the classified segments and 
one from the classified individual voxels, provide a consensus diagnosis of the 
brain tumor, which is described in Chapter 6. In Chapter 7 several feature 
reduction methods are compared. It is examined which one provides the best 
input to classify brain tumors of different type and grade, normal tissue and 
cerebro-spinal fluid. Next to the comparison of these feature reduction 
methods also the influence of MRI information and the water signal intensity 
is considered. Finally, concluding remarks and recommendations are given for 
future research and researchers. 
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Introduction 
One of the many tangential benefits of the computer revolution has been 
the development of chemometrics, which has been adopted for many 
application in analytical chemistry. Chemometrics uses statistical and 
mathematical methods to unravel chemical problems. As described in various 
textbooks, chemometrics plays a decisive role in process analytical chemistry, 
both in monitoring and control application, and is increasingly used in areas 
such as analyzing images and optimizing molecular structures on the basis of 
their properties and activities1-4. 
Nuclear magnetic resonance (NMR) of molecules in living tissue is a new 
challenge for chemometrics. NMR can be performed as either spectroscopy 
(MRS) or imaging (MRI). MRI is an established medical technique for 
examining different internal organs like the brain, prostate, and heart and is an 
accepted clinical tool for imaging blood vessels and musculoskeletal tissue. 
In particular, MRI is the most useful imaging modality for examining brain 
tumors. Acquiring MR images of representative cross-sectional slices of the 
head to detect and localize a brain tumor is a daily occurrence. One or more 
small tissue samples called biopsies are then removed from the localized 
tumor to determine identity and grade. Depending on the diagnosis, a patient 
next receives chemotherapy, radiation treatment, or undergoes surgery. 
However, a biopsy is far from optimal for the diagnosis of brain tumors 
because it is invasive, subject to sampling errors, and provides no information 
about the tissue heterogeneity of the tumor. Therefore, MRI, MRS, and a 
combination of these techniques called magnetic resonance spectroscopic 
imaging (MRSI) are being developed in clinical trials in the hope of providing 
noninvasive brain tumor diagnosis. 
Here lies the major challenge for chemometrics: No breakthroughs are 
expected in clinical MR examinations of brain tumor patients, because analysis 
and interpretation of the acquired MR data are still the major bottleneck. But 
the combination of MRI, MRSI, and chemometrics may advance the fast, 
noninvasive diagnosis of brain tumors. 
In this feature we will explain some basis elements of MRI and MRSI in 
human brain studies and focus on the possibilities and added value that 
chemometrics can offer the techniques. 
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MRI basics 
In figure 2.1a the spatial distribution of the proton NMR signal of water in 
a cross-sectional tissue slice of the human brain is shown as an image. The 
voxel (volume element) of each pixel in a MR image is ~0.01 cm3. The 
strength of MRI is the possibility it offers the user to manipulate the image 
contrast by varying acquisition parameters. The so-called spin-echo imaging 
technique is used routinely in the clinical environment. It consists of (as any 
other MRI sequence) radio frequency pulses and magnetic field gradients, that 
are applied to a subject placed inside a homogeneous static magnetic field. The 
pulse sequence generates the proton NMR signal, while the gradient sequence 
spatially encodes the proton NMR signal. 
The proton-density (ρ), and the spin-lattice (T1) and spin-spin (T2) 
relaxation times are tissue parameters that determine the NMR intensities of 
the different tissue types. The echo time (TE) and the repetition time (TR) are 
acquisition parameters that determine the ρ-, T1-, and T2-sensitivity of the 
acquired spin echo images. According to equation 1, the signal intensity (S) in 
each voxel can be described to a first-order approximation (i.e., assuming that 
TR >> TE) as: 
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S is heavily ρ-weighted if TR is long with respect to T1 and TE is short 
with respect to T2. S is T2-weighted if TR is long and TE is long, and S is 
T1-weighted if TR is short and TE is long. Thus tissues which differ in ρ, T1, 
or T2 show different intensities in the ρ-weighted, T1-weighted, or T2-weighted 
images. 
In the hospital, the ρ-weighted, T1-weighted, and T2-weighted images are 
commonly acquired with the spin echo technique with different combinations 
of TE and TR. These images are usually combined for the segmentation of 
normal brain tissue, i.e., the discrimination between white matter, gray matter, 
and cerebro-spinal fluid. However, additional feature images are required for 
the segmentation of brain tumors. Usually, a T1-weighted spin-echo image 
after contrast agent administration is added to the standard images. The 
contrast agent shortens the T1 of brain tissue that has a disrupted vascular 
structure as a result of tumor proliferation. 
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Figure 2.1. MR data acquired from a cross-sectional image slice through the 
brain tumor. (a) The MR image shows the proton NMR signal of water and a high spatial 
resolution. The grid indicates the lower spatial resolution of the spectroscopic image. (b) Part of the 
spectroscopic image showing the MR spectra from adjacent spectroscopic voxels in the tumor region. 
Each spectrum shows the proton NMR signal of various metabolites like NAA, Cho, and Cr. 
Understanding MRSI of brain tumors 
Figure 2.1b shows data from a MR spectroscopic image that shows the 
spatial distribution of the proton NMR signal of various metabolites in a 
cross-sectional tissue slice of a human brain. The voxel size in a MR 
spectroscopic image has to be 2-4 cm3 to acquire proton NMR signals of 
metabolites with adequate signal-to-noise ratio. Only metabolites with 
concentrations higher than about 0.1 mM are visible in the MR spectrum. A 
spin-echo based pulse sequence is often exploited during MRSI in 
combination with additional pulses to suppress the large proton signal of 
water and possible fat that would spoil the spectrum5. Proton signals of N-
acetyl-aspartate (NAA), phosphocreatine and creatine combined (Cr), choline-
containing compounds (Cho), and lactate (Lac) can be observed in spatially 
resolved MR spectra. The metabolite levels in tumor and normal brain tissue 
are quite different. For example, the concentration of NAA, a neural marker, 
is low in tumor tissue because of the loss of neuronal cells in tumor tissue. 
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Cho is elevated in tumor tissue because of the increase in membrane synthesis 
and degradation. The Cr signal is reduced or even absent in tumor spectra 
because of the reduced energy metabolism in tumor tissue. Lac is usually 
observed in tumor spectra because it indirectly marks abnormal glycolysis. 
Thus the levels of various metabolites, reflected by the signal intensities in the 
MR spectra, are potential markers for the tumor identity and tumor grade. 
However, the observed signal intensities in the MR spectra may not directly 
reflect the relative concentrations of the metabolites present in the 
spectroscopic voxels. That is, different combinations of TE and TR yield 
different spectral profiles of the spectroscopic voxels because the various 
metabolites have different T1 and T2 relaxation times. Only MR spectra of 
voxels acquired at identical combinations of TE and TR can be compared for 
tissue characterization. Usually, short echo-time or long echo-time spectra are 
acquired. 
The acquisition of short echo time spectra reduces the signal loss due to T2 
relaxation. This means that spectra with higher signal-to-noise are obtained 
and additional resonance peaks of metabolites with short T2 are detected (such 
as myo-inositol, glutamate, and glutamine). On the contrary, broad 
background signal appears in the spectra from macromolecules with short T2. 
Although short echo time spectra provide more biochemical information, they 
are more difficult to analyze and to interpret due to their contamination with 
broad peaks of short T2 macromolecules. 
Diagnosing brain tumors 
MRI and MRSI will irrevocably improve patient diagnosis and patient 
treatment if viable tumor tissue can be distinguished in the images from other 
abnormal non-malignant tissue types within the tumor bed, like necrosis, 
edema, and possibly radiation necrosis and scar tissue. The delineation of 
viable tumor will facilitate noninvasive diagnosis, or will at least guide the 
sampling of biopsies to regions of viable tumor. Moreover, the delineation of 
viable tumor is very important for studying the effect of chemotherapy or 
radiation treatment in time as well as for monitoring patients after surgery. 
Additionally, it helps the radiologist in surgery planning, treatment planning, 
and in the development and evaluation of new treatment strategies. 
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The standard ρ-, T1-, and T2-weighted MR images hardly allow proper 
tissue discrimination within the region affected by the tumor. Contrast agent 
administration enhances the lesion in the MR image where the blood-brain 
barrier is defect. This barrier may be variably affected and the extent of tumor 
tissue may be under- or overestimated in this way. Diffuse regions of 
abnormal tissue outside the enhanced region may still be seen. Moreover, 
combined MRI/MRSI studies have revealed that the contrast-enhanced lesion 
is much smaller than the region of abnormal metabolism6. MRSI studies have 
shown that metabolite levels are highly variable for individual tumors: large 
standard deviations have been found in metabolite levels of one tumor type 
and substantial overlap of metabolite levels between different tumor grades6. 
Other studies showed clear differences between necrosis and other abnormal 
tissue, although these studies are limited by a low spatial resolution6. These 
findings indicate that MRSI and MRI are complementary techniques. 
Chemometrics should facilitate the fusion of morphologic (MRI) and 
metabolic (MRSI) data to improve the delineation of brain tumors. 
The data analysis methodology must quickly process the large stream of 
MRI and MRSI data to ensure continuation in the clinical workup of patients. 
Moreover, it must cope with specific difficulties encountered in the MR data. 
Due to time constraints, spectroscopic images of low signal-to-noise ratio are 
acquired. Furthermore, MR data is gathered under in vivo conditions. A 
patient can move during acquisition and the resulting artifacts may complicate 
the data analysis. In vivo examinations also hamper any form of sample 
preparation to facilitate the data analysis. Therefore, MR examinations of 
brain tumor patients are to a large extent at the mercy of proper data 
processing 
A chemometric methodology will only be accepted in the clinical 
environment if it produces reliable results with minimal user-subjective 
interaction. Laboratory assistants are usually unfamiliar with sophisticated data 
analysis techniques. The simplicity and transparency of the data analysis 
methodology is crucial for its implementation in the hospital. 
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Processing MR images 
Image registration. Image registration, also called image matching, 
compensates for patient movement between the acquisition of different MR 
images during the course of a MR examination. The images to be registered 
may also be from serial MR examinations of a single patient. Serial MR 
examinations are performed to study for instance tumor growth/shrinkage 
after radiation treatment. A suitable registration algorithm should then be able 
to quickly detect the same tissue slice as the one previously measured. 
Precautions are taken to restrict the movement of the head during a MR 
examination of a brain tumor patient. Possible patient movement only results 
in small shifts between different images of the patient, which can be corrected 
for by a simple cross-correlation method7. However, a disadvantage of cross-
correlation methods is their sensitivity to intensity differences in different 
contrast images. In serial brain tumor MR examinations, feature-based 
registration methods can help the radiologist in finding the target position of 
the tissue slice. These methods can perform the alignment of images by means 
of translation, rotation, and uniform scaling transformations. On beforehand, 
proper features are sought in the image for matching which are insensitive to 
changes in tissue and acquisition. These registration points are, for example, 
edges and corners in normal brain tissue regions. Then a suitable algorithm, 
like the Procrustes algorithm, can be used to find the least-squares solution by 
minimizing the distance among all paired points in the two images8. The 
execution time of the algorithm linearly decreases with the number of 
registration points used. Multiscale approaches using wavelets have been 
proposed to increase the computation speed of registration algorithms. Image 
representations on different spatial resolutions allow the sampling of fewer 
registration points sufficient for adequate registration9. 
Removal of non-brain tissue. Image segmentation of brain tissue is 
simplified if non-brain material such as bone, skull, face muscles, and air is 
removed from the images. The removal of these non-brain materials can 
simply be achieved by drawing a region of interest in the image containing 
only brain tissue. A simple algorithm for the automatic removal of skull tissue 
and air is presented in10. The method is based on the construction of a radius 
image of the r-weighted image. The ρ-weighted image is used because it clearly 
shows the transition between brain tissue and skull. The ρ-weighted image can 
subsequently be used as a mask image to remove skull tissue and air from 
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other registered contrast images. Another accepted method for the 
(semi)automatic removal of the skull is based on a multiresolution 
algorithm11, 12. 
Image filtering. Image filtering is particularly applied in brain MR imaging 
of thin tissue slices (thinner than 1 cm). A popular MR image filter is the 
nonlinear anisotropic diffusion filter13, 14. This filter improves the signal-to-
noise ratio without blurring of the fine structural details in the image. 
Field inhomogeneity correction. Magnetic field inhomogeneities 
decrease the digitized signal amplitude (pixel intensity) of a voxel in a MR 
image. An inhomogeneous static magnetic field (B0) of the scanner broadens 
the water resonance peak because the resonance frequency is proportional to 
the strength of the applied magnetic field. This results in a decrease in pixel 
intensity. Usually, the spatial inhomogeneity of this field is negligibly small. 
However, the spatial inhomogeneity of the rf magnetic field (B1) produced 
by the coil surrounding the head may be significant. The coil is used to excite 
the proton spins and to receive the proton signal of a selected tissue slice. 
Regional field strength differences inside the coil are caused by 
inhomogeneities in rf coil sensitivity and rf transmission. The non-uniform 
excitation and reception profiles of the coil yield non-uniform intensity 
variations across the image. The image non-uniformity depends on the coil 
design, slice orientation, pulse sequence, and patient. It appears as a low spatial 
frequency component in the image and is commonly removed by two-
dimensional low-pass filtering. 
An experimental method to correct for image non-uniformity is to image a 
uniform sample with the head coil15. The correction coefficients for producing 
uniform intensity images of the sample are stored and are subsequently 
applied to the brain MR images. An important disadvantage of this method is 
that the rf penetration through the sample is not the same as through the 
patient being imaged. A promising method for inhomogeneity correction is 
based on the acquisition of two identical images under different flip angle16. 
However, this method demands the acquisition of a second image, which 
takes some valuable acquisition time. 
Multivariate image segmentation. A multivariate image consists of a 
series of MR images of the same tissue slice, e.g., ρ-weighted, T1-weighted, 
and T2-weighted MR images. Segmentation means dividing a multivariate 
image into regions of different tissue types. Multivariate image segmentation 
 Better Brain Imaging with Chemometrics 
 33 
starts after removal of non-brain tissue and, if necessary, after image 
registration, field inhomogeneity correction, and image noise removal. 
The simplest use of multivariate image segmentation is to combine two 
registered MR images. For each pixel, the intensity in one image is plotted 
against the intensity in the other image to define a two-dimensional (2D) 
variable or feature space. Image segmentation is achieved by defining regions 
in the 2D feature space corresponding to the different tissue types. In case 
three registered images are involved, a 3D feature space can be defined in 
which the different tissue types are located at different positions. This 
approach becomes, however, more difficult if more than three registered 
images need to be combined. The lack of visual inspection complicates the 
isolation of different clusters, corresponding to different tissue types, in the 
multidimensional feature space. Pattern recognition techniques have been 
exploited to deal with this problem. Pattern recognition is an important area 
of chemometrics. 
Principal Component Analysis (PCA) is the most popular technique in the 
field of chemometrics, which has been utilized in the visualization of 
multivariate image data17. PCA transforms a set of registered MR images to a 
new set of abstract images, called the PCA score images, in such a way that the 
image contrast information is condensed into the first few PCA score 
images18. By defining a 2D feature space defined by the first two PCA score 
images, an expert can delineate the different tissue regions in this 2D plot 
based on 80-90% of the information present in the set of MR images.  
However, due to possible field inhomogeneities and the partial volume 
effect, i.e., the mixing effect of multiple tissue types within one voxel, no 
distinct groups of pixels appear in the 2D PCA score plot. In fact, no 
dedicated technique to date is able to reduce the dimension of multivariate 
MR images in such a way that distinct tissue clusters can be visualized. 
Therefore, supervised or semi-supervised pattern recognition methods, such 
as discriminant analysis, neural networks, fuzzy clustering methods, and 
k-nearest neighbors have been applied to the segmentation of multivariate 
images. However, these methods may also produce misleading segmentation 
results because of the subjectivity of the user input. Therefore, PCA is still a 
valuable tool for visualizing and exploring multivariate images. 
Linear discriminant analysis (LDA) is the best-known technique for 
supervised pattern recognition. LDA utilizes a subset of pixels of known tissue 
type, a training set, to calculate a classification model. It maximizes the ratio of 
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the between-class variance and the within-class variance of the tissue classes 
present in the training set using linear combinations of the original MR 
images. The calculated discriminant axes (lds), linear combinations of the MR 
images, discriminate between the tissue classes defined in the training set. The 
first discriminant axis (ld1) has the largest discriminative power, the next 
discriminant axes show less discriminative power with increasing ld number. 
The use of LDA in multivariate image segmentation is illustrated in figure 2.2. 
 
Figure 2.2. LDA applied to the segmentation of a multivariate image. (a) 
Discriminant scores of the training pixels for white matter, gray matter, cerebrospinal fluid, and 
tumor in the ld1-ld2 score plot. (b) Discriminant scores of all pixels in the same ld1-ld2 score plot. 
(c) Classification of all pixels based on the Euclidean distance: the shortest distance to a class center 
determines the class membership of the pixel. (d) Classification of all pixels shown in the 
corresponding image domain. The tissue classes are color-coded: white is tumor, light gray is 
cerebrospinal fluid, gray is gray matter, and dark gray is white matter. 
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As in any supervised or semi-supervised segmentation technique, the 
training pixels need to be selected by a human interpreter. Different operators 
will select different training sets (inter-observer variations) at different times 
(intra-observer variations), resulting in different segmented images or tissue 
maps. A radiologist has to assess the quality of these calculated tissue maps 
because there is no definitive method (ground truth) that can verify the 
segmentation results, which is a fundamental problem in medical image 
processing. Therefore, segmentation performance is usually determined by the 
stability of the applied method, i.e., its sensitivity to operator input, and not by 
the accuracy of tissue volume estimation. Several studies have shown that the 
segmentation of brain tumors strongly depends on method and training data 
19-21. The major challenge is to develop novel multivariate segmentation 
techniques that minimize operator input but are robust enough to withstand 
small variations in input. 
Processing MR spectroscopic images 
Eddy current correction. Switching magnetic field gradients induces small 
currents in the magnet system, called eddy currents. These time dependent 
currents disturb the field homogeneity and cause time dependent frequency 
shifts of the resonances in the selected voxel. This results in a distortion of the 
spectrum after Fourier transformation of the time signal (echo). Unlike MRI, 
MRSI suffers from eddy currents because of the low signal intensity of the 
metabolite resonances. Therefore, to remove eddy current distortions, both 
water-suppressed and water-unsuppressed MRSI images of a selected tissue 
slice are acquired in a single examination, as shown in figure 2.3a.  
For each voxel, eddy current correction is accomplished in the time domain 
by dividing the water-suppressed signal by the phase factor of the water signal 
for each data point (the influence of metabolite protons in the water-
unsuppressed MRS image is negligible)22. Figure 2.3b demonstrates a spectrum 
corrected for eddy currents that is aligned in phase and in spectral position to 
the water resonance peak within the voxel. 
Residual water filtering. The eddy current corrected MR spectrum in 
figure 2.3b still contains a residual water peak. Filtering of this intense peak is 
usually done with a Hankel Lanczos Singular Value Decomposition 
(HLSVD)23. The first few singular values account for the intense water 
resonance and are subtracted from the spectrum. The algorithm is applied in 
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the time domain to be able to remove the long tails of the water peak 
overlapping with some metabolite peaks in the spectrum. The result of 
residual water filtering of the MR spectrum in figure 2.3b is shown in 
figure 2.3c. 
 
Figure 2.3. (a) water-suppressed in vivo MR spectrum acquired from a voxel in the human 
brain. (inset) Water-unsuppressed spectrum from the same voxel. Water suppression is accomplished 
by using additional rf pulses to saturate the water resonance. (b) After eddy current correction of (a), 
demonstrating that the metabolite peaks are phased with the phase of the water peak. (c) After 
filtering the residual water peak at 4.7 ppm of (b). 
Phase and frequency shift correction. Small phase differences between 
metabolite peaks in the MR spectrum remain after eddy current correction. 
These remaining phase shifts are frequency-dependent (first-order) phase 
shifts. Phase correction is performed to obtain complete absorption-mode 
spectra, which simplify interpretation and analysis of the spectra. MR 
instruments are standard equipped with interactive phase-correction facilities. 
However, fast and automatic phasing is desirable for processing the large 
number of spectra and for obtaining unbiased results. 
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Frequency shifts, or peak shifts between spectra of different voxels may 
also distort further analysis of the spectra. Although frequency shifts induced 
by the spatial inhomogeneity of the rf field are removed after eddy current 
correction, they may be induced by patient movement between the acquisition 
of water-unsuppressed and water-suppressed MRSI data. Patient movement 
changes the coil loading and as a result changes (deteriorates) the spatial 
homogeneity of the rf field inside the coil. A novel method has recently been 
developed for removing quickly phase shifts and frequency shifts across a 
large series of single resonance peaks24. The method performs well on noisy 
and distorted MR spectra acquired under in vivo conditions. 
Pattern recognition. After preprocessing, MR spectra can be classified 
according to their tissue identity. It is impossible to categorize the processed 
MR spectra with respect to tissue identity by visual inspection of the data, 
which makes pattern recognition methods indispensable. These methods 
cluster the spectra on their mutual characteristics. 
Selecting spectral features that provide the best discrimination are 
important considerations when designing a pattern recognition model. For the 
pattern recognition of brain MR spectra, the estimated levels of metabolites 
are used rather than the complete spectrum. The relative levels of NAA, Cho, 
and Cr are derived from long echo time spectra by curve fitting routines. 
These estimated levels considerably reduce the dimension of the input data of 
the pattern recognizer. Moreover, spectral noise is omitted in the pattern 
recognition. 
Metabolite levels from short echo time spectra are much harder to 
estimate. Short echo time spectra are contaminated with broad peaks of non-
relevant macromolecules which distort the classification performance. The 
fitting of short echo time spectra is usually done in the time domain. An 
important advantage of time domain fitting is that complicated model 
functions can be used to improve the fitting of short echo time spectra. For 
example, the useful Voigt function can only be approximated in the frequency 
domain or must be calculated by numerical integration25. Nonlinear iterative 
methods, such as the Levenberg-Marquardt algorithm26, are preferably utilized 
in spectral fitting. These methods allow any mathematical form of the model 
function, like the Voigt function. 
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Moreover, prior knowledge of, for example spectral position and relative 
amplitudes can be incorporated in the model function and improve the 
quantification of resonance peaks27. Recently, novel quantitation methods 
have been developed which operate on complete series of MR spectra instead 
of on each separately24,28-30. These have been proposed for the fast and 
accurate quantitation of resonances in series of relatively simple in vivo MR 
spectra. 
Figure 2.4a demonstrates the pattern recognition of a spectroscopic image 
of a patient with a brain tumor. Two of the MR spectra acquired from the 
patients brain are plotted in figure 2.4b. The six resonance peaks labeled in the 
spectra were quantified and subsequently normalized to the unsuppressed 
water signal within the voxel. These normalized quantified peaks define the 
input vector for the pattern recognizer.  
 
Figure 2.4. (a) Background: Gd-enhanced T1-weighted MR image of a brain tumor. 
Foreground: Grid of spectroscopic voxels. The symbols indicate the group membership of each 
spectrum, as determined with hierarchical cluster analysis. (b) Two of the MR spectra of the 
spectroscopic image, belonging to two different groups. The left one originates from a healthy region, 
the right one from a malignant region. 
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The MR spectra, as represented by the aforementioned input vectors, could 
roughly be divided into four different groups, which was performed by means 
of hierarchical clustering. The result of the hierarchical clustering analysis is 
plotted as a dendrogram in figure 2.5. Hierarchical clustering merges the 
individual samples into groups, which are subsequently merged until only one 
group remains. The merging of the samples is based on the distances between 
the input vectors, which can be the Euclidean distance. Selection of the 
number of groups is performed by setting a threshold which cuts the 
dendrogram. 
 
Figure 2.5. Hierarchical clustering of MR data. The data of the patient depicted in 
figure 2.4a. is used. The symbols on the left of the figure correspond with the symbols used in figure 
2.4a. The horizontal axis represents the Euclidean distance. 
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PCA and LDA can also be used to cluster the MR spectra of different 
patients with brain tumors. These methods also use the six quantified 
resonances as input. With PCA, a set of linear combinations of the quantified 
peaks, called the principal components, is constructed in such a way that as 
much as possible variation is squeezed in as few as possible new variables 
(PCs). The PCA score plot defined by the first two PCs yields a visualization 
of the spectra, which is based on a large part of the total information. With 
LDA a set of linear combinations of the quantified peaks, called the 
discriminant functions, is constructed which have the highest possible 
discrimination power among the classes of spectra defined on beforehand. 
The LDA model is biased by the labeling of the spectra by the investigator. 
The application of LDA to MRSI data is problematic because accurate 
histological characterization of all spectroscopic voxels is often impossible. 
Thus, overall, a reliable discrimination among brain tumors based on MRSI 
has yet to be accomplished, although progress has been made31. Some clinical 
trial studies involving multiple sites have attempted to combine MRSI and 
MRI data to improve tumor discrimination. 
Prospects of combining MR images 
On one hand, MR spectroscopic imaging provides metabolic information 
on a low spatial resolution; on the other hand, MR imaging provides 
morphological information on a high spatial resolution. The combination of 
MR imaging and MR spectroscopic imaging improves the MR characterization 
of brain tumors. The levels of metabolites differ in different parts of the brain. 
For example, the MR spectra of normal (left) and malignant tumor (right) in 
figure 2.4b clearly show differences. In addition, several studies have 
demonstrated that levels of NAA, Cr, and Cho differ between white matter 
and gray matter and may be affected by the contribution of cerebrospinal 
fluid32-34. Therefore, to classify the spectra accurately, the MR spectra must be 
normalized to the tissue composition within the spectroscopic voxel. 
 Better Brain Imaging with Chemometrics 
 41 
Classifying the MR spectra on the basis of the estimated metabolite levels 
and the fraction of white matter, gray matter, cerebrospinal fluid, viable tumor, 
and necrosis within the spectroscopic voxel may be the best approach. In this 
way image and spectroscopic data are merged into one classifier or pattern 
recognizer. Several groups are developing an overall classifier of MR image 
and spectroscopic data35. Such a classifier is also being developed at the 
University Medical Center Nijmegen, the Netherlands. 
The measurement protocol involves the acquisition of the standard 
ρ-weighted, T1-weighted, and T2-weighted spin echo images, a T1-weighted 
spin echo image after contrast agent administration, a so-called relative 
regional cerebral blood volume (rCBV) image, and a short echo time 
spectroscopic image. The five MR images define a multispectral or 
multivariate image in which each pixel (image element) is characterized by its 
pixel intensities in the five MR images. 
The multivariate image will be segmented into regions of white matter, gray 
matter, cerebrospinal fluid, viable tumor, and necrosis. Hopefully, patients will 
benefit from advanced evaluation and treatment by combining the segmented 
image with the spectroscopic image to improve the demarcation of the brain 
tumors from healthy tissue and the delineation of tissue heterogeneity within 
the tumor bed. 
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Abstract 
A commonly applied step in the postprocessing of gradient localized 
proton MR Spectroscopy, is correction for eddy current effects using the 
water signal as a reference. However, this method can degrade some of the 
metabolite signals, in particular if applied on proton MR Spectroscopic 
Imaging data. This artifact arises from the water reference signal in the 
presence of a second signal which resonates close to the main water 
resonance. The interference of both resonances will introduce jumps in the 
phase of the reference time domain signal. Using this phase for eddy current 
correction will result in a ringing artifact in the frequency domain of the 
metabolite signal over the whole frequency range. 
We propose a moving window correction algorithm, which screens the 
phase of reference signals and removes phase jumps in time domain caused by 
interference of signals from multiple spin systems. The phase jumps may be 
abrupt or gradually distributed over several time data points. Because the 
correction algorithm only corrects time data points which contain phase 
jumps, the phase is minimally disrupted. Furthermore, the algorithm is 
automated for large datasets, correcting only those water reference signals 
which are corrupted. After correction of the corrupted reference signals, 
normal eddy current correction may be performed. The algorithm is compared 
with a method which uses a low-pass filter and tested on simulated data as 
well as on in vivo proton spectroscopic imaging data from a healthy volunteer 
and from patients with a brain tumor. 
 
Keywords: Magnetic Resonance Spectroscopic Imaging, eddy current 
correction, data processing, reference deconvolution, artifact.  
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Introduction 
In proton magnetic resonance spectroscopy, eddy current correction 
(ECC)1-5 is a standard correction method6 which requires a metabolite signal as 
well as a reference signal. In in vivo MR studies, the reference signal normally 
consists of the unsuppressed water signal. Theoretically, ECC corrects for 
time dependent eddy current phase effects in the free induction decay (FID). 
Besides, it resets the zero-order phase and resets the water frequency to 0 Hz. 
However, ECC may lead to a severe ringing artifact in the metabolite 
spectrum7-9 if the envelope of the water reference time domain signal crosses 
zero, causing the phase of the water reference signal to flip 180 degrees at a 
specific time point. The zero crossing of the envelope may occur because the 
single water reference peak has acquired some doublet character because of 
poor shimming or due to susceptibility effects7,9. Generally, these artifacts 
appear more frequently in magnetic resonance spectroscopic imaging (MRSI) 
data than in single voxel data because of the much larger volume of interest. 
In addition, signals with slightly different water frequencies originating from 
different voxels in the MRSI dataset may be mixed as a result of the point 
spread function10. The eddy current division will introduce the 180 degree 
phase jumps into the metabolite time domain signal, causing severe ringing in 
the frequency domain after Fourier transformation. 
A solution to this problem has been presented by Wild7, who used low-pass 
filtering of the total phase of the water reference time domain signal to 
remove unexpected phase jumps. They tested the efficiency of two low-pass 
filters, an infinite impulse response Butterworth filter and a finite impulse 
response filter. The Butterworth filter was found to be more effective. 
This paper also deals with the implementation of a correction algorithm 
which detects phase jumps in the phase of reference time domain signals, but 
instead of filtering the whole phase our algorithm has a local nature. It 
searches for specific features in the magnitude and the phase of the reference 
time domain signal, and only corrects time points when specific conditions are 
met. The advantages of our method are; (a) only the time points at a phase 
jump are altered; (b) reference signals which do not contain phase jumps 
remain unchanged and therefore the correction algorithm can be applied on 
large datasets like MRSI data, and (c) the correction algorithm identifies abrupt 
changes as well as more gradual distributed transitions, which also induce 
ringing in the frequency domain of a metabolite signal. 
Chapter 3 
48 
In order to validate the correction algorithm, we tested it on simulated data, 
compared it with the filter described by Wild7 and used it to screen brain 
MRSI datasets of a volunteer and several patients with a brain tumor. In 93% 
of the cases the unwanted phase jumps in the reference time domain signal 
were identified by our method, resulting in substantial improvement of the 
metabolite spectrum after ECC.  
Theory 
Eddy current correction. The theory of ECC has been frequently 
described in literature1-5, 8 and will therefore be discussed concisely. To 
perform ECC, the metabolite time domain signal is point-wise divided by the 
phase factor of the reference signal in the time domain. Practically, the phase 
of the reference signal is calculated by taking the arctangent of the quotient of 
the imaginary and real part of each time point. 
The correction only holds when the reference signal contains a single 
dominant component. If this is not the case, one should use other techniques 
like described by9. However, in the correction of large sets of data, as in MRSI, 
which only contain few reference signals with some doublet character, ECC is 
still very effective. Correction of the largest artifact introduced in the 
metabolite spectrum, i.e. the ringing due to phase jumps in the phase of the 
reference time domain signal, ensures that the metabolite spectrum can still be 
of use. 
The ringing artifact. The origin of the ringing artifact is explained in 
figure 3.1. As an example we have simulated a metabolite and two reference 
signals. The metabolite signal contains two resonances. The first reference 
signal contains one resonance and the second two. These two resonances are 
close together, in order to simulate a water reference signal with some doublet 
character. Information about the signals can be found in table 3.1. 
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Figure 3.1. Example of ECC and the ringing artifact. Parameters for the simulated 
data can be found in table 3.1. (a) Magnitude of the simulated reference time domain signal 
containing 1 resonance. (b) Phase of this reference signal. (c) Frequency domain of the simulated 
metabolite spectrum. (d) ECC-corrected metabolite spectrum. The zero-order phase is corrected and 
the two resonances are shifted 10 Hz to the left. (e) Magnitude of the simulated reference signal 
containing 2 resonances. (f) Phase of this reference signal. The phase jumps are gradually distributed 
but will nevertheless introduce ringing in the metabolite spectrum (g) when ECC is performed (h). 
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The left column in figure 3.1 gives an example if the reference signal only 
contains 1 resonance. Figure 3.1a and b show the magnitude and phase of the 
reference time domain signal. Both magnitude and phase do not show any 
irregularities. When the phase is used to perform ECC on the metabolite 
signal (figure 3.1c), this results in a phase corrected spectrum (figure 3.1d) 
which has shifted 10 Hz to the left due to the offset frequency of the 
reference to the detector. 
In the right column of figure 3.1 the same metabolite spectrum is used 
(figure 3.1g), but in this situation the reference signal contains two resonances 
which are only 3 Hz apart. Because of interference, the magnitude (figure 3.1e) 
of the reference signal shows beats at specific points in time domain. The 
phase of the reference signal contains phase jumps which are gradually 
distributed and not exactly 180 degrees, because the amplitudes A1 and A2 are 
not the same (figure 3.1f). ECC of the metabolite FID with the phase of this 
reference signal will introduce severe ringing in the spectrum (figure 3.1h). 
This ringing is asymmetrical around the tops of the resonances, because the 
phase jumps are distributed over a certain number of points. If the phase 
jump occurs over one time point the ringing is symmetrical, but in practice 
this hardly ever occurs. 
 
Table 3.1.  Parameters for the simulated data presented in figure 3.1a 
 
metabolite 
signal 
reference 
signal 1 
reference 
signal 2 
ω1 100 10 10 
ω2 185  13 
d1, 2 (Hz) 8 6 6 
Φ1, 2 (O) 35 35 35 
A1 (a.u.) 1 95 50 
A2 (a.u.) 2  45 
a Each  signal is constructed using the following equation: 
nkkkk k
tidiAFID )2exp()360/2exp( πωππ +−∗Φ∗= ∑ , with Ak the amplitude, Φk the phase, dk 
the damping and ωk the frequency of resonance k. tn is the time instance. 
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Outline of the correction algorithm. To remove the jumps in the phase 
of the reference time domain signal, we have developed a correction algorithm 
which moves along it, correcting it if certain conditions are met. If one of the 
conditions fails, the reference signal is not changed. A flow-chart of the steps 
in the correction algorithm is presented in figure 3.2.  
Step a: if the reference signal contains two interfering resonances, its 
magnitude will contain one or more minima. Normally only one minimum 
occurs in the signal-containing part of the magnitude of the FID. However, if 
necessary it is possible to search in a successive way for more minima and 
investigate if the phase at that point also needs a correction. Each minimum 
can be found by searching for a change in the sign of the first derivative of the 
magnitude signal from negative to positive. Reference signals from in vivo 
experiments normally have a large signal to noise ratio, therefore finding a 
zero crossing in the first derivative is straightforward. If the signal is noisy, 
smoothing of the magnitude can be applied. 
Step b: a minimum in the magnitude must coincide with a sigmoidal shape 
in the phase of the reference signal. This shape can be found in the first 
derivative of the phase, by searching for a successive number of data points 
which are above or below the baseline. 
Step c: the location of the minimum in the magnitude is compared to the 
location of the sigmoidal shape. They have to be at the same time point. If 
there is no minimum, no sigmoidal shape or the two do not coincide, then 
there is no phase jump due to interference and the correction algorithm is 
aborted. 
Step d: to find the beginning and the end of the phase jump, the first 
derivative of the phase is fitted to a model function (e.g. Gaussian). This can 
be done in a robust way, because the position and maximum are known and 
the width is rather small for phase shifts which corrupt the metabolite 
spectrum after ECC. There is no theoretical basis for fitting to a Gausssian, 
but in practice this works fine.  
Step e: from the fitted first derivative of the phase, the beginning and the 
end of the part of the phase which needs to be corrected can be found. The 
first point of this region can be found by subtracting twice the FWHM from 
the x-value belonging to the maximum of the first derivative of the phase. The 
last point is found by adding twice the FWHM to the x-value belonging to the 
maximum. The factor of two ensures that all corrupted points are corrected. 
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Figure 3.2. Flow-chart of the correction algorithm 
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Step f: the slope of the phase at the start and end point is set equal and is 
approximated by taking the offset of the fitted first derivative. This slope is 
used to plot two lines (L1 and L2) which are parallel and go through the begin 
and the end point. The part of the phase after the end point is corrected by 
adding the difference of the intercepts of L1 and L2 for each point. 
step g: finally, the part between the begin and the end point is interpolated, 
resulting in a straight line with the slope of L1 between these points. This part 
of the phase is approximated and replaces the incorrect sigmoidal shape. 
If one of the steps a to d fails, the original phase of the reference signal will 
be used. This ensures that only appropriate corrections are performed. 
Although the correction algorithm is assumed to be robust for data acquired 
using several acquisition protocols (e.g. PRESS, STEAM), some parameters 
have to be checked and adjusted. The phase of the reference signal may 
become noisy when the magnitude approaches zero. Correcting it in this part 
of the signal will become difficult, but is also not necessary because it is more 
probable that a phase jump in that area is introduced due to the noise in the 
signal than due to interference of resonances. Therefore we only screen the 
phase of the reference signal until its magnitude has decreased to 1 percent of 
its maximum. A second parameter which can be adjusted concerns the 
maximum width of the fitted model function in step d of the correction 
algorithms design. When the width increases, the total number of time data 
points which are interpolated will also increase. This may prevent a good 
correction. Furthermore, a large width of the fitted model function indicates a 
slowly changing phase, which will not introduce ringing. Therefore, a 
maximum should be set for this parameter. If the fitted model function 
exceeds this maximum, the correction algorithm is not triggered. For our in 
vivo data we found a width of 40 ms to be convenient. 
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Experimental 
In order to compare our algorithm with the filter implemented by Wild, we 
copied his simulated data, which consisted of the metabolite and reference 
signals listed in table 3.2. 
In addition, water suppressed and unsuppressed 2D 1H MRSI datasets of 
the human brain were acquired from one healthy volunteer as well as from 
patients with a brain tumor. The measurements were performed on a 1.5 T 
Siemens Vision whole body MR system, with the following parameters: 16x16 
matrix size, STEAM volume pre-selection and outer volume suppression, a 
repetition time of 2500 ms, an echo time of 20 ms, a slice thickness of 15 mm 
and a field of view of 200 mm. The number of time points sampled was 1024 
with a dwell time of 1 msec. 
 
Table 3.2. Parameters for the simulated data presented in figure 3.3a 
 metabolite signal reference signal 
ω1 (Hz) 8.1 8.1 
ω2 (Hz) 97.3 16.2 
ω3 (Hz) 110.6  
ω4 (Hz) 176.0  
d1 (Hz) 22.2 2.2 
d2, 3, 4 (Hz) 3.2 2.2 
Φ1, 2, 3, 4 (O) 0 . 0 . 
A1 (a.u.) 20 . 1000 . 
A2, 3, 4 (a.u.) 2 . 1000 . 
a For explanation of the parameters we refer to table 3.1. 
 
The acquired metabolite- and reference- data were first Fourier 
transformed in the direction of the spatial axes only. Mild Hamming 
smoothing was applied prior to Fourier transform to lower the ripple effect10 
introduced by the point spread function. 
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Only mild smoothing was used to prevent significant broadening of spatial 
structures. Before ECC, all reference signals within the STEAM box of each 
MRSI dataset (~80 time domain signals) were automatically screened and 
corrected for phase jumps -if present- as described. After ECC of all 
metabolite signals, the residual water in the metabolite signal was removed. 
This was performed by HLSVD filtering11 of a region between 4.3 and 5.1 
ppm in the spectrum, with 10 singular values. The HLSVD filtering enables a 
better comparison of the relevant part of the spectrum. Finally, each 
metabolite time domain signal was Fourier transformed to get 1H MR spectra. 
Results and Discussion 
 The use of our correction algorithm on the simulated data (table 3.2) 
and the comparison with the one Wild presented is visualized in figure 3.3. 
The phase of the reference signal, which is plotted in figure 3.3a, shows 8 
phase jumps. When this phase is used to perform ECC on the metabolite 
signal, the result is a heavily corrupted spectrum (figure 3.3b). In figure 3.3c, 
the corrected phase using our correction algorithm is shown (dotted line). The 
jumps in the corrected phase are totally removed, except for the two last ones. 
At that location the amplitude of the FID magnitude is below 1% of its 
maximum, causing the moving window algorithm to stop. After ECC of the 
metabolite signal, this results in a virtually uncorrupted spectrum (figure 3.3d). 
The effect of low-pass filtering the phase of the reference signal using Wilds 
method is presented in figure 3.3e. The phase steps have been removed 
effectively (dotted line), although a delay has been introduced and the phase is 
curved at the first 200 points. The resulting spectrum after ECC (figure 3.3f) is 
much better than the original, but still some artifacts are visible at the base of 
the peaks. Wild has shown that mild smoothing of the frequency domain will 
effectively remove the artifacts at the base. 
In in vivo MRSI data, the moving window correction algorithm was found 
to be very effective and robust in correcting data in batch mode. In one 
volunteer and several patients, the screening resulted in correction of up to 
10% of the reference signals. Of this 10%, some of the reference signals are 
erroneously corrected due to supposed phase jumps in the last (noisy) part of 
the phase. However, these erroneous corrections are not harmful, because 
they occur in the noise. 
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Figure 3.3. Comparison of ECC corrected simulated spectra. When the non-
corrected phase in (a) is used, the metabolite spectrum is heavily corrupted (b). When the phase is 
corrected with our algorithm (dotted line in c), the metabolite spectrum (d) is virtually uncorrupted. In 
(f) the metabolite spectrum after correction with the phase filtered by Wilds method (dotted line in e) 
is shown.  
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In figure 3.4 an example is given of one corrected time domain signal from 
the volunteer. Figure 3.4a and b show the magnitude and phase of the 
reference signal. Figure 3.4c shows the ECC-corrected metabolite spectrum if 
the phase shown in figure 3.4b is used. Ringing is especially visible in the 
residual water signal, but is present over the whole frequency range. In figure 
3.4d, the first derivative of the phase is plotted together with its fitted function 
(dotted). Information from the fit is used to correct the phase of the reference 
signal as described (figure 3.4e), and this phase is used for ECC of the 
metabolite signal. The resulting ECC-corrected metabolite spectrum is plotted 
in figure 3.4f and is virtually free of ringing. 
 
 
Figure 3.4. Example of the application of the correction algorithm on MRSI 
data from a volunteer. (a) Magnitude and (b) phase of the reference time domain signal. (c) 
The metabolite spectrum after ECC correction with the phase shown in (b). (d) The first derivative of 
the phase locally fitted to a model function. (e) Correction of the phase as explained in the theory 
section. f) The metabolite spectrum after ECC correction with the corrected phase. 
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Figure 3.5 gives examples of corrected spectra from which the water 
residual has been removed by HLSVD. The upper spectrum of each subplot 
has been ECC-corrected with the uncorrected phase of the water reference 
signal. In the middle of a subplot, spectra are depicted which have been 
corrected by our method. It is clearly visible that; a) in the uncorrected cases a 
lot of residual water remains after removal of the water resonance by HLSVD; 
b) The metabolic resonances in the corrected spectra have narrower lineshapes 
and have higher amplitudes, since line broadening by ringing is removed, and 
c) in cases of severe ringing or low signal to noise ratio some resonances are 
completely flooded in the uncorrected case, thus making it impossible to 
quantitate these resonances in the frequency domain12. Also quantitation in the 
time domain13 will be difficult, because the metabolite FID contains an 
unexpected phase jump. The lower spectrum of each subplot shows the 
corrected spectrum using Wilds filter. After manually setting the filter 
parameters, it performs under visual inspection equally well as ours. 
 
Figure 3.5. Examples of spectra. (a) from a volunteer and (b, c and d) several patients. 
The upper spectrum is ECC-corrected without correcting the phase of the reference signal, the middle 
spectrum is ECC-corrected using the presented correction algorithm, the lower with Wilds filter.  
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Robustness of the correction algorithm is based on the fact that reference 
signals are only corrected when they satisfy three criteria; a) a local minimum 
in the magnitude reference signal; b) a sigmoidal shape in the phase of the 
reference signal, and c) the possibility to fit a model function through the first 
derivative of the phase with a low error and a relatively small width. When one 
of these criteria is not met, it is assumed that correction is not needed. Next to 
robustness, these criteria also ensure that only phase jumps caused by two 
interfering resonances are corrected, therefore the algorithm can be applied on 
large datasets. 
The algorithm also takes the steepness of the phase jump in the reference 
signal into account; when the discontinuities in the magnitude and phase are 
large (and ringing is severe), they are easily detected. If the discontinuities are 
more gradual, they will be more difficult to correct, but this is not a problem 
because the ringing will be less. 
Conclusion 
We have presented a method to locally remove jumps in the phase of water 
reference time domain signals. The removal of these jumps prevents the 
metabolite signal to become corrupted after ECC by severe ringing, which 
may completely obscure all resonances. The correction algorithm only corrects 
specific regions of the phase and is able to do so for sharp as well as gradually 
distributed transitions, which both can occur if the water reference obtained 
some doublet character. 
In contrast to low-pass filters, our method uses features within the 
reference time domain signal which are related to the artifact. Using these 
features ensures a robust correction and enables the application of the 
algorithm in an automated manner on large datasets like MRSI, because only 
reference signals which need to be corrected are changed. Moreover, taking 
into account these features may prevent erroneous corrections of phase jumps 
which were induced by eddy currents. 
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Abstract 
In clinical decision making, (semi-)automatic unsupervised classification of 
data for diagnostic purposes is becoming more and more important. The 
paper describes the application of mixture modelling, a clustering where 
multivariate gaussians are used to describe clusters in the data, to in vivo 
nuclear magnetic resonance data of patients with brain tumors. Images as well 
as localized spectra are analyzed. The method is able to automatically generate 
meaningful classifications. Moreover, the results of clustering both the image 
and spectral data are in close  agreement. 
Keywords:  model-based clustering, image segmentation, MRI, 1H-MRSI, 
brain tumor, classification 
Introduction 
Nuclear magnetic resonance imaging (MRI) has become one of the most 
important non-invasive diagnostic aids in clinical decision making, mostly 
because of the good visibility of soft tissue structures. In the diagnosis and 
treatment of brain tumors, this is of prime importance since it enables the 
expert to assess location and size of brain tumors. Single images, however, do 
not always show the desired information and therefore multiple, 
complementary images are routinely recorded. Although increasing the 
amount of information, this may hamper diagnosis since radiologists have to 
investigate multiple images. Therefore, (semi-)automatic methods extracting 
the relevant features of the images can be of great benefit. Several methods for 
distinguishing structures in the brain (segmentation) and labeling of these 
structures have been described in literature1-3. 
A second and potentially even more powerful use of NMR is to record 
spectra from specific volumes in the brain (usually called proton-magnetic 
resonance spectroscopic imaging, 1H-MRSI). These volumes are cubes of 
typically 2 cm3, called voxels4. The spectra, containing  information about 
specific ratios of brain metabolites, can be used to accurately determine the 
type of tissue in the voxel. Again, automatic or semi-automatic processing of 
the data can be of tremendous importance. In this paper, an automatic 
method for the unsupervised classification of both MRI and 1H-MRSI data is 
described using mixture modelling. The results of the clustering of both types 
of data show good agreement. 
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Mixture modelling is an approach to clustering where the data are 
described as mixtures of distributions, usually multivariate normal 
distributions5, 6. Each gaussian can be considered as one cluster, or a cluster 
with a non-normal shape can be described by two or more gaussians. Several 
advantages to model-based clustering over other, more common forms of 
clustering can be identified: 
The clustering has a statistical basis, which allows for inference. It is, e.g., 
possible to derive uncertainty estimates for individual classifications, as well as 
for the clustering as a whole. 
Several criteria can be used to assess the optimal number of clusters, a 
direct consequence of the statistical model used to describe the data. This is a 
large advantage compared to, e.g., hierarchical clustering methods, where a 
cut-off value must be chosen by the user. In most cases, no clear criteria exist 
for such a choice. 
The clustering method can be selected according to the same criteria used 
for the choice of the number of clusters. As is the case in hierarchical 
clustering, several closely related clustering methods exist, and the one that fits 
the data best can be distinguished in an objective way. 
Noisy objects can be explicitly incorporated in the clustering procedure; 
these objects are then treated as one separate, widely spread cluster polluting 
the neat grouping of the other objects. In the current application, this feature 
is not used. 
Visualization of the cluster shapes is possible in the space of the original 
variables. In some cases, this allows for an easier interpretation of the results; 
e.g., in the current application, neurologists can use domain knowledge to label 
the different clusters. 
Mixture modelling has been applied to a wide variety of clustering 
problems (for an overview, see5), including image segmentation of MRI brain 
images of healthy volunteers7. In this paper, mixture modelling is applied to 
two types of data sets obtained from five patients with a brain tumor. The first 
type consists of MRI images of the brains of the patients. The second type of 
data consists of levels of a small set of metabolites, quantitated in 1H-MRSI 
data. Although the tumors in many cases can be recognized from the raw data, 
either the MRI images, or the spectra recorded in the separate voxels, an 
automatic unsupervised segmentation is very useful to the physician. The 
individual clusters can be investigated further, e.g. by labeling them as healthy 
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tissue (e.g. gray matter, white matter), or unhealthy tissue (e.g. tumor, necrotic 
tissue), or labeling according to the type of tumor. At this stage, supervised 
methods or expert knowledge may be used. The image segmentation provides 
an objective definition of the size and location of the clusters, taking into 
account all data simultaneously. The latter  property is important because MRI 
images can be misleading, especially when only one or two images at the same 
time are considered: sometimes a tumor seems to be much larger than it 
actually is, and sometimes it does not show up at all. It is imperative that all 
data are taken into account, in order to minimize the number of false 
negatives  and false positives. 
Mixture modelling is applied to the MRI images of the patients and the 
levels of the five metabolites. It is shown that tumors can be located in the 
MRI images as well as in the quantified-metabolites case without human 
interference. The results for the two types of data show very good agreement. 
The clustering method is flexible enough to allow for easy  assessment of 
other choices of clustering method or number of clusters.  
In the next section, we will briefly review mixture modelling in the context 
of cluster analysis. Next, the data are presented, followed by the results of 
clustering both the MRI images and the voxels with the metabolite levels. 
Although no true values for the patients are known (these can only be 
obtained by an autopsy), the  agreement between the clusterings of the two 
types of data sets indicates that tumors can be located in this way. 
Mixture modelling and clustering 
Describing a multivariate data set by a mixture of normal distributions is 
analogous to curve fitting in one dimension, where peaks in, e.g., a 
chromatogram can (ideally) be described by one or several gauss functions. 
The sum of these gaussians should fit the original spectrum as close as 
possible. In mixture modelling, it is the density of the points in multivariate 
space that should be described by the mixture of normal distributions. This is 
visualized in figure 4.1. 
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Figure 4.1. The analogy between curve fitting and mixture modelling In the  
left panel, a curve (e.g., a chromatogram) is modeled by the sum of several gaussians. In the right plot, 
the density of points in two-dimensional space is modeled by a mixture of gaussians (indicated by 
ellipses). 
 
The x parameters of these gaussians, means, covariance matrices and 
proportions, must be estimated from the data. If the class of each object is 
known, maximum likelihood can be used to obtain these parameters. The 
density at point xi of a multivariate normal distribution, characterized by the 
mean µ and covariance matrix Σ is given by: 
 
1
 
The likelihood L(θ|x) that all objects are coming from a specific 
distribution, characterized by θ = (µ, Σ ), is the product of the densities: 
 
2
 
The estimates for the distribution describing the data optimally are those 
that maximize the likelihood L(θ|x). Many methods can be used for this. 
Often, the log-likelihood l(θ|x) = log L(θ|x) is maximized instead of the 
likelihood.  
In the case of mixture modelling, objects may belong to one of several 
distributions, or clusters: 
 
3
 
where φ k is the density of the data from cluster k, and µk and Σk are the 
mean vector and covariance matrix, respectively, of cluster k. In the case of G 
clusters, the likelihood is given by: 
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where τk is the fraction of objects in cluster k. 
The problem now is that the classes of the objects xi are unknown. The 
Expectation-Maximization (EM) algorithm by Dempster8, 9 iteratively solves 
this problem. The first step in the EM algorithm for mixture models is the 
calculation of zik , the conditional probability that object i belongs to class k, 
given an initial guess for the parameters θ (= τ, µ, Σ ): 
  
This is done for all objects and all classes. This is the expectation step; the 
second step is the maximization step, in which the parameters θ for the 
mixture model are estimated. The zik are used in this estimation and therefore 
these parameters (graphically expressed as the ellipses in figure 4.1) may differ 
from the initial estimates. The E- and M-steps alternate until convergence. 
Eventually, objects can be classified to the cluster with the highest zik for that 
object: maxk (zik). 
Usually, one does not start the EM algorithm with initial values for θ, but 
with an initial partitioning and the M-step. Since the choice for an initial 
partitioning can influence the eventual classification significantly5, most 
applications start from a number of different starting points and use the one 
leading to the best clustering, or use another clustering method to obtain the 
initial classification. In this case, fast hierarchical methods10 are used (see 
software section) for the initialization. 
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Several restrictions to the shape of the clusters may be imposed. It is, e.g., 
possible to require that all clusters have the same shape, the same volume, the 
same orientation or combinations of these7, 11. Also completely unrestricted 
models are possible. Each set of constraints corresponds to a different 
clustering criterion: if the clusters are restricted to be spherical and identical in 
size, the criterion that is used equals the criterion in Ward's clustering and k-
means clustering6, 12. Several constraints for which algorithms have been 
published are gathered in table 4.1; further information on mixture models 
with restricted covariance matrices may be found in e.g. references5, 6, 12. 
Table 4.1 Covariance matrix constraints encountered in mixture 
modelling. Adapted from reference 6 
 distribution cluster volume cluster shape cluster orientation 
EI spherical equal equal - 
VI spherical variable equal - 
EEE ellipsoidal equal equal equal 
VVV ellipsoidal variable variable variable 
EEV ellipsoidal equal equal variable 
VEV ellipsoidal variable equal variable 
 
Although the computations involved can take quite some time, they are 
quite feasible for limited numbers of objects and variables. If the number of 
objects is large, one can perform a clustering on a smaller subset and classify 
the remainder, as already shown by Banfield and Raftery7. The subset is used 
to set up the mixture model by identifying the parameters θ. One application 
of an E-step then leads to a clustering for all pixels in the image7, 13. This 
strategy does bring the risk that small clusters are missed; however, in the 
current application the stress is less on the detection of small brain tumors 
than on the exact localization of different tissue types such as tumor and 
necrotic tissue. If the number of variables is very large, one can use variable 
reduction techniques such as PCA. However, in some cases it has been shown 
that such a PCA transformation can destroy cluster structure14, 15. 
Furthermore, the clusters defined in PC space may not be easily interpretable 
in the space of the original variables.  
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Assessing the quality of the clustering 
Because the data are described by a statistical model rather than a heuristic 
procedure, it is possible to choose the optimal number of clusters and the best 
clustering model. The likelihood of the classification is a first indication, but 
fails to incorporate the complexity of the model; more complex models will 
find it easier to fit the data well. Several measures that correct for this are 
available, of which Akaike's information criterion (AIC) and the Bayesian 
information criterion (BIC) are the most well-known. The AIC16 is given by 
  
where L  is the likelihood and np the number of parameters in the model 
(here τ, µ and Σ); the model that minimizes the AIC value is picked. The AIC 
tends to overestimate the number of clusters5, but it is still often used in 
practice.  The BIC17 is given by the following equation: 
  
where n is the number of objects*. In comparison to the AIC, the BIC will 
select models with fewer parameters (at least for cases where n>8). Although 
certain regularity conditions used in the derivation of the measure in practice 
will not be satisfied, this measure has appeared to work very well. Other 
methods, including parametric bootstrap methods and cross-validation have 
been proposed as well (see reference 5 for an overview). In the MCLUST 
software13 employed in this paper (see below), the BIC value is used to choose 
the optimal model and the optimal number of  clusters. It should be noted 
that optimal model and optimal number of clusters are used here in the 
sense of best describing the data; whether this is also optimal in terms of 
interpretation of the clustering should be assessed afterwards. 
One further consequence of the statistical model behind the clustering is 
that we can assess the level of confidence in individual classifications. A 
natural measure of uncertainty for the classification of object i is given by 
ui = 1 - maxk (zik)5, 6. Maximal certainty is obtained when maxk (zik) = 1; because  
Σk zik = 1, all other classes have a posterior probability of zero. A measure of 
the overall uncertainty of the classification is then given by the mean: 
                                                 
* The BIC value is more often used in its negative form, analogous to the AIC. Here, we will 
adhere to the original definition, as is done in MCLUST. 
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This measure is obviously biased, since the same data are used to set up the 
model and to estimate the uncertainty. This can be (at least partially) be 
corrected for, e.g. by bootstrap methods18. However, it does give a useful 
indication on which  objects are clustered with relatively large confidence, and 
which are  more uncertain. 
Software 
Calculations in this paper have been performed by the MCLUST package 
for model-based clustering, by Fraley and Raftery13. Also, figures 4.3 and 4.4 
were created with the MCLUST software. The original program 
(http://www.stat.washington.edu/fraley/mclust/soft.shtml) is an add-on 
package for S-plus (http://www.insightful.com); here we have used the 
implementation for R19. R, which was used for the other calculations and 
visualization procedures in this paper, and MCLUST for R, can be 
downloaded from the R home page (http://www.r-project.org). A more 
complete account of currently available software for mixture modelling is 
given in reference 5.  
Data 
Data for five patients (hereafter denoted with D, G, K, M, and W) with an 
oligodendroglioma tumor in the brain will be used. The tumors have been 
pathologically identified by a biopsy, but the exact location and size have not 
been determined. The first type of data consists of MRI images of four 
varieties: T1- and T2-weighted images, a proton density image and a 
gadolinium-enhanced (Gd-DTPA) image. In the T1- and T2-weighted images 
the contrast is obtained by differences in T1- and T2-relaxation rates, 
respectively, of the water protons in the brain. In the proton density image, it 
is the distribution of protons in the brain that is important. The Gd-DTPA 
image is obtained by injecting a contrast fluid in the blood of the patient. This 
influences the relaxation of protons, and therefore regions are highlighted 
containing large blood vessels or regions where the blood-brain barrier is 
disrupted due to proliferation of malignant tissue.  
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To avoid misclassification due to non-important regions in the images, the 
skull and fat tissue surrounding the brain have been removed20. Images of 
each patient are aligned to correct for patient movement during the 
experiments. Intensities are range-scaled so that the largest intensity is 256 and 
the smallest (in the brain) is 1; pixels outside the brain are not taken into 
account in the following analysis. The number of pixels included in the 
analysis for each of the patients is given in table 4.2. 
Table 4.2 Properties of the MRI (top row) and quantified metabolite 
(bottom rows) data sets for the five patients. 
 patient D patient G patient K patient M patient W 
no. of pixels 23557 20907 13195 22987 27684 
grid 6 x 7 6 x 6 6 x 6 7 x 8 6 x 6 
no. of foxels 42 36 33 56 36 
For patient K, three corner foxels are not taken into account because they are partially located outside 
the brain region 
 
From all patients 1H-MRSI data are available, acquired both with and 
without water suppression using a 16 X 16 2D STEAM 1H-MRSI sequence 
(Tr = 2500 ms, TE = 20 ms, slice thickness 15 mm, FOV 200 mm, BW = 
1000 Hz, NS = 1024 pts). The STEAM box was positioned in the brain and 
contained, depending on the patient, between 33 and 56 voxels, each with a 
separate spectrum. The exact number of voxels per patient is given in table 
4.2. All spectra are preprocessed in the same automatic way: Eddy current 
correction21 to correct for Eddy currents and zero order phase, HSVD 
filtering22 to remove the residual water signal between 4.3 and 5.0 ppm, and 
baseline correction by exponential filtering in the time domain of broad  
resonances. First order phasing was not necessary because the signal was  
sampled from the top of the echo. Prior to Fourier Transform, the spectra 
were zero-filled to 2048 points. 
Examples of spectra from normal and tumor areas in the brain of patient 
M are depicted in figure 4.2. The low signal-to-noise ratio is characteristic for 
this kind of spectra. In some cases, especially at the outer voxels, effects from 
outside the grid are noticeable, so that the spectra from the inner voxels are 
usually of a higher quality. 
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Figure 4.2. Typical spectra, obtained from patient M, from normal brain tissue (top spectrum, 
location 9, 5 in figure 4.6) and tumor tissue (bottom spectrum, location 7, 7). The grey bands 
indicate the integration regions for the five compounds studied. 
 
A recent overview of NMR data for metabolites that are important for the 
diagnosis of brain tumors can, e.g., be found in23. From the corrected spectra, 
the levels of five metabolites are determined by integrating the intensities 
within a window of 17 points (0.13 ppm) at the expected chemical shift. These 
windows have been indicated with grey bands in figure 4.2. The five 
components, myo-inositol (at 3.56 ppm), choline (3.20 ppm), creatine (3.02 
ppm), N-acetyl-aspartate (NAA, 2.02 ppm), and lactate (1.30 ppm), have been 
chosen because of their diagnostic importance and the ease of quantification. 
NAA is hardly ever found outside the nervous system and  is considered to be 
a neural marker. Its levels are shown to decrease in  areas with neuronal loss. 
The choline resonance arises from a group of compounds which are involved 
in membrane synthesis and degradation. Both  increases and decreases in 
choline levels have been reported in pathological conditions. The creatine 
signal consists of compounds involved in energy metabolism via the creatine 
kinase reactions. It is thought to be constant in different brain regions and 
pathological processes, but can decrease when general cell loss occurs. Lactate 
is normally below detection limit, but is found to increase in brain tumors and 
other conditions. Finally, the function of myo-inositol is largely unknown, but 
it appears to be altered in many pathological conditions. Summarizing: tumor 
spectra are often characterized by high lactate values and large choline/ 
creatine ratios23. 
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This quantitation procedure is simple and robust, and has the advantage 
that it will never return completely incorrect results. More elaborate 
quantitation algorithms, e.g. fitting a Lorentzian at the required location, will 
sometimes fit the baseline in the absence of a peak. This then leads to 
completely wrong values, which will not  occur with the method used here. 
Nevertheless, some variation in the levels of the compounds is unavoidable. It 
should be noted that the levels found with our procedure are only an 
approximate indication of true concentrations: only part of the peak width is 
taken into account and negative values are acceptable. For classification 
purposes,  this appears to be adequate. 
Results 
MRI data. Because the number of pixels in the MRI images is quite large, 
the classification of MRI images starts with a random selection of 2000 
training pixels for each patient. These will be used to build and evaluate the 
cluster models; the other pixels will be classified with the optimal model. BIC 
values are calculated from one up to seven clusters. In all cases there is 
significant structure in the data, showing from the fact that the best BIC value 
for only one cluster was always significantly lower than the maximal value. As 
an example, the BIC plot for patient W is shown in figure 4.3. 
1 2 3 4 5 6 7
−
84
00
0
−
80
00
0
−
76
00
0
−
72
00
0
number of clusters
BI
C
EI
VI
EEE
VVV
EEV
VEV
 
 Figure 4.3. BIC plots for the training set of patients W. 
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The two least constrained models, VVV and VEV, show the highest BIC 
values. The optimal model is VEV with six clusters. At four clusters a plateau 
is reached after which the BIC values do not increase very much. A more 
parsimonious model, therefore, could be the VVV model with four clusters. 
Similar behavior is observed for the other patients. In table 4.3 the optimal 
BIC values and the values at which the plateau flattens are gathered. 
Uncertainty estimates for the classification, calculated by Equation (5), are 
included as well. With a larger number of clusters, these values are higher, 
which is to be expected since Σk zik = 1.  
 
Table 4.3 Optimal cluster models identified from the maximal BIC value 
and optimal models with fewer clusters 
 maximal BIC start  of  plateau 
patient model BIC uncertainty model BIC uncertainty 
D VVV 5 -68798 0.086 VVV 4 -69075 0.061 
G VVV 5 -36150 0.096 VVV 4 -36224 0.082 
K VEV 7 -73149 0.158 VVV 3 -73537 0.089 
M VVV 7 -67117 0.111 VVV 5 -67474 0.078 
W VEV 6 -71839 0.107 VVV 4 -72074 0.054 
 
The training set and the definition of clusters in the first two dimensions 
(the T1- and T2-weighted images) of patient W are shown in figure 4.4. The 
optimal model contains six clusters, indicated  by the ellipses. The clustering 
model is VEV, indicating that all ellipses have the same shape but differ in 
volume and orientation. The cluster with high T1 values corresponds to the 
tumor. Unfortunately, this is not always the case, so for the identification of 
the clusters other sources of information are necessary. 
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Figure 4.4. Definition of clusters in the space of the first two images. Each 
point corresponds to a pixel. The ellipses indicate the six  gaussians that describe the data optimally, 
according to the BIC criterion. The model is VEV, where the shape of all clusters is equal (although 
it seems to be different, due to the projection in two-dimensional space), and size and orientation are 
variable. 
 
The classifications corresponding to the optimal BIC values are depicted in 
figure 4.5. Using knowledge of the structure of the brain and information on 
the patients, the separate clusters could be assigned to specific brain tissues. 
Clusters describing one type of tissue have been plotted in the same color. In 
all cases, the tumor, indicated in black, is clearly visible. For clarity, grey and 
white matter are both depicted in white but in the original color-coded 
pictures they are clearly distinguished. The cerebro-spinal fluid (CSF) is 
indicated in grey. The tumor pixels consist of elements from a single cluster, 
except in the case of patient K, where the tumor is described by two gaussians. 
For all patients, two clusters are used to describe the CSF. If clusterings with 
fewer clusters are used, tumors and CSF are always described with only one 
cluster. 
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The tumor in patient K is the least well defined: tumor pixels are found in 
almost all regions of the brain of the patient, although the bulk of the tumor is 
in the lower left region. Patient W shows tumor pixels at several locations as 
well, but again the bulk of the tumor cluster is in a closely defined region. The 
three other patients show well-defined tumor regions. Patient M shows two 
CSF regions within the tumor: the top left region is known to result from a 
bleeding in that area. 
 
Figure 4.5. Automatic segmentations of MRI images from patients D, G, K, 
M and W (left to right). Tumors are indicated in black; cerebro-spinal fluid in grey. Top row: 
optimal models; bottom row: models with fewer clusters from table 4.3. 
 
As a measure of agreement between the optimal and more parsimonious 
models, we calculated the percentage of pixels in the optimal clustering that 
was classified similarly in the more parsimonious clustering. These 
percentages, for the tumor and CSF clusters, are given in table 4.4, indicating 
that the choice of model and number of clusters is not very sensitive, as long 
as reasonably high BIC values are chosen. The BIC values differ by as much as 
300 units, but still the classifications are more or less similar. For all patients, 
more than 90 percent of all pixels that are classified as tumor in the optimal 
models are also classified as tumor in the clustering with fewer clusters. The 
CSF classification for patients K and M is also in very close agreement; in 
patient D the CSF layer at the outer edge of the skull is somewhat thicker in 
the optimal BIC clustering, and also shows a bit more detail. The reverse is 
true for patient G, where the four-cluster solution shows a thicker CSF layer 
than the (optimal) five-cluster solution. The CSF clustering with four clusters 
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for patient W deviates significantly from the one with six clusters because the 
tumor cluster also contains a large part of the CSF, while the CSF in the 
butterfly-like structure in the centre of the brain is classified separately. 
The influence of the choice of the training set can be significant in terms of 
the model that is chosen and the number of clusters that appears optimal. 
However, repeated application of the clustering procedure in this case shows 
only minor differences in the optimal model or the number of clusters; the 
classification of the pixels changes very little as well. Differences are larger 
when smaller training sets are used; in experiments where only 500 training 
pixels were selected, the optimal number of clusters could range from four to 
seven for different training sets. The major structure, however, was retained in 
all cases. 
 
Table 4.4 Percentage of tumour and CSF pixels respectively of the optimal 
models that are calssified identically in the models with fewer 
clusters 
patient tumour (%) CSF (%) 
D 99.8 80.7 
G 93.7 100.0 
K 95.9 94.7 
M 98.3 94.6 
W 100.0 34.1 
 
Metabolite data. Because the number of voxels for which quantitation has 
been done is much smaller than the number of pixels in the images, all voxels 
can be taken into account when constructing the clustering models. All 
models with three to five clusters were considered; more clusters would not be 
informative, given the small number of voxels, and fewer clusters would 
probably not discriminate tumor tissue from healthy tissue. The results of the 
optimal models are shown in table 4.5 and figure 4.6. The tumor clusters are 
indicated in dark grey, the other clusters in lighter shades. Uncertainties in the 
classification are indicated as well. In most cases, the region of the tumor is 
classified with little uncertainty. 
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Table 4.5 Optimal cluster models for the metabolite data of the five 
patients 
 D G K M W 
optimal model VI 5 EEE 3 EI 3 EEV 4 EEE 3 
no. of clusters per tumour 1 2 1 2 1 
no. of tumour voxels 10 12 3 18 4 
 
 
 
Figure 4.6.  Automatic clustering of brain tumors using metabolite levels of 
patients D, G, K, M and W. Top row: location of tumor, according to MRI segmentation, and 
voxels. Middle row: optimal classification with three to five clusters. Three corner voxels of patient K 
are not taken into account: these are indicated in white. Bottom row: uncertainties in the 
classification. Dark values indicate larger uncertainties. The largest uncertainties are 0.29, 0.02, 
0.45, 0.02 and 0.49 for patients D, G, K, M and W, respectively. 
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Identification of each cluster is performed by looking at the mean 
component levels in the clusters. As an example, the box plot for patient W is 
shown in figure 4.7. Clearly, the first cluster constitutes the tumor (high lactate 
values and a large choline/creatine ratio), while the other two clusters 
constitute normal brain tissue. 
Instead of analyzing data from each patient separately, one can also pool 
the patients and classify all of them at once. This is only possible if there are 
no major inter-patient differences. In this case, box plots of metabolite levels 
for these five patients showed that differences were not very big. Indeed, the 
automatic classification of the pooled patients showed clearly the same tumor 
regions as the patient-per-patient classification. All models with one to seven 
clusters were evaluated. The model with the highest BIC value was EEV with 
six clusters. The classification with this model and the associated uncertainties, 
are shown in figure 4.8; two tumor clusters were identified. The area of the 
bleeding in patient M is classified as a completely separate cluster. Again, the 
regions of the tumors are classified quite confidently. Uncertainties are 
somewhat higher than in the patient-per-patient classification, which is to be 
expected because of natural variation between patients. On the other hand, all 
the patients are now classified with more or less the same uncertainty. 
 
Figure 4.7. Metabolite levels in the clusters of patient W. The first of the three 
clusters corresponds with the tumor. The horizontal line in a box depicts the median, the box itself is 
bounded by the upper and lower quartiles of the data, and the whiskers extend to the most extreme 
data points not more than 1.5 times the interquartile range from the box. 
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Comparison of results. A comparison with true values is impossible, but 
further insight can be obtained when the clusterings based on the two data 
types are compared with each other. We concentrate on the tumor clusters.  
Although the MRI images provide more detail, they are not always a better 
indicator of tumor size and location. An example can be seen in the 
classification of patient M in figures 4.6 and 4.8. In all cases where the voxels 
are dark, there is a corresponding tumor classification in the MRI image. 
However, the top part of the MRI tumor cluster is not recognized as a tumor 
in the metabolite classification. This may be caused by gadolinium leaking into 
a cavity in the brain, with a high intensity in the Gd-enhanced image as a 
result. The classification of the tumor in the image may therefore cover too 
large a region. The four light-shaded voxels in the top left of the tumor in 
figure 4.6 correspond to an area in which a bleeding has occurred; this is also 
visible in the MRI classification. Similar findings are visible for patients D and 
W: not all voxels covering the tumor cluster in the MRI image are classified as 
tumor tissue. 
 
Figure 4.8.  Classification based on pooled patient data. Top: optimal model with 
six clusters (EEV). Dark voxels correspond with tumor tissue. For patient K, three of the corner 
voxels are not classified because they are outside the brain (depicted in white). Bottom: uncertainty in 
the clustering. Dark voxels correspond with higher uncertainties. The largest uncertainties for the five 
patients are 0.33, 0.24, 0.30, 0.35 and 0.44, respectively. 
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The patient-per-patient metabolites classification of patient K shows a large 
difference with the MRI classification. Whereas two of the three tumor voxels 
coincide with the tumor cluster in the MRI image, the third voxel contains 
mostly CSF, according to the MRI. Moreover, the majority of the tumor pixels 
do not have features characteristic for tumor in their spectrum. The pooled-
patient classification is in better agreement with the classification of the MRI 
data. This may be the result of a better definition of the tumor cluster, taking 
into account metabolite levels of the other patients. A possible reason for the 
relatively bad agreement may be the fact that the grid is acquired high in the 
brain and therefore lies close to the skull. This can cause artifacts arising from 
fatty acids in tissue surrounding the brain. 
Patient G shows the nearly perfect agreement between the MRI 
classification and the metabolites classification: in the patient-per-patient 
classification, voxels completely overlapping with the tumor cluster in the 
MRI images form one tumor cluster. Voxels partially overlapping form a 
second cluster, still with tumor characteristics, so the boundary of the tumor 
forms a separate class. The agreement with the pooled-patient data is also very 
good; this goes for all patients with the exception of patient K. 
With the MRI data it was not possible to pool the patient data. The 
absorption levels differed too much between the patients, resulting in e.g. the 
tumor of patient D being classified in the same cluster as the CSF of patient 
M. Nevertheless, the overall structures were very similar to the results of the 
patient-per-patient classification, and a suitable scaling of intensities in the 
images could very well lead to a correct overall clustering. This falls outside 
the scope of this paper. 
Conclusion 
Mixture modelling is a powerful and flexible technique for clustering in  
cases where the number of dimensions is not too large. In such cases, direct 
interpretation of the cluster shapes in the space of the original variables is 
possible. Large numbers of objects can be easily tackled by specifying training 
sets to set up the model, which in turn can be used to classify the other 
objects. This makes the method very suitable for use in such fields as data 
mining24, 25 or image analysis26. Of course, the training set should be represen-
tative for the other data; more specifically, all clusters should be well 
represented. 
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The problem of selecting the optimal clustering method and the optimal 
number of clusters is usually tackled by a combination of common sense, 
domain knowledge and trial and error. This, unfortunately, adds a level of 
subjectivity which can make it difficult to reproduce or interpret results. In 
this paper, the use of BIC values, which are used in MCLUST as indicators for  
clustering method and number of clusters, is assessed. Ultimately, there is no 
guaranteed way to assess the quality of a partitioning other than post-hoc 
validation. Several different partitionings should be looked at before deciding 
which one is best. Nevertheless, all classifications in this paper using the 
highest BIC values were very good. 
In this paper, we have not taken into account the spatial relations between 
objects that are clustered (pixels and voxels). If objects within one cluster are 
also located close to each other in, e.g., an image, this leads to a higher 
confidence that the partitioning is meaningful. Thus, domain knowledge can 
be used to obtain at least a partial validation of the clustering. Another 
approach is to include the distance of pixels in the image in the clustering, so 
that one increases the chance that nearby pixels are classified in the same 
cluster. How to do that in the context of model-based clustering is as yet 
unclear.  
Although no true classifications were available, the use of two different 
types of data of the same patients confirmed that the clusterings described the 
structure of the data well. The identity of clusters found in the MRI images 
could be established by aligning the images with the tumors identified in the 
coarser grid of voxels. In this way, the advantages of both methods are 
combined: the large spatial resolution of MRI imaging with the high 
information content of the 1H-MRSI data. Mixture modelling is an attractive 
way to obtain such clusterings. 
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Abstract 
A new classification approach was developed to improve the non-invasive 
diagnosis of brain tumors. Within this approach information is extracted from 
magnetic resonance imaging and spectroscopy data, from which the relative 
location and distribution of selected tumor classes in feature space can be 
calculated. This relative location and distribution is used to select the best 
information extraction procedure, to identify overlapping tumor classes and to 
calculate probabilities of class membership. These probabilities are very 
important, since they provide information about the reliability of classification 
and might provide information about the heterogeneity of the tissue. 
Classification boundaries were calculated by setting thresholds for each 
investigated tumor class, which enabled the classification of new objects. 
Results on histopathologically determined tumors are excellent, demonstrated 
by spatial maps showing a high probability for the correctly identified tumor 
class and, moreover low probabilities for other tumor classes. 
Introduction 
Magnetic Resonance Imaging (MRI) has become one of the most 
important non-invasive aids in clinical diagnosis of brain tumors, because it 
enables the radiologist to assess the anatomical location and size of tumor 
tissue. Normally, multiple complementary images are recorded, as the 
acquisition of only one image may not show the desired information. Another 
use of clinical MR is to perform spatially resolved Magnetic Resonance 
Spectroscopy (MRS). In contrast to MRI, which has a high spatial resolution, 
this method is performed at low spatial resolution, but it involves the 
acquisition of metabolic information. The method allows the use of several 
MR sensitive nuclei, but often the proton nucleus is used as it is the most 
sensitive one. Proton MRS at multiple spatially resolved locations is referred to 
as Proton Magnetic Resonance Spectroscopic Imaging (1H-MRSI)1. 
When applying 1H-MRSI on the human brain, the MR spectra obtained on 
a clinical 1.5 T MR system commonly arise from volumes (called voxels) of 
approximately 2-4 cm3. The spectra contain information from important brain 
metabolites like glutamate, myo-inositol, choline, creatine, N-acetyl aspartate 
(NAA), lactate and fatty acids2. NAA is considered to be a neuronal marker of 
which the levels are decreased in brain tumors. The choline resonance arises 
 A new chemometric approach for brain tumor classification 
 89 
from a group of compounds which are involved in membrane synthesis and 
degradation, which is often increased in tumors. The creatine signal reflects 
compounds involved in energy metabolism and may be decreased in brain 
tumors. Lactate is normally below detection limit, but it is often increased in 
brain tumors. The function of myo-inositol is largely unknown, but its signal 
appears to be altered in some pathologies. The signals from fatty acids are 
known to be increased in several brain tumors, especially high grades, and are 
an indicator for necrosis (cell death). Glutamate is an important 
neurotransmitter in brain and elevated in oligodendrogliomas 3. 
The MRSI spectra could be used collectively with the anatomical MR 
images to spatially determine the type of tissue with a high reliability. 
However, in a clinical setting the increased amount of information hampers 
the diagnosis, since radiologists have to investigate multiple MR images and 
spectra. This is time consuming and often clinicians are not familiar with 
spectral information. To deal with this problem, a project called INTERPRET 
(http://carbon.uab.es/INTERPRET) was funded by the European 
commission. This project had the goal to develop new methodologies to 
automatically type tumors in the human brain with the use of MRS and MRI 
data. The resulting decision support system enables clinicians to utilize MRS 
information for the diagnosis of brain tumors. In this paper a new approach is 
presented to explore the information content of the combined MRI and MRSI 
data, collected from patients with a brain tumor. Image like maps can be 
generated which show the classification of the tissue and the probability of 
classification in order to assist the clinician in the interpretation of the data. 
The development of statistical models (especially multivariate ones) which 
are focused on the classification of brain tumors from MRSI data is rather 
new. Some attempts have been made 4-7, but a dedicated multivariate 
determination of the location and distribution of classes in feature space has 
not been performed yet. Both, Preul 4 and Szabo de Edelenyi 6 focus on the 
quantitation of metabolite regions from the spectroscopic data, followed by 
linear discriminant analysis. Others have used pattern recognition 8, 9 on single 
voxel MR spectra to classify 10-13  or cluster 14, 15 multiple tumor classes. The 
emphasis of data analysis is often put on pre-processing 16, 17, data reduction 
and the search for appropriate classification algorithms. However, a very 
important part of a classification approach has not received much attention 
yet. This deals with the assumption of multivariate normality, the identification 
of class boundaries for each tumor class, the recognition of overlap between 
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classes and the probability of classification. Multivariate normality is important 
to consider if the classification method assumes it, especially when also 
probabilities of class membership of a certain class are to be given. The 
identification of class boundaries is important since there are many different 
types of brain tumors. The usually limited number of investigated tumor 
classes in a classification procedure should therefore have strict class 
boundaries. This leaves room for the non investigated classes in feature space, 
which will (hopefully) be classified as unknown by the classifier. The 
probability of classification is important, because it provides information on 
the reliability of classification. 
Few papers deal with the combination of MRI and MRSI data (Szabo de 
Edelenyi 6 uses information from the T2-weighted image, combined with 
MRSI). If a patient with a brain tumor is investigated, always MR images with 
different contrasts are acquired. If also a MRSI measurement is performed, it 
would be a waste to leave out the MRI information in the statistical models, 
since the MR images are already available. It is possible to identify 
morphological different regions in the brain with MRI information alone 18. If 
this information is combined with MRSI data, the pathology of the regions 
might also be identified. Therefore, we combined MRI and MRSI data in all 
our experiments. 
The goal of this paper was three fold. First, to find an appropriate feature 
selection technique for the MRSI data, while preserving the distances and 
distribution of the classes in feature space. We compared two techniques, 
simple quantitation of spectral regions and principal component analysis. The 
second goal was to find the isolated and overlapping classes of tissue types in 
feature space and to create plots which showed their distribution. These 
distribution plots can be used to generate spatial probability maps, which 
show for each voxel the probability that it belongs to a certain tissue class. The 
third goal was to develop a classification model, which uses thresholds which 
are set with use of the distribution plots. These thresholds define class 
boundaries for each class, enabling the classification of voxels to a specific 
tissue type or as unknown.  
To address the above research issues, a training set was setup using data 
from volunteers and patients with a brain tumor. The construction of the 
distribution plots was performed with a cross validation method. The 
evaluation of the classifier was performed with the leave one out method on 
the training set. Furthermore, the resulting classification maps of the patients 
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were visually investigated. Most of the voxels within each classification map of 
a patient were not selected within the training set. If the classification map of a 
patient contained homogeneous regions of healthy tissue, cerebro-spinal fluid 
and tumor tissue, then this demonstrated robustness of the system to a large 
extent. Next to this, two patients from which no data was selected for the 
training set were validated. 
Experimental section 
Data. Data from 18 patients with a brain tumor and 4 volunteers selected 
from the INTERPRET 19 database were used. Each patient case had passed 
strict quality control and validation procedures, including consensus 
histopathological determination of the tumor according to the rules of the 
World Health Organization. For two of the 18 patients (I-1172 and I-1281) a 
consensus was not reached. Therefore, data from the tumor region of these 
patients was not used in the training set.  
For each subject, stacked MR images of cross-sections of the whole brain 
at four contrasts were acquired: T1- and T2- weighted images, a proton density 
image and a gadolinium-enhanced T1-weighted image (256 x 256, FOV = 200 
mm, slice thickness = 5 mm). In the T1- and T2-weighted images, the contrast 
reflects differences in T1- and T2-relaxation times of the water protons in the 
brain, respectively. In the proton density image, the distribution of protons 
produces the contrast. The contrast enhanced image (GD-image) is obtained 
after intravenous administration of Gd-DTPA solution. The paramagnetic Gd 
compound influences the relaxation times of water protons and therefore 
regions are high-lighted which contain large blood vessels or where the blood-
brain barrier is disrupted due to proliferation of malignant tissue. To ensure 
that image pixels from subsequent images originate from the same spatial 
location, the images have to be co-aligned. The co-alignment was performed 
by calculating the maximum correlation between two images while shifting 
them left-right and up-down. Co-alignment is difficult, but does not need to 
be perfect in this method, because the high resolution images are combined 
with the low resolution MRSI eventually. 
Besides the acquisition of images, also 1H-MRSI data was acquired from 
each subject, both with and without water signal suppression using a 2D 
STEAM 1H-MRSI sequence (16 x 16 x 1024 matrix size, Tr = 2000 or 2500 
ms, TE = 20 ms, slice thickness 12.5 or 15 mm, FOV = 200 mm, spectral 
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width = 1000 Hz, NS = 2 (for the MRSI without water suppression, NS = 1)). 
When STEAM 20 is applied, a box is selected from which the signal is acquired 
by the application of three slice-selective radiofrequency pulses in the presence 
of x-, y-, and z-gradients. Only the MRSI voxels within the STEAM box will 
contain signal, while signals in voxels from outside the box are suppressed. 
The STEAM box was positioned totally in the brain, therefore disturbing 
signals arising from the fat tissue surrounding the skull were avoided. The 
location of the 1H-MRSI slice was selected and aligned with the Gd-image 
which showed the largest enhanced tumor area. Thus, the MRSI slice (of at 
most 15 mm thickness) was centered around a MRI slice of 5 mm. Since the 
MRI slices above and below the selected MRI slice have a gap of 1.5 mm with 
the selected slice, they are partially outside the view of the MRSI slice. 
Therefore, only MR images from one slice location have been used.  
Proper pre-processing of the MRSI data is essential for successful 
classification. All data were processed in the same automatic way. In short: k-
space data (16 x 16) was filtered by a hanning filter of 50% using the LUISE 
software package (Siemens, Erlangen, Germany), followed by zero filling to 32 
X 32 and 2D Fourier transformation to obtain time domain signals for each 
voxel. Then, each voxel within the pre-selected STEAM box was corrected for 
eddy current effects in the spectra using a method which prevents the 
occasional occurrence of eddy current correction induced artifacts 21. This was 
followed by HLSVD 22 filtering to remove the residual water signal between 
4.3 and 5.5 ppm. Next, a simple but efficient baseline correction was applied, 
which removed broad resonances. This was performed by exponential filtering 
of the time domain signal of each voxel with a filter width of 5 ms, followed 
by the subtraction of the residual from the original time domain signal. To 
correct for first order phase effects (in principle the zero order phase is 
removed by the eddy current correction), the mean spectrum which was 
calculated from all spectra within the STEAM box of each patients MRSI 
dataset was manually optimized. This correction value was then applied to 
each separate time domain signal of that dataset. Finally, each time domain 
signal was Fourier transformed and only the real values of the complex 
spectrum was retained between 0.5 to 4.0 ppm (230 points). To normalize 
between patients, all spectra of one dataset were divided by the patients mean 
water signal of all voxels within the STEAM box, as calculated by singular 
value decomposition 23 from the unsuppressed MRSI data. 
 A new chemometric approach for brain tumor classification 
 93 
Next, the spatial resolution of the MR images and the MRSI grid had to be 
readjusted, so that the two were in agreement. Therefore, the resolution of the 
MR images was lowered to the resolution of the MRSI grid by averaging the 
image pixels within each spectroscopy voxel. The values within each low 
resolution image were scaled to the same range as the spectral data. After pre-
processing, each voxel within the grid was represented by a spectrum of 230 
variables (the region between 0.5 to 4.0 ppm) and 1 variable from each MR 
image. This is schematically represented in figure 5.1a-c. 
 
Figure 5.1. Representation of pre-processing and data reduction. a) The images 
with the four contrasts (top: T1- and T2- weighted image, bottom: proton density and Gd-image) are 
aligned (the lower right image has been shifted up) and the spectral grid within the STEAM box 
has been superimposed on the images; b) a spectrum after pre-processing, obtained from the indicated 
voxel; c) the resolution of the images is reset to the MRSI resolution. Each voxel is represented by 
four image variables now; d) data reduction is performed either with quantitation of important 
regions in the spectrum (indicated with  gray bands in figure 5.1b) or with PCA of the spectra; e) the 
image variables from each voxel are combined with the variables obtained from either data reduction 
technique. In this example the image variables are combined with the variables (scores) obtained by 
PCA. 
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Setup of a training set. Based on the 16 patients for which consensus 
about the histopathology was reached, four different tumor classes were 
selected. The first three classes contained glial tumors with different grades, 
grade II (6 patients), grade III (4 patients) and grade IV (5 patients). A fourth 
class consisted of a patient (I-1283) with a meningioma (MNG). No classifier 
for this class was calculated, because the size was to small, but it was used to 
validate results of the classifier. 
To create the training set, a selection of voxels from patients who were in 
the same tumor class was made using the MR spectra and the four MR images. 
The voxels were selected from regions which clearly consisted of tissue 
belonging to the correct class. Boundary voxels were not selected.   Also 
classes for healthy tissue and cerebro-spinal fluid (CSF) were created. The 
voxels for healthy tissue were selected from the contralateral region of several 
patients and from healthy volunteers. Data for the CSF was selected from CSF 
voxels which were not in close contact with the tumor region. The total 
number of voxels selected from a subject was never more than 30%.  
Patient I-1172, for which no consensus was reached, was used for the 
selection of training set data for healthy tissue and cerebro-spinal fluid. Data 
from patient I-1281 was not used for the training set at all, but was used as an 
independent test case for evaluation, just like patient I-1283 (the MNG case). 
An overview of the training set is given in table 5.1. 
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Table 5.1. Selected patients, volunteers and number of voxels for each class 
in the training set. 
tumor class patient number (I-) a no. of voxels selected total 
grade II 1227 1233 1260 1275 
1278 1318 
07 20 28 12 
14 09 
 90 
grade III 1212 1229 1230 1232 17 06 26 4  53 
grade IV 1231 1234 1285 1286 
1322 
12 06 16 17 
08 
 59 
MNG 1283 15  15 
healthy (volunteer) 
healthy (patient) 
1236 1237 1238 1239 
1172 1212 1231 1285 
1318 
29 31 25 37 
13 32 21 39 
17 
122 
122 
CSF 1172 1230 1231 1234 
1275 1318 
15 09 26 03 
09 16 
 78 
no consensus 1281 used as independent test case 
   total 539 
a The patient numbers correspond with the INTERPRET 19 database. 
 
Data reduction methods. After selection of the training set, two different 
data reduction techniques were used to create two separate training sets with 
reduced dimensionality, which were validated for their robustness. The 
following techniques were used: 
a) Quantitation of important spectral regions. Quantitation was performed in the 
following way: from the pre-processed spectra, intensities of seven spectral 
ranges encompassing the brain metabolites mentioned in the introduction 
were determined by integrating the intensities within a window of 0.13 ppm at 
3.75 ppm (glutamate), 3.56 ppm (myo-inositol), 3.20 ppm (choline), 3.02 ppm 
(creatine), 2.02 ppm (NAA), 1.33 ppm (lactate), and 0.90 ppm (fatty acids). 
These seven windows have been indicated with gray bands in figure 5.1b. The 
quantitation procedure is simple, robust and easily automated. It should be 
noted that the levels found with our procedure are only an approximate 
indication of the true levels: only part of the peak width is taken into account 
and negative values are acceptable in case of a negative baseline. However, for 
classification purposes this appears to be adequate. The seven spectroscopic 
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variables (figure 5.1d) and the four image variables (figure 5.1c) were 
combined to create a training set which contained 11 variables for each voxel. 
b) principal component analysis of the spectral data. The second data reduction 
technique used principal component analysis (PCA) 24. PCA was performed on 
the spectra of the training set, which consisted of 524 (MNG excluded) 
spectra with 230 variables each. PCA finds directions in the data which explain 
most of the variance. These new axes are linear combinations of the original 
ones, are orthogonal and ordered with respect to the amount of explained 
variance. After PCA, the first seven principal components, which explained 
95.3 % of the variance were retained. The number of principal components to 
use is normally not straightforward. We used seven to make a comparison 
with the seven variables obtained by the quantitation of important spectral 
ranges as described above. By chance, the seven principal components 
retained more than 95% of the variance, which is also a limit used to choose 
the number of principal components. After PCA, each voxel was described by 
7 variables (called scores, figure 5.1d) obtained from the MRSI modality and 
four from MRI (figure 5.1e).  
Exploration of the classes in feature space. In order to develop a 
classifier which is able to classify a voxel as belonging to one of the 
investigated classes or as unknown or as undecided between some tissue 
classes, we explored the distribution of each class in feature space and 
compared it with the distribution of all other classes. This was done for each 
class in both training sets created by the two data reduction methods. First, 
the data representing the voxels (objects) of the class under investigation was 
split, separating at random ten percent (A) from the rest (B). Then the 
covariance matrix of B was calculated and used to calculate the mahalanobis 
distances (d) of all objects in A with respect to the centroid of B. Also the 
mahalanobis distances of all objects in the other classes with respect to the 
centroid of B were calculated. This procedure was repeated successively 
leaving the next 10 percent of the class under investigation out, until all 
objects were left out once. This procedure was repeated for all classes. 
Eventually, for each tissue class a plot was created which showed the 
percentage of objects against the mahalanobis distance from the classes 
centroid for members of the class itself and for non members. An example of 
such a distribution plot is shown in figure 5.2. The solid line represents the 
percentage of healthy objects within a certain mahalanobis distance d from the 
centroid of the healthy class. 100% of the healthy objects in the training set 
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(created by the first data reduction method) are within a distance of 6 d from 
the healthy centroid. The dotted line represents the percentage of all other 
objects in the training set (not belonging to healthy) within a certain distance 
to the centroid of the healthy class. Only a small percentage of non healthy 
objects are within a distance of 6 d from the healthy centroid, and the healthy 
class is therefore relatively isolated from the other classes. 
 
Figure 5.2. Distribution plot showing the distribution of healthy objects (solid) and objects from 
other classes (dotted) with respect to the centroid of the healthy class.  
 
Calculation of probabilities of class membership. The probability of 
class membership of a new object for a class was calculated based on the true 
distribution of the class, which is reflected by the distribution plot. The density 
at point xi of a multivariate normal distribution (with p dimensions), 
characterized by the mean µ and covariance matrix Σ is given by: 
 
1
 
In a non normalized way, the density is a direct estimator of the probability 
that an object at point xi belongs to this multivariate normal distribution. If the 
mahalanobis distance of a new object to a class centroid is know, the density 
and thus probability of class membership can be calculated using this 
equation. In the proposed approach a slightly different method was used, 
based on the true distribution of each class shown in the distribution plots. 
To calculate the probability of class membership of a new object to the 
healthy class (for example), first its mahalanobis distance to the class centroid 
was calculated. Using the experimentally determined distribution plot in figure 
5.2, the percentage of objects of the training set within this distance could be 
red. E.g., when an object has a distance of 3d from the centroid of the healthy 
class, then 28% of the objects in the training set was within this distance 
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(arrow at 3d in figure 5.2). Last, from a theoretical determined curve, which 
showed the number of objects a certain distance from the centroid of a 
multivariate normal distribution against the density, the density could be red. 
If the distribution plot in figure 5.2 was precisely following the theoretical 
distribution of a multivariate normal distribution, then the density calculated 
by our approach would give the same result as the density calculated by 
equation 1. 
Classification of voxels. In order to use the distribution plots as a 
classifier, thresholds have to be set for each class. The value of the threshold is 
depending on the errors one is accepting to take for a specific tissue class. If 
one wants to classify 95% of the healthy objects correctly (the α error is 5%), 
then the threshold has to be set at the position shown in figure 5.2 (dashed 
vertical line). However, this means that ~2% of the objects will be classified 
incorrectly (β error) as healthy.  
Classification of a new voxel is performed by projecting it in the feature 
space. Then, its distance to the centroid of each class is calculated. The voxel 
is only assigned to the closest class when its distance to the centroid does not 
exceed the threshold. If the distance exceeds the threshold, then it is classified 
as unknown. If overlapping classes are found, rules can be setup to classify 
voxels as belonging to either one of these classes, as described in the 
discussion. If a voxel is classified as such, it may be re-classified with another 
classifier, like a support vector machine, especially constructed for the 
classification between two classes 25. 
Evaluation of the system. Evaluation of the system was performed at 
four levels. First, the best data reduction method was selected by comparison 
of the distribution plots constructed with both methods. Secondly, the 
classifier was tested by a leave one out procedure on the training set (n= 524). 
Leave one out testing is an accepted validation procedure when the number of 
samples is low. The leave one out procedure was executed in the following 
way. From the training set the first sample was left out. The remainder of the 
training set was used to calculate new (independent to the left out sample) 
distribution plots. Then the left out sample was classified with use of the 
calculated distribution plots. The classification thresholds were kept the same 
during the leave one out procedure. This was repeated until all samples were 
left out of the training set once. 
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Third, the classifier was evaluated using all the data from all patients in the 
training set. This was performed by calculation of the classification maps and 
probability of classification maps. Most of the voxels of the patients were not 
used in the training set and therefore could be used for validation. Since no 
true tissue type for these voxels were available, all maps were visually 
inspected for obvious misclassifications. Regions which could be assigned 
visually as healthy tissue, CSF or the tumor by means of the MR images had to 
be homogenously classified as such in the classification map. Last, the 
classification results of patient I-1283 (the meningioma) and patient I-1281 
(for which no consensus was reached) were also used for validation.  
Results and discussion 
Exploration of classes in feature space. The distribution plots can be 
used to compare data reduction techniques as described above, or the 
influence of other processing steps, e.g. normalization or scaling. In this study 
only a comparison of data reduction techniques was made. Each subplot in 
figure 5.3 shows the distribution plot of a tissue class. The solid-black and 
dashed-gray visualize the percentage of objects of the class itself within a 
certain mahalanobis distance from its centroid. Theoretically, the squared 
mahalanobis distance should follow the Hotelling T2 statistics 26, which is 
plotted as the gray thick line for each class. For all tissue classes the plots 
follow T2 statistics, suggesting that the multivariate data is normally distributed 
in space and that using the mahalanobis distance is justified for both 
approaches. This is important, because the probabilities can only be calculated 
if the data follows a normal distribution. The approach using quantitated 
values seems to be better than the approach using PCA, since objects not 
belonging to a class are always further away from the class centroid for this 
method. This is especially visible for the grade III and grade IV class (figure 
5.3d and 5.3e) in which the black-dotted line is lower than the gray dashed-
dotted. This suggests that the classes are more separated in the approach using 
quantitated values and therefore this data set is used in the remainder of the 
paper. 
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Figure 5.3. Distribution plots for each class using both data reduction 
approaches. 
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Caption of figure 5.3. 
a) The distribution of the healthy class is plotted in solid-black for the quantitation of spectral ranges 
method, and in dashed-gray for the PCA method. Both distributions follow Hotelling T2 statistics 
which is plotted as a thick gray band. Also the percentage of non-healthy training samples within a 
certain mahalanobis distance from the centroid of the healthy class is plotted for each data reduction 
approach. The dotted-black corresponds with the quantitation of spectral ranges method, and the 
dashed-dotted-gray for the PCA method. b, c, d, e) The same as a), but now for the CSF, grade II, 
grade III and grade IV class, respectively. 
 
To investigate the distribution of all tissue classes which surround a 
particular class, we plotted the mahalanobis distance of all objects (including 
MNG) within a class to the centroid of the particular class under investigation 
(figure 5.4). The surrounding of the healthy class is relatively empty. At a 
mahalanobis distance of 6 d from its centroid, objects from the cerebro-spinal 
fluid class arise. Objects from other classes however, are almost absent until a 
distance of 8 d. The CSF class has some overlap with objects from the healthy 
class at 6 d, but no overlap with other classes at all (figure 5.4b). This suggests 
that healthy tissue and CSF are dense clouds in feature space, which have 
some overlap with each other, but not with malignant tissue. Therefore, one 
may expect some error between these classes, but low error between 
healthy/CSF and any of the other classes. This is in agreement with findings 
of other researchers  6, 12, 13 who found that healthy tissue can be classified with 
a high reliability. This can be explained by the stringent concentrations of 
metabolites in the human brain for healthy tissue. The overlap of CSF with 
healthy is likely due to partial volume effects. 
The grade II class overlaps with the grade III class, but not with grade IV 
or MNG (figure 5.4c). It is therefore very well possible to separate grade II 
from grade IV and MNG objects, but separation of grade II from grade III 
will be hard. The same can be concluded from figure 5.4d, which describes the 
grade III distribution. The grade IV class is separated from all other classes, 
suggesting that this class can be classified with a high reliability. As pointed 
out, we included the MNG class in figure 5.4a-d, because it gives relevant 
information about the location of MNG in feature space. 
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Figure 5.4. Distribution plots of each class and its surrounding classes using 
the quantitation of spectral ranges method for data reduction. 
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Caption of Figure 5.4 
In each sub-plot the solid black line represent the percentage of healthy objects within a certain 
distance to the centroid of the class under investigation. The dashed-dotted-black line represents CSF, 
the dashed-black line, grade II. The solid-gray, dashed-dotted-gray and dashed-gray respectively 
represent grade III, grade IV and MNG. The vertical dotted lines indicate the thresholds used for 
the classification. 
 
The distribution plots are very import for the interpretation of the classes 
in feature space. If a new class is added, one can directly see whether this new 
class has a significant overlap with any of the other classes. Assume that a new 
class A is overlapping with class B. If a new object is classified to class A, but 
the probabilities for both class A and B are high, then the reliability of 
classification is low. The object might also be a member of class B. If the 
classes A and B are from totally different tumor types, which normally do not 
occur together in the brain, then the classification is A, with a low reliability. 
On basis of other information the clinician might decide that the true 
classification is A. It can also be that the classes A and B are from the same 
tumor type, but with a different grade. This is for example the case for the 
grade II and grade III classes of glial tumors described in this paper. A 
mixture of these two tumor types can occur in the brain. If the probability for 
class A and B are high now, and the two classes are from different grades, 
then the tissue could also be a mixture of both classes and thus 
heterogeneous. The expert user has to keep this in mind during the usage of 
the classifier. 
As explained in the methods section, probability maps for a new patient 
can be constructed using the distribution plots of figure 5.4. Maps are 
presented from patients with a histologically proven grade III (figure 5.5a and 
d), a grade II (figure 5.5b) and a grade IV (figure 5.5c) tumor. The darker a 
voxel in a map, the higher the probability that the underlying tissue belongs to 
the class represented by the map. The images give a very consistent indication 
of the different tissues in the brain, indicating robustness of the system. 
Remember that only several voxels of each patient have been used in the 
training set. The number of voxels used in the training set and the number of 
total voxels is specified in the figure caption for each patient. For the 
interpretation of the probability maps, it is important to compare them region 
wise, because the probabilities are relative. When a region in the probability 
map of grade II is dark, while it is bright on the other maps, then the 
estimation of class membership is high. When the region is dark in more than 
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one map, then the estimation of class membership is lower. As explained, the 
probabilities of classification might also be important for the assessment of 
tumor heterogeneity. When the probability in a region is high for only one 
tissue type, then the tissue will be, in general, homogeneous. If the probability 
in a region is high for two tissue types, then the region might be a mixture of 
these tissues, and therefore heterogeneous. However, this can only be the case 
if the mixture of these two tissues are possible from a clinical point of view. 
Otherwise, on can only say that the reliability of classification is low. In 
addition to other classification procedures which try to assess tissue 
heterogeneity with a spatially resolved classifications algorithm 4, 6 or the 
construction of metabolic maps 27, 28, the use of statistically calculated 
probabilities could be an important asset to the mapping of tumor 
heterogeneity.  
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Figure 5.5. Overview of probability maps of 4 patients. For each patient a MR 
image is shown on the left with a contrast that clearly identifies the tumorous region. The MR images 
are zoomed and only the MRSI grid within the STEAM box is depicted. Next to the MR image 
the probability maps for the five classes are shown. a) patient I-1229 (6/156), which has a grade 
III tumor. After the patient label, the number of voxels used in the training set and the total number 
of voxels for this patient are depicted between brackets. The MR image is T2-weighted. b) patient I-
1275 (21/180), which has a grade II tumor. The MR image is T2-weighted. c) patient I-1285 
(55/168), which has a grade IV tumor. The MR image is proton density-weighted. d) patient I-
1212 (49/171), which has a grade III tumor. The MR image is T2-weighted. 
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Classification of voxels. For the classification, we created classification 
rules based upon the results presented in figure 5.4. The healthy and the CSF 
classes are isolated in feature space, having some overlap with each other. To 
minimize the α error, we have set the threshold to 6 d for these classes as 
shown by the vertical dotted line in figure 5.4a and 5.4b. The same can be 
concluded for the grade IV class, with a threshold of 5.5 d. This leaves some α 
error for grade IV, but minimizes the chance that a healthy or CSF object will 
be falsely classified as grade IV. Because of the overlap of the grade II and 
grade III classes we defined different rules for these classes. When an object is 
very close (≤ 2.5 d) to the centroid of one of these classes it is appointed to it 
(threshold at 2.5 d), but when the distance is between 2.5 d to 5.5 d, other 
rules were applied. a) If the object was closest to the grade II class and the 
distance of the object to the grade III class was 1.3 times larger than to the 
grade II class, then it was assigned to the grade II class. This rule can be 
applied because all other classes are far away from the grade II class. b) If the 
distance of the object to the grade III class is smaller than 1.3 times the 
distance to the grade II class, then it is a grade II or a grade III member and 
thus undecided between these two classes. We applied identical rules when the 
object was closest to the grade III class. The value of 1.3 was found by 
repeating the classification for different values, and assessing the number of 
objects which were classified as undecided. 
Classification using leave one out is excellent for the healthy (100 % 
correct), CSF (97 % correct, the 3 % being misclassified as healthy) and grade 
IV (100 % correct) class. Classification results for GII and GIII were 
promising. 83% of the GII objects were classified correctly and 88% of the 
GIII class. However, the largest part of the misclassified objects in the GII 
and GIII classes were classified as undecided (12 % for the GII and 4 % for 
the GIII class), which is to be expected since these classes are overlapping. 2% 
of the GII objects were misclassified as GIII and 3% of the GIII as GII, 
respectively. Last, some objects of the GII and GIII classes were classified as 
unknown (3% and 5%).  All MNG objects were classified as unknown, 
which is correct as we did not build the classifier to be able to take MNG into 
account. 
 A new chemometric approach for brain tumor classification 
 107 
To compare the method with a commonly used algorithm 4, 6, we 
performed linear discriminant analysis (LDA) 24 with use of leave one out. In 
general, the number of correctly classified objects for each class using LDA 
was in correspondence with the presented method, but when LDA was used, 
the misclassified objects were often assigned to classes not expected. Objects 
from the healthy and CSF classes were wrongly assigned to grade II 
(respectively 0.5 % and 1 %). 5 % of the GII were misclassified as GIII, and 
11 % of the GIII as GII. 1.5 % of the GIII were misclassified as GIV.  
The results of LDA may be caused by the fact that LDA can only be used 
if the classes under investigation have equal covariance in size and shape. In 
our data set this was not the case. The healthy and CSF classes are much more 
condensed than the tumor classes. This will probably always be the case, 
because the highly structured brain will give rise to spectra with low variance, 
while heterogeneous tumor tissue with a broader range of morphologic and 
metabolic abnormalities will give rise to MR images and spectra with high 
variance. 
In figure 5.6, the classification results of the patients presented in figure 5.5 
are shown, together with  two other patients. The patient in figure 5.6e (I-
1318) has a grade II tumor, the pathology of the tumor of the patient in figure 
5.6f (I-1281) is unclear, since the pathologists who validated the tumor 
disagreed between grade II and grade III. Therefore this patient has not been 
used during training of the classifier, but was used as a test case. Also all other 
patients have been evaluated, showing similar results as the patients presented.  
Although only a small part of the voxels from patients a to e are used for 
training the classifier, the results look very good. As an example we have 
indicated the voxels used in the training set for the patient in figure 5.6a with 
white circles. Only 6 of the 156 voxels of this patient were used for training! 
Important considerations for the evaluation are; a) voxels which are identically 
classified tend to be spatially grouped, b) the spatial distribution of 
classification is in agreement with morphological information from the MR 
images, c) in most patients only one tumor type is assigned, and this 
assignment is always in agreement with the pathology of the patient, d) most 
grade III patients also show grade II voxels which can be expected, because 
the pathologist types the patient with respect to the most malignant tissue 
present. However, grade II patients do not show grade III classified voxels. 
This is important since otherwise a clinician could assume grade III tumor 
based on 1 or 2 falsely classified grade II voxels. In figure 5.6d and e, voxels 
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have been misclassified as grade IV. In the case of d the misclassification 
could have occurred because it is a corner voxel. These voxels normally have a 
low signal, since the boundary setup by the STEAM box is never perfect. 
The classification result of the patient in figure 5.6f is fairly good for the 
healthy and CSF tissue. There are misclassified voxels in the border region of 
healthy and CSF which might be caused by partial volume. In the tumor area 
none of the voxels have been classified as grade III, suggesting this is a grade 
II tumor, but the probability of grade II shown on the probability maps (inset) 
is not very high for most voxels. The disagreement between the two 
radiologists of this patients pathology is therefore reflected in the results of 
the classifier and probability maps. 
Last, the patient with the meningioma tumor was evaluated (classification 
result not shown). Again, no voxels from this patient were selected for the 
training set. The classification map shows normal tissue in regions outside the 
tumor. The area of the tumor is classified as unknown, which is correct as the 
classifier was not build to be able to classify meningiomas. 
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Figure 5.6. Classification result of six patients. The classification is projected over a MR 
image with a contrast that clearly identifies the tumorous region. a) patient I-1229, pathology: grade 
III, T2-weighted image, b) patient I-1275, pathology: grade II, T2-weighted image, c) patient I-
1285, pathology: grade IV, proton density-weighted image, d) patient I-1212, pathology: grade III, 
T2-weighted image, e) patient I-1318 (42/195), pathology: grade II, T2-weighted image, f) patient 
I-1281, no consensus of the patients pathology was reached. The radiologists differed between grade II 
and III. None of the voxels of this patient have been used for training. The inset shows a section 
(indicated by the black square on the classification map) of 3 probability maps of healthy, grade II 
and grade III. Note that a voxel classified as undecided can either be a grade II or a grade III.   
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Conclusions 
A new classification approach was developed which enables the 
classification and probability of classification of brain tumors on the basis of 
magnetic resonance spectroscopy and imaging data. The model can be used to 
determine the best preprocessing or data reduction technique in feature space 
and to recognize overlap of classes. The results of classification, including 
probabilities, are presented as images to facilitate the interpretation in a clinical 
environment. 
Comparison of PCA and quantification of spectral ranges to reduce the 
number of variables in feature space gave similar results. The last method was 
favored, because it was slightly better and because the variables retain a 
meaningful property. However, PCA is much easier to perform and is not 
subjective to quantification error and is therefore a good competitor. 
Exploration of the classes in feature space as presented is a powerful 
method to compare class distances, distributions and class boundaries. It can 
be used to identify tumor classes which are not separable, because they 
overlap in feature space. The overlap between the grade II and III tumor 
classes can be understood if the method to identify the pathology is 
considered. When only a small part of the tumorous cells are found to be 
grade III, the pathology of the patient will be grade III, whereas the spectral 
features may arise from a bulk of grade II tissue. It is therefore never possible 
to separate these two classes perfectly. The classification thresholds of the 
model thus have to be set to minimize the number of voxels falsely classified 
as grade III in patients with a grade II tumor. 
The calculation of probabilities of classification from MRI and MRS data is 
relatively new. The probability maps are very important for the interpretation 
of the classification image. It provides information of the reliability of 
classification for each voxel, shows whether voxels have a high probability for 
a class they were not classified to and can be used as a direct identifier of 
tissue heterogeneity in certain cases. 
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Unfortunately, as in any classifier, the classification approach is limited to 
classification of the classes in the training set. There are many different types 
of tumor, so an addition of classes to the training set in future would be highly 
desirable. Then it would also appear whether totally different tumor classes 
show overlap in feature space. However, the presented approach recognizes 
unknown tumor classes, so at the moment it is a valuable method to 
differentiate between glial tumors and other tumors. Furthermore, it provides 
the grade and probability of class membership for glial tumors, which are 
important parameters in tumor diagnosis.  
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Abstract 
Purpose. To investigate whether an automated medical decision support 
system that uses pattern recognition and the combined power of magnetic 
resonance imaging and proton spectroscopy can aid radiologists in the 
diagnosis of brain tumors. 
Materials and methods. Information is extracted from the MR data and 
used to segment pathologically similar brain regions. A classification model 
classifies the segments and individual voxels. For each classification result a 
probability is calculated. 
Data from 22 subjects is used to build and assess the system. Evaluation is 
performed by the comparison of classification results from the segmentation 
and individual voxels, by visual evaluation and by a clinical evaluation by four 
expert radiologists. 
Results. The clinical evaluation shows that radiologists agree with the 
location and extent of brain tumor segments, as found by the segmentation. 
Of 16 brain tumors, 15 were correctly classified. The probability of 
classification for individual voxels are mostly high in the center of the region 
that is considered to be the tumor. 
Conclusion. The support system is a user friendly tool, that provides 
information on the location, type and grade of brain tumors. The reliability of 
classification can be assessed, and all results are presented as images to 
facilitate an easy interpretation. The large amount of data obtained by the 
combination of MR imaging and spectroscopic data can be exploited by 
automated pattern recognition to achieve a robust tumor classification. 
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Introduction 
In the diagnosis, therapy prediction, and assessment of brain tumors, 
imaging techniques play a critical role, among which magnetic resonance 
imaging (MRI) is most prominent. Since the assessment of tumor tissue in the 
brain, based on imaging procedures alone is still a challenging problem, proton 
Magnetic Resonance Spectroscopy (MRS) has been introduced as an 
additional noninvasive diagnostic tool. Proton MRS provides completely 
different information as compared to MR imaging, but can be obtained with 
most 1.5 T MRI instruments used for routine radiological examinations. MRS 
spectra provide localized metabolic information, related to cell membrane 
proliferation, neuronal damage and energy metabolism. MRS can be extended 
to an imaging mode called MRS imaging (MRSI), in which the acquisition of 
multiple voxels provides spatially encoded chemical information. MRS(I) has 
been found useful in the diagnosis and grading of brain tumors1, 2 and could 
possibly reduce the need for an invasive biopsy3-6.  
The application of different MR approaches results in scattered 
information within a large amount of data, from which it may be difficult to 
derive a final diagnosis. To avoid that the clinician is overwhelmed with 
information, automated statistical methods have to be developed to process, 
combine and classify the data. In the past, several investigators have exploited 
MRI or MRSI7 information to classify brain tumors1, 3, 5, 6, 8-11. Only a few 
researchers4, 12 combined the spectral and image features to improve the 
classification result. If MRSI is performed next to MRI, then the combination 
of data from both modalities seems to be a logical extension, based on the 
idea that this synergy of data will improve substantially the power and 
robustness of the classification model.  
Next to classification, also the exact boundary and degree of heterogeneity 
of the tumor is very important in the diagnosis, prognostics and treatment of 
brain tumors. The use of metabolic maps, derived from MRSI data has been 
discussed frequently in literature13-17. These maps provide a good insight in the 
increase or decrease of important brain metabolites, like creatine, choline and 
N-acetylaspartate. Often, a significant statistical change in one of the 
metabolite levels is used as a marker for malignancy of the tumor. However, in 
most cases merely univariate methods are used, while the availability of 
information is highly suited for a multivariate approach. 
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In order to increase the reliability of classification, several classification 
approaches have been developed. The tree-like classifiers18 use multiple binary 
classifiers, each optimized for a specific decision. Another approach is to use a 
so-called consensus diagnosis9, in which several independent classifiers work 
in parallel. Last, reliabilities can be estimated from the calculation of posterior 
probabilities11 or from probabilities based on the actual distribution of the data 
itself12. 
This paper reports on the development of a decision support system to 
investigate whether multivariate automated pattern recognition of combined 
MRI and MRSI data could aid the clinician in diagnosing brain tumors. The 
methodology provides a spatially resolved classification result, a reliability of 
classification and a consensus diagnosis, that could lead to a better 
understanding of brain tumor type and morphology. 
Materials and methods 
This study has been approved by the ethical committee of the university 
medical center and from all patients written informed consent was obtained. 
MR data was acquired following a well defined acquisition protocol designed 
within the EU project INTERPRET19. Examinations were performed on a 
1.5 T Siemens Vision whole body system, using a CP-head coil. First, 
conventional transversal T1-weighted, T2-weighted and proton density 
weighted images (PD-image) were acquired. The MR images were collected 
using the following parameters: 23 slices of 5-mm thickness, inter-slice 
distance 1.5 mm, FOV 230 mm, matrix 256x256. For the T1-weighted images 
(TE/TR=15/644 ms) a standard spin echo sequence was used. The PD-
images (TE/TR= 16/3100 ms) and T2-weighted images (TE/TR= 
98/3100ms) were simultaneously acquired using a turbo spin echo sequence. 
This was followed by acquisition of a set of T1-weighted images after 
intravenous administration of a bolus injection of 15 ml 0.5 M Gd-DTPA 
Gadolinium-DTPA (Gd-image). 
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The protocol was concluded by water suppressed and unsuppressed proton 
MR Spectroscopic Imaging (1H-MRSI) with the use of a 2D STEAM 1H-
MRSI sequence with short echo time. The STEAM box was positioned in a 
transversal plane through the brain showing the largest Gd enhanced tumor 
area on a Gd-image. It was placed entirely in the brain parenchyma avoiding 
leakage of disturbing signals from fatty tissue surrounding the skull. MRSI 
parameters were: 16x16x1024 samples, TR/TE/TM = 2000 or 2500 ms / 20 
ms / 30 ms, slice thickness = 12.5 or 15 mm, FOV = 200 mm, spectral width 
= 1000 Hz and NS = 2 (1 for the MRSI without water suppression). 
Data sets. Data of a total of 18 patients and 4 volunteers were used in the 
study. Each patient case had passed strict quality control and validation 
procedures, including consensus histopathologic determination. 15 patients 
were diagnosed with a glial brain tumor of specific grade and one with a 
meningioma. For the two other patients no consensus of the grade could be 
reached, but both had a glial tumor. For the set-up of the training set, the data 
of the 15 patients diagnosed with a glial tumor of specific grade were divided 
into three classes according to the rules of the World Health Organization 
(WHO): grade II (6 cases), grade III (4 cases) and grade IV (5 cases) tumors. 
In order to create a sufficiently large training set, multiple MRSI voxels located 
within the tumor were selected from each patient. Also classes for healthy 
brain tissue and cerebrospinal fluid (CSF) were selected. The data for healthy 
tissue were selected from the contra-lateral brain region of several patients and 
from 4 healthy volunteers. Data representing CSF were selected from CSF 
voxels which were not in close contact with the tumor region. 
The patient with the meningioma was not used in the training set, but as a 
test case for contra-validation, that is, for this case the classifier should not 
assign the meningioma region to any of the classes used to construct the 
classification model.  
Preprocessing of spectroscopic data. The MRI and MRSI data were 
preprocessed in the same unique way for each case and automated where 
possible. Preprocessing of the MRSI data12 was performed as described in 
chapter 5 and comprised of the steps presented in figure 6.1. After 
preprocessing, each MRSI time domain signal was Fourier transformed to 
obtain a spectrum from which the real part of the region between 0.5 to 4.0 
ppm was retained (230 spectral points). To normalize the signals originating 
from different patients, all spectra of one patient were divided by the mean 
water signal of all voxels within the patients STEAM box. 
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Finally, from the processed MR spectra, intensities of seven spectral ranges 
encompassing signals of important brain metabolites were determined by 
integrating the intensities within a window of  0.13 ppm. The integration 
regions were chosen around the expected chemical shift of the main 
resonances of the following metabolites; glutamate/glutamine (at 3.75 ppm), 
myo-inositol (3.56 ppm), choline (3.20 ppm), creatine (3.02 ppm), N-acetyl 
aspartate (NAA, 2.02 ppm), lactate/fatty acids (1.33 ppm) and fatty acids (0.90 
ppm). 
Matching image resolution. The MR images were aligned with respect to 
each other, by successively shifting the T1- weighted and Gd-image with 
respect to the PD-image until a maximum of spatial correlation was reached. 
Then, the image pixels not within the boundary of the STEAM box were 
discarded, and the resolution of the remaining part of the MR images was 
lowered to the resolution of the MRSI grid. This was performed by averaging 
the intensities of the image pixels which were covered by each spectroscopic 
voxel. Last, the low resolution images were scaled. After scaling, the minimum 
and maximum intensity values in an image were in agreement with the 
minimum and maximum values of the integrated regions of the spectral data. 
However, the minimum intensity value could not be lower than 0. After 
preprocessing, each voxel within the STEAM box was represented by 7 
spectral variables obtained by the integration of metabolite regions and 4 
variables extracted from the four MR images. 
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Figure 6.1. Flow diagram of the processing of data, followed by 
segmentation, classification and visualization procedures. For specific settings12 used 
for the processing steps, and general information about the eddy current correction20, 21used, HLSVD 
filtering22 and baseline correction23, we refer to chapter 3, 5 and 7. 
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Segmentation with mixture modeling. For the segmentation of the brain, a 
clustering program based on mixture modeling was used. For an extended 
explanation of this method7, we refer chapter4 and24. Mixture modeling fits 
the input data space with a set of multi-dimensional Gaussian bells, whose 
location, shape, orientation and volume have to be determined. The method 
starts with an initial partitioning of the data in as much fractions as the 
number of clusters (k) one expects. On basis of this partitioning, the 
parameters for the k multi-dimensional Gaussians are calculated. Then the 
conditional probabilities of all objects for all classes k are calculated. On basis 
of the probabilities of each object for all classes, the data can be re-partitioned 
and new parameters for the Gaussians can be calculated. This is repeated 
iteratively until convergence of the likelihood occurs. The likelihood is used as 
an estimator for the underlying distribution describing the spread of the data 
in an optimal way. The clustering can be repeated with differences in the 
model to find the optimal clustering. The most important difference concerns 
the number of clusters (Gaussians) one assumes to be present in the data.  
To select which clustering is optimal, the quality of the clustering can be 
assessed. The likelihood of the clustering is a first indication, but fails to 
incorporate the complexity and number of clusters of the model. A measure 
which corrects for this is the Bayesian Information Criterion (BIC)25. With the 
use of the BIC value, the model that fits the data best, if a specific number of 
clusters is used, is selected. Selection of the best number of clusters is left to 
the clinical expert to allow a synergy between the statistically based 
segmentation and the medical expertise (partially based on a patients casus). 
Practically, all voxels of a patient, using the 11 selected variables as input, 
are clustered. Clustering is repeated with 3, 4, 5, and 6 clusters, each with 6 
different models (restrictions on the Gaussians). The clusterings with the best 
model for the 3, 4, 5, and 6 cluster solution are chosen automatically using the 
BIC values. Finally, the clinician decides what number of clusters is optimal 
for the best possible segmentation. At this point it is also possible to manually 
rearrange the segmentation by deselecting voxels or changing segment 
membership. The clustering result is projected on a high resolution image and 
the clusters can be colored according to the classification with the 
classification algorithm. 
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Classification. Previously, a classifier has been developed to classify grade 
II, grade III, and grade IV glial tumors, healthy tissue and CSF12. It classifies 
new objects to one of these classes, as unknown (meaning that the object 
does not belong to any of the pre-defined classes) or as undecided (indicating 
that the object possesses a multiple class membership) between grade II and 
grade III tumor. Classification is based upon the Mahalanobis distances26 of a 
new sample towards the centroids of all classes. The sample is assigned to the 
class it has the closest distance to, if this distance does not exceed a critical 
value. If the distance exceeds this critical value, the sample is assigned as 
unknown. Because the grade II and grade III classes were found to be 
overlapping, a sample is only assigned to one of these classes if its distance is 
sufficiently lower than to the other class. If the distance to both classes is 
within the same range, then the sample is assigned to be undecided between 
grade II and III.  
Next to classification, also relative probabilities of classification are 
calculated by the method. This is based on the distance of the sample to each 
class and the distribution of the classes. The probabilities of classification 
indicate whether the classification is reliable. If the probability for only one 
class is high, then the reliability of classification is high. If probabilities for 
several classes are in the same range, then the reliability of classification is low.  
The classifier has been extended to facilitate the classification of segments 
found by the clustering model. This is performed by averaging the MRI and 
MRSI information of voxels belonging to the same segment, followed by 
classification of this average information. Theoretically, this is possible, if the 
voxels within a segment are from the same type of tissue. Classification could 
even become more robust, since the averaging of similar voxels might 
improve coherence of the input data. 
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Evaluation. To evaluate the decision support system and the classification 
results, the classification of the segments was compared with the classification 
of the individual voxels and with the results of the histopathologic 
determination. The classification and probability of classification maps were 
visually inspected to investigate whether the classification result showed a 
homogeneous section in the brain. Also the occurrence of outliers was 
investigated visually. Four radiologists of the University Medical Center 
Nijmegen (UMCN) evaluated the segmentation by assessing the results of five 
patients. For each case they had to draw the malignant area (or areas) in the 
patients brain, based upon all available image information and clinical 
information. After drawing the malignant area, the radiologists were asked to 
select from the 3 to 6 segmentation result, produced by the clustering the one 
which corresponded best to their drawing. Then they were asked to what 
extent the selected segmentation agreed with their drawing. 
Results 
The result of the classification strategy, that can be displayed on a monitor, 
is shown in figure 6.2. Figure 6.2a provides the clinician with the MR images 
of the patient. In figure 6.2b the segmentation of  the brain into 3, 4, 5 and 6 
segments respectively, is shown. Note that voxels assigned to different clusters 
in one segmentation solution may be combined in another clustering solution. 
The colors in each segmentation are only used to visualize the results, so 
corresponding colors for different segmentations have no specific meaning. 
After segmentation, the information from voxels that are within the same 
segment is averaged, and can be used for classification.  
To help the clinician to decide which segmentation is best, figure 6.2c is 
displayed. It shows for each segment in the 3-6 segment solution of figure 
6.2b, the probabilities that it belongs to one of the investigated tumor classes. 
Each row shows the probabilities of class membership of a specific segment, 
for all classes. Each cell is colored gray, a darker color means a higher relative 
probability for a class. The first row, for example, represents the blue segment 
in the 3 cluster solution. It has relatively low probabilities for all classes. This 
either means that the segment does not belong to any of the classes 
investigated, or it may mean that the segment does not contain voxels with 
similar features for the investigated classes. The black segment (second row) 
has the highest probability for grade III, but also some for grade II. The green 
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segment has a high probability for healthy, but also some for grade II. In 
comparison, the five segment solution (row 8-12) shows a high probability for 
grade III for the blue segment. The black segment has a high probability for 
grade II, the green for grade II and III. The red and yellow segments have a 
high probability for healthy tissue. If compared with the 3 segment solution, 
the 5 segment solution has more segments with a high probability for one 
class and is thus to be favored above the 3 segment solution. figure 6.2c 
provides the clinician with an easily visualized statistical measure, that can be 
used to assess the clustering. Together with the MR images and the clinical 
information, the best clustering can be chosen by an expert in the field of 
radiology. The five segment solution is selected, because of the very high 
probability of the blue segment for grade III in the five segment solution and 
the consistency with the MR images. 
 
Figure 6.2. Results of the classification strategy for patient I-1229. The patient 
has a grade III glial tumor. The I-number corresponds with the INTERPRET database. See the 
text for the explanation of the figures. 
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The classification result of the segmentation is shown in figure 6.2d. From 
now on, the colors of the segments represent a classification result: black) 
undecided,  purple) unknown, red) grade IV, blue) grade III, green) grade II, 
cyan) cerebrospinal fluid, and yellow) healthy. Different segments can be 
classified to the same class, as shown in the example. The former red and 
yellow segments have been assigned to healthy and are therefore colored 
yellow. Most of the brain is classified as healthy. In the tumor area, a small 
grade III classified section (blue) is surrounded by two other sections. The 
black one is undecided. The green one is classified as grade II.  
Next to the probabilities and classification of the segments, also the 
probabilities and classification of the individual voxels may be of clinical 
interest. The probability maps of the individual voxels for each class are 
plotted in figure 6.2e. There are as many maps as there are classes. In each 
map, the probability of class membership for all voxels for a specific class is 
plotted in gray. The gray levels are comparable with the levels found for the 
probabilities of the segments. The interpretation of the maps is very 
important. If a voxel has a high probability of membership for only one class, 
then the classification will be reliable. If  a particular voxel has a probability 
for more classes, then the resulting classification will be unreliable. In certain 
cases it may indicates that the tissue is heterogeneous. Low probabilities for all 
classes indicates that the underlying tissue type is unknown. Using the 
classification rules dictated by the classifier, each voxel can be classified. The 
result of classification is presented in figure 6.2f. The colors represent the 
same tissue type as in the classification of the segments. 
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To compare the classification result of the segments and the individual 
voxels with each other and with the pathology of each patient, a single 
classification result from each had to be deduced. This single classification 
result is summarized in table 6.1, and compared with the classification 
obtained by the radiologist. To obtain a single classification result from the 
spatially resolved segmented brain, the following rules were applied: a) first, 
the best segmentation was selected by comparing the MR images, the 
segmented images and the accompanying probabilities; b) then, the tumor was 
assigned to the classification of the segment with the highest grade. If the 
voxels of this segment were not next to each other, but for example, were 
situated in the corners, then the classification result of this segment was not 
taken into account. Then, the segment with the next highest grade was 
validated. For patient I-1229, the five segment result was chosen, thus the 
tumor was classified as a grade III. 
A single classification result of the tumor using the individual voxels was 
more difficult, because the classification was normally heterogeneous. 
Classification was performed as followed: a) the number of voxels was 
counted that were classified the most malignant (with the same grade); b) it 
was checked whether these voxels were next to each other, and in the vicinity 
of the tumorous area. If so, the tumor was assigned to this class. If this was 
not the case, another class was selected based upon the voxels with the second 
highest grade. This selection method was used, since it often occurred that 
voxels at the edge were misclassified as grade IV. Hence, to circumvent this 
artifactal problem, voxels with the same classification had to be next to each 
other and inside the clearly visible tumorous area. 
Table 6.1 (page 129) shows that only one of the cases in the training set is 
misclassified. I-1232 is classified as a grade II tumor while its pathology is 
grade III. The independent test case I-1283, is classified as unknown, which 
is correct, since the classifier was not trained to take meningiomas into 
account. The two cases for which the pathologists could not reach a 
consensus are also classified to test the system. In both cases, the classification 
result of segments and individual voxels is in accordance with the morphology 
of the brain, as seen on the MR images. The healthy tissue and CSF can be 
clearly identified. The classification result of the tumor of patient I-1281 is 
grade II for the classification using segments as well as for the individual 
segments. The case I-1172 is shown in figure 6.3, to illustrate the result of a 
test case from which no tumor voxels have been selected in the training set.  
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Figure 6.3. Decision support results of patient I-1172. 
 
The MR images for patient I-1172 show a malignant area in the lower left 
of the brain. This part is isolated in the 3, 4, 5 and 6 segment solution. Only in 
the 5 and 6 segment solution the ventricles are isolated. Also the probabilities 
for class membership are higher for the segments in the 5 or 6 segment 
solution, if compared with the 3 and 4 segment solution. The classification 
result of the 5 segment solution is plotted on the lower left of figure 6.3. This 
shows a large unknown segment and a grade II segment. The individual 
classification shows the heterogeneity of the malignant area. Voxels are 
classified as grade II, grade III, grade IV and unknown. This reflects the 
difficulties of the pathologists to validate this patient. 
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Table 6.1. Classification results using pathology, classification of seg-
mented brain and classification of individual voxels. 
I-a Pathologyb Sc classification
segmentsd 
classification
individual 
voxelse 
remarks 
1227 II 4 II II  
1233 II 4 II II 1 gIV voxel outside tumor 
1260 II 4 II II 3 gIV voxels outside tumor 
1275 II 5 II II  
1278 II 3 II II 3 gIV voxels outside tumor 
1318 II 6 II II  
1212 III 3 III III 1 gIV corner voxel 
1229 III 5 III III  
1230 III 3 III III 4 gIV voxels inside tumor 
1232 III 5 II II not one gIII voxel or 
segment; one gIV voxel 
1231 IV 4 IV IV  
1234 IV 5 IV IV tumor area is surrounded by 
unknown 
1285 IV 4 IV IV  
1286 IV 3 IV IV all segments and most 
voxels other than gIV are 
classified as unknown  
1322 IV 5 IV IV  
1283 MNG 3 unknown unknown  
1172 II/III 5 II IV tumor area is a mixture 
1281 II/III 5 II II  
a: patient number. The numbers correspond with the INTERPRET database. 
b: Pathology (only the grade if glial) of the tumor as validated by consensus histo-pathologic 
determination. 
c: The optimal number of segments in the brain as selected by an expert. 
d: See the text for explanation of the single classification deduced from the classification of segments. 
e: See the text for explanation of the single classification deduced from the individually classified 
voxels. 
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The results of the evaluation of the segmentation is schematically 
represented in table 6.2. For each subject, the number of pathologists is given 
that selected the 3, 4, 5 or 6 segment result as best. In two cases all radiologists 
agreed that the same segmentation result corresponded best with their 
drawing. In one case the radiologists choose between the 4 and 5 
segmentation result, and in another between the 3 and 4 segmentation result. 
Only in one case the radiologists disagreed between 3 segmentation results. 
 
Table 6.2. Results of clinical evaluation  
 question 2 of questionnairea  question 3 of questionnaireb 
subject 3 segm. 4 segm. 5 segm. 6 segm. yes no 
I-1229  2 2  4 0 
I-1231  4   3 1 
I-1260 2 1 1  3 1 
I-1278 4    4 0 
I-1285 2 2   3 1 
a: Question: which segmentation result produced by the clustering corresponds best to the drawing 
you made of the tumor? 
b: Question: does the selected segmentation agree with the drawing you made? 
 
Remarks of the radiologists were that sometimes the tumor extended 
outside the STEAM box, causing this part of the tumor not to be taken into 
account by the segmentation algorithm. Other remarks were that the 
tumorous part was sometimes divided into multiple segments by the classifier, 
or that the healthy region consisted of multiple segments. This was considered 
to be a disadvantage by some, but not all by radiologists. However, usually, 
multiple segments were combined after the classification procedure because 
the segments were identically classified. During the clinical evaluation of the 
clustering this was not taken into account.   
In the example case presented in figure 6.2 (I-1229), all radiologists draw an 
equally large region at the same location. Subsequently, two radiologists draw a 
smaller region within the first one. These two radiologists favored the five 
segment result, while the other favored the four segment result. 
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Discussion 
A medical decision support system has been developed to aid clinicians in 
the diagnosis of patients with a brain tumor. The system condenses spectral 
information that may be difficult to assess, combines it with MR imaging 
information and provides a classification result. The classification results are 
displayed as images, which will facilitate the interpretation and provides 
information of the heterogeneity of the tumor. Tumors are known to be 
heterogeneous. Several groups16, 13-15 have reported that MRSI can play a role 
in the detection of metabolic changes in the tumor tissue as well as in the 
surrounding tissue, but mostly univariate methods are used. Only few reports 
have appeared which discuss the use of multivariate approaches on MRSI 
data4, 5, 12 in the classification of brain tumors, whereas the data is highly 
suitable for multivariate analysis. One of the major advantages of MRS is that 
it allows the observation of a large number of metabolites simultaneously. 
During multivariate analysis this information is combined (possibly including 
MRI or other information) and pattern recognition8, 10, 27 is used to identify and 
interpret the meaningful regularities in the data. Pattern recognition has shown 
to provide good classification results on spectroscopy data6, 11, 28 and MRI 
data29, and the combined findings of MRI and single voxel spectroscopic data 
by experts in the diagnosis of intracranial mass lesions has shown to increase 
the correct diagnosis30. Therefore, the combination of MRI and MRSI data in 
a multivariate classification approach may serve as a solid basis for reliable 
automated brain tumor classification. Since our results show a correct 
classification of 14 of the 15 cases, this indeed seems to be the case. 
Especially, since only a maximum of 30% of the voxels of each patient were 
within the training set. 
One of the difficulties in the use of both spectral and image data in tumor 
classification, is the harmonization of both data sources for input. Since the 
images only add four extra variables, feature reduction applied to exclusively  
the spectra seems a meaningful solution. In our approach a simple 
quantitation of relevant metabolite peaks was used. This, to incorporate prior 
biochemical knowledge into the feature reduction method. Next to feature 
reduction on the spectroscopic data, the spatial resolution of the MRI and 
MRSI have to be matched. Since the two are acquired with a large difference 
in spatial resolution the selection has to be chosen carefully. Lowering the 
MRI resolution will lead to loss of information, but when the MRI resolution 
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is kept, the registration of the images needs to be very accurate in order to 
avoid mixing of pixels (due to patient movement). At a higher resolution, the 
weighting of the image variables is larger than the MRSI variables. Details in a 
region within a spectroscopic voxel would be due to the image variables alone. 
Furthermore, when increasing the resolution of the MRSI data, the 
information from each MRSI pixel is still acquired from a large volume. This 
will lead to pixels which are described by variables which contain information 
from a much larger volume than the pixel volume itself. Since normally the 
tumor covers multiple MRSI voxels, it was decided to use a resolution of twice 
the true MRSI resolution. In this way we used the spectral variables optimally, 
avoiding problems with co-registration of MRI images, modeling complexity 
and computation time. 
To further increase the reliability of the system, it is important to calculate 
probability values for the classification. High probabilities for a tumor type in 
a specific region may help to localize the most malignant part of the tumor, 
and thus play a role in the assessment of heterogeneity. This is especially 
helpful in guiding the clinician towards the best location to perform a biopsy.   
A consensus diagnosis can be considered as another method to improve 
the classification result9. Consensus diagnosis involves the analysis of the same 
data by several multivariate methods. In our approach the classification of the 
segments and individual voxels is performed by the same method. However, 
the segmentation algorithm is totally independent to the classifier. We have 
found in several cases that the probability of classification of a segment in the 
tumor was higher than any of the probabilities of the individual voxels. Since 
the tumor normally originates from one type of cell and is often larger than 
one voxel, it could be advantageous to combine voxels within the tumor 
during the classification process. However, instead of averaging all voxels in 
the tumor manually, the segmentation algorithm only averages those voxels 
which share features. Therefore, it reckons with the spatial heterogeneity of 
the tumor. The algorithm needs no prior knowledge, nor normalization 
between patients. It is therefore independent of a training set and will always 
provide relevant information of the location and different fractions within the 
tumor, even in the case if classification is not possible. Evaluation of the 
segmentation is very difficult as there is no golden standard available. 
However, most of the time the ventricles and the contra-lateral healthy brain 
were found as separate segments. Often the tumor area itself was divided in 
several segments, which can be explained by the presence of heterogeneous 
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tissue. Radiologists who were asked to validate the segmentation were positive 
on the results. For all five investigated cases, the radiologists were able to 
point out a clustering result that to their opinion covered the region that they 
had drawn as malignant. 
Classification of the segments is convincing for all patients. Always at least 
one segment is found which covers most of the tumor and that is classified in 
agreement to the pathology of the patient, except for patient I-1232. This 
patient is misclassified as a grade II, while it has been validated as a grade III. 
Calculation of an objective criterion for the evaluation of each segment is 
difficult. However, a comparison of the classified segments with the high 
resolution images and the pathology seems to indicate that classification of the 
segments is robust. In the case of patient I-1172, a consensus regarding the 
pathology was not reached by the three radiologists who validated the patient. 
The radiologists opinions disagreed between tumor type and grade: a) 
astrocytoma grade III, b) astrocytoma grade II, and c) oligodendroglioma 
grade II. The segmentation of this patient only seemed meaningful in the five 
and six segment solution and exhibited multiple segments in the malignant 
area. The probabilities of class membership for the blue and black segment 
were low for all classes in the five segment solution. These segments could not 
be classified (unknown). The relatively small green segment had a high 
probability of class membership for the grade II as well as grade III class, but 
was classified as grade II. The classification of the individuals voxels showed 
grade II, III, IV and unknown in the malignant area. The classification 
reflected the difficulties of the radiologists in typing the malignancy of this 
patient. 
The classification results of the individual voxels was for each patient in 
agreement with the pathology of the tumor, except again for I-1232. However, 
in some cases voxels in the vicinity of the tumor or at the border of the 
STEAM box were misclassified as grade IV, which could lead to 
misclassifications. This shows the importance of the classification of the 
segments, which did not show this kind of errors. The consensus of both 
methods seems to improve the reliability. The probability values of the 
individual voxels are also important. They provide information about the 
reliability of classification and sometimes the heterogeneity of the tissue. If a 
voxel has a high probability for a specific tissue type and only for this tissue 
type, then the tissue at that location will be relatively homogeneous. If the 
probabilities of  a particular voxel are the same for two tissue types, then the 
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reliability of classification will be lower. If the probabilities of class 
membership are the same for two tissue types which both can be present in 
the brain, then this can also indicate tumor heterogeneity. If the probabilities 
are high for two totally different tumor types, then the reliability of 
classification is low. This phenomenon is also reflected in the probability maps 
of patient I-1172 (figure 6.3). The healthy and CSF regions have high 
probabilities for healthy and CSF, which indicates homogeneity of the tissue in 
that area. In the right part of the brain, several voxels have high probabilities 
for grade II as well as grade III, indicating tissue heterogeneity. 
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Abstract 
The purpose of this paper is to investigate feature selection on several 
sources of MR data, to provide an optimal basis for brain tumor classification. 
Suppressed and unsuppressed short echo time magnetic resonance 
spectroscopic imaging data (MRSI) and MR imaging data from 28 subjects 
were used during the investigations. Four different feature reduction 
procedures were applied on the MRSI data; simple quantitation, principal 
component analysis, independent component analysis and LCModel. From 
the unsuppressed MRSI data, the intensity of the water signals were calculated. 
Different combinations of the MRSI features, the water signal and the MRI 
features were used as input for a classification procedure, that was setup to 
classify four types of tumor, healthy brain tissue, and cerebrospinal fluid. The 
classification results were compared to investigate the best feature selection 
procedure.  
Conclusions are that feature reduction on the MRSI data, if carefully 
executed, is not critical for the classification result. However, combination of 
features from MRSI and MRI data improves the classification result with 
approximately 15%. The addition of features from the water signal additionally 
increases the classification result, although not significantly. The combination 
of data from different sources (including for example clinical information) 
may be very important for the result of brain tumor classification, particularly 
if a large number of tumors is needed to be classified simultaneously. 
 
Keywords:  magnetic resonance spectroscopy, data processing, feature 
selection, classification, pattern recognition, brain tumor. 
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Introduction 
The correct diagnosis of tumor type and grade is very important for the 
treatment of patients with a brain tumor. At the moment, the diagnosis is 
mostly made through a histopathologic determination of a tissue sample taken 
from a biopsy. Imaging techniques, like magnetic resonance imaging (MRI), 
are used to locate the position and extent of the tumor and are a further help 
in the diagnosis. 
To diminish the use of an invasive biopsy, which is very stressful for the 
patient, the usefulness of proton magnetic resonance spectroscopy (MRS) for 
tumor typing is under investigation1-3. Proton MRS provides completely 
different information as compared to imaging tools, but can be obtained with 
most 1.5 T MRI instruments used for routine radiology. The acquired MR 
spectra provide localized metabolic information related to cell membrane 
proliferation, neuronal damage and energy metabolism of brain or tumor 
tissue. The spectra contain information from important brain metabolites like 
glutamate, myo-inositol, choline, creatine, N-acetyl aspartate (NAA), lactate 
and fatty acids4. Proton MRS can be extended to an imaging mode called 
proton MRS imaging (MRSI), in which the acquisition of multiple voxels 
provides spatially encoded chemical information from the brain. MRSI, in 
combination with MRI5-9, could possibly be used to resolve tumor location, 
type and grade in an automated noninvasive way. However, the large amount 
of data acquired during the investigation of the patient, and the difficult 
interpretation of the spectroscopic data requires the development of 
classification strategies that are based on pattern recognition.  
Four stages can be defined in the strategy of developing automated tumor 
classification models with the use of pattern recognition. The first comprises 
of a selection of training samples (training set) for the tumor classes to be 
classified. Optimally, for each class also an independent test set is selected, in 
order to test the accuracy of the classifier. The second step consists of 
preprocessing on the data. This may involve several steps of which the 
following are the most common; a) Eddy current correction10, b) water 
filtering with HLSVD11, c) adjustment of begin time (first order phase 
correction in time domain), d) Fourier transformation, and e) normalization 
with a separately obtained water signal. 
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The third step involves feature selection of the highly dimensional 
spectroscopic data. During feature selection, variables are selected from the 
data, which are meaningful for the classification. This is especially important 
when spectroscopic data is used in the classification, since in this case the 
number of variables normally exceeds the number of objects. Feature selection 
should only retain the information that optimally discriminates the tumor 
classes under investigation. Unfortunately this is not a straightforward task. 
Feature selection also implies that features from different sources of data are 
combined. In the case of data obtained from clinical MR systems, this is not 
only reserved to the combination of water suppressed proton MRSI and MR 
imaging data. Also the water signal which is obtained from the unsuppressed 
MRSI can be used, or spectroscopic information from other MR sensitive 
nuclei, like 31P. 
The last step in automated tumor classification, involves the actual 
classifier. If the feature selection has been sufficient, the shortest distance to 
the centroids of the classes, or the k-nearest neighbors12 can be used as 
classifier. The data can also be used as input for methods which further reduce 
the dimensionality by finding optimal separable directions, e.g. linear 
discriminant analysis or quadratic discriminant analysis. There are much other, 
more specialized methods, for example based on density functions13, neural 
networks14 or support vector machines15.  
In the search for the best strategy for brain tumor classification, feature 
selection has not received much attention. In this paper, several feature 
selection methods are compared. First, features are selected from MRSI data 
with four different feature reduction methods. Also features are selected from 
MRI data and from water signals obtained from unsuppressed MRSI data. 
Then, combinations of the selected features are used to build classification 
models. Last, the classification results of an independent test set are compared 
to find the best feature selection method.  
Experimental 
Data acquisition protocol. This study has been approved by the ethical 
committee of the university medical center and from all patients written 
informed consent was obtained. Data of 24 patients with a brain tumor and 4 
volunteers were used in the study. Each patient case had passed strict quality 
control and validation procedures, including consensus histopathologic 
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determination. 21 patients were diagnosed with a glial brain tumor of specific 
grade and 3 with a meningioma. 
MR data from each patient was acquired following a distinct defined 
acquisition protocol setup by the INTERPRET consortium16. All 
measurement were performed on a 1.5 T Siemens Vision whole body system, 
using a CP-head coil. The protocol consisted of the acquisition of 
conventional T1-weighted, T2-weighted and proton density weighted images 
(PD image). This was followed by a T1-weighted image after intravenous 
administration of Gadolinium-DTPA (Gd image), and concluded by water 
suppressed and unsuppressed proton MR Spectroscopic Imaging (1H-MRSI). 
Transversal MR images were collected using the following parameters: 23 
slices of 5-mm thickness, inter-slice distance 1.5 mm, FOV 230 mm, matrix 
256x256. For the T1-weighted images (TE/TR=15/644 ms) a standard spin 
echo sequence was used. The PD image (TE/TR=16/3100 ms) and the T2-
weighted images (TE/TR=98/3100ms) were simultaneously acquired using a 
turbo spin echo sequence. After a bolus injection of 15 ml 0.5 M Gd-DTPA a 
T1-weighted measurement was performed to obtain the Gd image. Eventually, 
only the four images (with different contrasts) acquired from the same 
location as the MRSI were retained. Images just below or above were 
discarded, since they were not totally within the MRSI slice. 
The MRSI were acquired using a 2D STEAM 1H-MRSI sequence with 
short echo time. The STEAM box was positioned in a transversal plane 
through the brain showing the largest Gadolinium-DTPA enhanced tumor 
area in the Gd image. It was placed entirely in the brain parenchyma avoiding 
leakage of disturbing signals from fatty tissue surrounding the skull. MRSI 
parameters were: 16 x 16 x 1024 samples, TR/TE/TM = 2000 or 2500 ms/ 
20 ms / 30 ms, slice thickness = 12.5 or 15 mm, FOV = 200 mm, spectral 
width = 1000 Hz and NS = 2 (1 for the MRSI without water suppression). 
Data preprocessing. The MRI and MRSI data were processed in the same 
unique way for each case and automated where possible. The preprocessing 
procedures are schematically presented in figure 7.1a. For the suppressed 
(metabolite) MRSI data (left column of figure 7.1a); K-space data was filtered 
by a Hanning filter of 50% using the LUISE software package (Siemens, 
Erlangen, Germany), followed by zero filling to 32 X 32 and 2D Fourier 
transformation to obtain time domain signals for each voxel. Then, each voxel 
within the STEAM box was corrected for eddy current effects in the spectra 
using a method which prevents the occasional occurrence of eddy current 
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correction induced artifacts17. This was followed by HLSVD filtering11 to 
remove the residual water signal between 4.3 and 5.5 ppm. Next, a simple but 
efficient baseline correction with a filter width of 5 ms was applied, that 
removed broad resonances18. To correct for first order phase effects (in 
principle the zero order phase is removed by the eddy current correction), the 
first order phase of the mean spectrum as calculated from all spectra within 
the STEAM box of each patients MRSI dataset, was manually optimized. This 
correction value was then applied to each separate time domain signal of that 
dataset. The resulting data consisted of the preprocessed free induction decays 
(FIDs) for each voxel within the STEAM box of the patient.  
In order to combine information from the spectroscopic data with 
information from the MR images they need to have the same resolution and 
have to be aligned. The MR images were aligned with respect to each other, by 
successively shifting the T1- weighted and Gd image with respect to the PD 
image until a maximum of spatial correlation was reached. The MRSI 
spectroscopic grid was assumed to be aligned with the PD image, since they 
were acquired consecutively. After alignment of the MR images, the image 
pixels which did not fit within the boundary of the STEAM box were 
discarded. Then, the resolution of the remaining part of the MR images was 
lowered to the resolution of the MRSI grid. This was performed by averaging 
the image pixels which were covered by each spectroscopic voxel.  
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Figure 7.1 Overview of data preprocessing and feature selection. A schematic 
overview of the preprocessing of the metabolite MRSI, water MRSI and MRI is shown in figure a. 
The feature reduction methods used on the metabolite MRSI are shown in figure b. The feature 
reduction is performed on the non-normalized data as well as on the water normalized data. 
Classification results were calculated for each of the shown combinations of different sources of data in 
figure c. 
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The unsuppressed water signal. The unsuppressed (water) MRSI was 
used for 3 specific reasons. First during preprocessing, to perform eddy 
current correction on each voxel. Secondly, the water signal for each voxel 
was quantitated. This was done as follows: K-space data were filtered by the 
same Hanning filter as the metabolite MRSI data, followed by zero filling to 
32 X 32 and 2D Fourier transformation to obtain time domain signals for 
each voxel. Then, the amplitude of the water signal was estimated with 
software provided by dr. L. Vanhamme (Katholieke Universiteit Leuven, 
Department of Electrical Engineering, SCD-SISTA, Kasteelpark Arenberg 10, 
3001 Heverlee, Belgium). This software models the water signal in the time 
domain by a Voigt model, with an additional first order term that corrects for 
eddy currents. HSVD is used to obtain initial estimates of the model 
parameters, that are subsequently used as starting values in a nonlinear least 
squares optimization algorithm to obtain the final parameter estimates. Third 
and last, the mean water signal of all voxels within the STEAM box of each 
subject was calculated. This value was used as an inter patient normalization 
factor. Water normalization of the metabolite MRSI was performed by the 
division of each metabolite FID in a patients data set by its calculated mean 
water signal. Also the calculated water signal of each voxel in a patients data 
set, was divided by the mean water signal, to obtain inter patient normalized 
water signals for each voxel. 
construction of the data set. To create a sufficiently large data set, several 
MRSI voxels from each subject were selected and assigned to one of the 
classes under investigation. The glial tumors were divided into three classes, 
according to the rules of the World Health Organization (WHO): grade II (10 
cases), grade III (4 cases) and grade IV (7 cases) tumors. Furthermore, classes 
for meningioma (MNG, 3 cases), healthy brain tissue, and cerebrospinal fluid 
(CSF) were constructed. The data for healthy tissue were selected from the 
contra-lateral brain region of 4 patients and from 4 healthy volunteers. Data 
for the CSF were selected from 8 patients. Only CSF voxels that were not in 
close contact with the tumor region were selected. This led to a data set 
containing 6 classes and data from 669 voxels.  
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All voxels in the data set were labeled, so when a specific feature selection 
method was applied, the data could be split afterwards into a training- and 
test-set, which for each feature selection method consisted of the same voxels. 
In table 7.1 an overview is presented of the total number of selected voxels for 
the different classes and the number of voxels in the training- and test-set, 
respectively.  
Table 7.1. Selected voxels for each class in the data set. 
tumor class data set training set test set 
healthy 218 153  65 
CSF 100  70  30  
grade II 176 123  53 
grade III  57  40  17 
grade IV  70  49  21 
MNG  48  34  14 
total 669 469 200 
 
Investigated feature reduction methods for the MRSI data. After 
preprocessing, the information from each voxel in the data set consisted of a 
metabolite FID of 1024 complex values, four variables from the MR images 
and one variable from the water signal. To use this information in a 
classification approach, at least feature reduction had to be performed on the 
high dimensional metabolite FID. In figure 7.1b an overview is given of the 
feature reduction methods used to extract new features from the metabolite 
MRSI data. Feature reduction was performed on the non-normalized and 
water normalized FIDs of the metabolite MRSI data. The feature reduction 
methods are explained in more detail below. 
After feature reduction, several combinations of the data were made, and 
used as input for the classifier. The output of the different feature reduction 
approaches were coded in the following way; qua for simple quantitation, 
pca for principal components analysis, ica for independent component 
analysis, and lcm for quantitation using LCModel. The feature reduction 
results of the water normalized metabolite MRSI data were coded quan, 
pcan, ican, and lcmn. The data containing the image information were 
coded ima. The data  containing the inter patient normalized water signals 
were coded watn. Figure 7.1c provides an overview of all 24 used 
combinations. 
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a) Simple quantitation. Each FID in the data set was Fourier 
transformed to obtain a spectrum from which the real part of the region 
between 0.5 to 4.0 ppm was retained (230 spectral points). An example of this 
part of the spectrum of 230 points is shown in figure 7.2. Then intensities of 
eight spectral ranges encompassing signals of important brain metabolites 
were determined by integrating the intensities within a window of  0.13 ppm 
(as indicated by the gray bands in the spectrum of figure 7.2). The integration 
regions were chosen around the expected chemical shift of the main 
resonances of the following metabolites; myo-inositol (3.56 ppm), glucose 
(3.44 ppm), choline (3.20 ppm), creatine (3.02 ppm), glutamate/glutamine 
(2.20 ppm), N-acetyl aspartate (NAA, 2.02 ppm), lactate/fatty acids (1.33 
ppm) and fatty acids (0.90 ppm).  
 
Figure 7.2. Example of spectrum and quantitated regions 
 
b) PCA. For the principal component analysis (PCA), also the real part of 
the spectral region between 0.5 to 4.0 ppm was retained (230 spectral points). 
All 230 points were used as input for the PCA. No extra scaling was 
performed. PCA finds directions in the data that explain most of the variance. 
These new axes are linear combinations of the original ones, are orthogonal 
and ordered with respect to the amount of explained variance12. After PCA, 
the first eight principal components, that explained 82.05 % of the variance 
were retained. The number of principal components to use is normally not 
straightforward. We used eight to make a comparison with the eight variables 
obtained by the quantitation of important spectral ranges as described above. 
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c) ICA. We also used independent component analysis (ICA)19 as a feature 
reduction technique to select 8 variables from the original 230 spectral points. 
During ICA, components that are linear combinations of the original variables 
are obtained that have the property to be as independent as possible. 
Theoretically, this means that all information within one component is from 
one independent source, and that another component cannot contain 
information from that source. Several algorithms have been proposed in the 
literature to perform ICA. In this study, the FastICA algorithm20 is used, 
because it is fast, relatively robust and easy to use.  
First, the dimensionality of the data was further reduced by PCA to 40 
components (89,25 % of eigenvalues) prior to the application of ICA, as 
suggested by A. Hyvärinen21. Then, 8 independent components were 
calculated using a symmetric approach and a skew nonlinearity function. We 
chose to calculate 8 components to match the number of metabolites 
quantitated and therefore facilitate the comparison of the different feature 
selection techniques. However, some additional study has to be performed to 
know if this number of components is optimal for the classification process. 
The algorithm allows to obtain the independent components as well as the 
mixing matrix containing the quantities of each component present in each 
voxel. The 8 scores of each voxel were then used as new variables. 
d) LCModel. The MR spectra in the data set were also analyzed with the 
LCModel 5.2-2 software package22. LCModel uses a linear combination of in 
vitro metabolite model spectra to fit the in vivo measured spectra. The in vitro 
metabolite spectra were separately obtained under similar experimental 
conditions as the in vivo measurements. Input of the LCModel was the time 
domain data of each metabolite FID in the data set, and the in vitro linear 
combination of metabolite model spectra, also referred to as 'basis set'. The 
LCModel23 program combines constrained least squares analysis with 
constrained regulation to optimize the estimated metabolite parameters with a 
line shape convolution to correct for in vivo distortions and a baseline 
correction of Cubic B-splines with equally spaced knots. Zero and first order 
phase correction and reference shift correction are included in the model. 
In this case, the zero order phase correction was fixed and the 'basis set' 
was extended by two frequency shifted singlets to simulate the lipid 
resonances at 0.90 and 1.33 ppm. This enabled additional parameter estimates 
of these lipid signals. The metabolite concentrations of NAA+NAAG, 
Cho+GPC+PCh, Cre, Lac+Lip(1.33), Glc, Ins, Glu+Gln and Lip(0.90) were 
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retained, to provide 8 variables for each FID that reflected the variables 
obtained by the simple quantitation. Since the classification model was not 
able to deal with missing values, always all concentration values were used, 
even when the standard deviation of a metabolic compound was higher than 
25%. Figure 7.3 shows an example of a fit obtained by LCModel.   
 
Figure 7.3.  Example of LCModel result on a spectrum. 
 
Classification. A classification method has been used5 that was specifically 
developed to classify glial tumors, healthy tissue and CSF. This method 
generates plots that give an impression of the distance of each class with 
respect to all other classes in the investigated feature space. These so-called 
distribution plots are important in the assessment of the input data. To be able 
to calculate the classification results, the classifier was used in its simplest 
form, which classified a new object to the class it had the closest mahalanobis 
distance to. 
One data set was classified with the use of classification boundaries. These 
boundaries defined the borders of the classes in feature space, and were setup 
by setting critical distance values for each class. The critical distances were 
obtained by inspection of the distribution plots. The critical distance for a 
specific class was that distance that included most of the objects of the class, 
while excluding the maximum number of objects of all other classes. During 
classification, if an object was, for example, closest to the centroid of 
meningioma, but exceeded the critical distance, then it was classified as 
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unknown. For the grade II and III class, an extra distance rule was setup, 
since they were found to show considerable overlap. If a new object was close 
to the grade II centroid, but close to the grade III centroid as well, then it was 
classified as undecided between grade II and III. 
The classifier has been trained with the training set for each different 
combination of input data. The classification result of the test set was 
compared with the result obtained by pathology. A classification table was 
constructed from which the α-errors of each class and a mean α-error of all 
classes was calculated. The same was done for the β-errors of each class and 
the mean β-error of all classes. The α-error is a measure of the number of 
objects of a specific class that are falsely assigned to other classes. The β-error 
is a measure of the number of objects falsely assigned to that specific class.  
The resulting distribution plots and classification tables were compared 
with each other to estimate the best feature selection procedure. The data 
from the best feature selection procedure was also used as input for the 
classifier containing critical distances. This was done to investigate whether the 
misclassified objects could be successfully identified with the use of selection 
rules.  
Results 
The water signal and the effect of normalization. To get an impression 
of the water signal distribution, as acquired with short echo time MRSI, the 
water signal image of a patient with a grade IV tumor is compared with its PD 
image, and the choline, creatine and NAA metabolic images obtained from the 
metabolite MRSI (figure 7.4). The metabolic images are obtained using the 
simple quantitation method on the preprocessed spectra. There is clearly 
structure in the water signal image. The tumorous region exhibits higher water 
signal (white areas, lower right) than the healthy white/gray matter region. The 
water signal in the CSF region is lower than in the healthy white/gray matter 
region. Also an overall lower water signal is visible at the border of the water 
image. This phenomenon is also visible in the metabolic images. However, the 
contrast in the water signal image is not as high as the contrast in the 
metabolic images, indicating that differences in water signal are not so high in 
the water signal image.  
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Figure 7.4. Comparison of the water signal image, the proton density image 
and three metabolic images of a patient with a grade IV tumor. 
 
To estimate whether the water signal had discriminating power, box plots 
were constructed that provide an overview of the water signal in the voxels 
selected for the six classes in the data set (figure 7.5). An increase of water 
signal is clearly visible between the voxels from healthy tissue and tumorous 
tissue. The water signal of CSF voxels is lower than the water signal of voxels 
from healthy tissue. Within the glial tumors, there is a gradual increase of 
water signal when the grade of the tumor increases. The water signal of the 
meningioma voxels is elevated with respect of healthy tissue, and comparable 
with the water signal from the grade II glial tumors. 
 
 
Figure 7.5. Box plots show the water signal levels in the voxels of the six 
classes of the data set. The median value for each class is shown by the middle horizontal bar. 
The box around each median indicate the upper and lower quartiles of the data. The whisker 
extends to the most extreme data points within 1.5 times the interquartile range of the box. The + 
signs are data points outside the whiskers. 
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To see the effect of inter patient normalization, the non-normalized values 
of each variable were compared with its normalized values. strikingly, the 
standard deviation of the values within each class for a certain variable did not 
show a significant change, when it concerned variables obtained from the 
metabolite MRSI data (e.g. from simple quantitation, pca, ica and LCModel). 
Also the means did not change significantly. 
However, there were differences visible if the normalization of the water 
signals was performed. In the example, the non-normalized water signals of all 
the voxels in each class are plotted (figure 7.6a). Figure 7.6b shows the 
normalized values. In the normalized case, the values within each class have a 
smaller distribution. The standard deviation of the values in the healthy class 
drops from 155 to 92. Also the standard deviations of the grade II, III and IV 
class drop significantly. The standard deviations for CSF and MNG are in the 
same order after normalization.  
 
 
Figure 7.6. Comparison of the non-normalized (a) and normalized (b) water 
signals of the voxels selected in the data set. The water signal of the healthy voxels in 
the data set are labeled with crosses. The CSF with circles, grade II with asterisks, grade III with 
plusses, grade IV with triangles and MNG with squares. After normalization, the spread within 
the classes is smaller for the healthy, grade II, grade III and grade IV class. 
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Since it is not very informative to show all classification tables for all 
combinations of features, table 7.2 is constructed, that only shows the mean α-
error and mean β-error of the independent test set for each feature selection 
method. The errors are percentages and the values are not corrected for the 
class sizes. From this table, several feature selection methods were selected 
which are discussed in the following sections. 
Table 7.2. classification errors on the test set using different feature 
selection methods. 
feature selection method mean α-error (%) mean β-error (%) 
qua 21 12 
pca 22 11 
ica 26 13 
lcm 26 21 
quan 22  8 
pcan 23 15 
ican 27 12 
lcmn 27 25 
qua + ima  6  4 
pca + ima 10  4 
ica + ima 11  7 
lcm + ima 11  8 
quan + ima  6  4 
pcan + ima 10  6 
ican + ima 12  8 
lcmn + ima  9  8 
qua + ima + watn  5  4 
pca + ima + watn 10  4 
ica + ima + watn  9  5 
lcm + ima + watn 11  7 
quan + ima + watn  5  2 
pcan + ima + watn 11  5 
ican + ima + watn 10  6 
lcmn + ima + watn  9  6 
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Based on the result shown in table 7.2 the following feature selection 
methods were selected for a further inquiry: qua, qua + ima, qua + ima + 
watn. These three methods were selected to compare between a method using 
only information from the supressed MRSI, a method that also used image 
information, and a method that included all three types of data. The methods 
that used water normalized values were not considered, since water 
normalization generally did not improve the results. The three selected 
methods performed best in their class. 
The distribution plots for the first two models are shown in figure 7.7 to 
illustrate the difference of class isolation in feature space between a data set 
which does not use image data and a data set which does. When image 
information is used (figure 7.7b), the classes are clearly more isolated. This 
should improve the classification result of especially CSF, grade II, grade III 
and meningioma.  
 
Figure 7.7. Distribution plots of input data from two feature selection methods. 
 
Distribution plots provide information of the overlap of classes in feature 
space. Each subplot shows the cumulative sum of objects for each class within 
a Mahalanobis distance to the centroid of one specific class. As example, the 
subplot with the healthy centroid as origin is explained (figure 7.7a, upper left). 
When the mahalanobis distance (x-axis) increases, only objects in the healthy 
class accumulate. This is normal, since the centroid of the healthy class is 
surrounded by healthy objects. After 3 times the Mahalanobis distance, also 
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CSF objects are encountered (dotted-gray), followed by meningioma objects. 
As a result, the healthy class appears to be quite isolated. Other objects in the 
neighborhood, are mostly from CSF. This implies that sometimes a real CSF 
object is misclassified as healthy. From the grade II plot in figure 7.7a, it is 
clear that CSF objects are also in the vicinity of the grade II centroid. 
Therefore, CSF objects will sometimes be misclassified as grade II. If the same 
two subplots are viewed in figure 7.7b, then it is immediately clear that objects 
from other classes are further away from all class centroids. CSF object do not 
interfere anymore with the healthy of grade II class, and thus will be less 
misclassified. This is immediately clear when table 7.3 and 7.4 are compared. 
To investigate the results of the 3 chosen feature selection methods, their 
classification tables are shown in tables 7.3, 7.4, and 7.5. When only 
quantitation is used, the results of CSF, grade III and meningioma are bad. 
For instance, CSF voxels are misclassified as healthy tissue (1) and grade II 
(11), which could have been to be expected from the distribution plot 
depicted in figure 7.6a. Also the misclassification of grade III objects as grade 
II and meningioma as grade IV is not a surprise. If also image information is 
used, the classification results increase substantially. CSF is 10 % correctly 
classified now, as well as classification of the meningiomas. Only 
misclassifications between grade II and III still occur (one grade II is still 
misclassified as grade IV). When the water signal is added during feature 
selection, the classification result slightly improves. Addition of the water 
signal increases the classification results of all feature selection methods, but 
only slightly.   
 
Table 7.3. classification result of the test set using the qua method for 
feature selection. 
 healthy CSF grade II grade III grade IV MNG α-error 
healthy 65      0 
CSF 1 18 11    40 
grade II   50 2 1  5.6 
grade III   9 8   53 
grade IV     21  0 
MNG     4 10 28.6 
β-error 1.5 0 28.5 20 19.2 0  
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Table 7.4. classification result of the test set using the qua + ima method 
for feature selection. 
 healthy CSF grade II grade III grade IV MNG α-error 
healthy 65      0 
CSF  30     0 
grade II   51 1 1  3.8 
grade III   6 11   35.3 
grade IV     21  0 
MNG      14 0 
β-error 0 0 10.5 8.3 4.5 0  
 
Table 7.5. classification result of the test set using the qua + ima + watn 
method for feature selection. 
 healthy CSF grade II grade III grade IV MNG α-error 
healthy 65      0 
CSF  30     0 
grade II   51 1 1  3.8 
grade III   5 12   29.4 
grade IV     21  0 
MNG      14 0 
β-error 0 0 8.9 7.7 4.5 0  
  
Last, the data set using  qua + ima + watn as feature selection was 
classified using selection rules in the classifier. The critical distances for 
assignment to unknown were estimated from the distribution plot setup by 
the qua + ima + watn data set. The following values were used: healthy, 6.0; 
CSF, 6.0; grade II, 6.0; grade III, 6.0; grad IV, 4.5; MNG, 8.0. If an object was 
assigned to grade II, but the distance to grade III was smaller than 1.3 time the 
distance to grade II, then the object was classified as undecided. The same 
rule applied if the object was assigned to grade III. These rules led to the 
classification as shown in table 7.6. 
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Table 7.6. classification result of the test set using the qua + ima + watn 
method for feature selection and selection rules in the classifier. 
 healthy CSF grade II grade III grade IV MNG unknown undecided 
healthy 61      4  
CSF  28     2  
grade II   50  1  1 1 
grade III   3 12    2 
grade IV     21    
MNG      14   
 
 
Discussion 
It is important to know the effect of feature reduction on MRSI data, if this 
data is going to be used for tumor classification. Feature reduction is 
obligatory, since the number of objects in each class should be 5  10 times 
higher than the final number of features. It is important to use the available 
MR information as extensively as possible, since classification is hampered by 
a low signal to noise ratio of the spectroscopic data, the low number of cases 
to build the model from and the large number of pathologic different brain 
tumors. Furthermore, an extensive extraction of class discriminating 
information can only be performed with a feature extraction method suited 
for the job. Papers have been published7, 24 which give a good overview of the 
preprocessing and feature reduction methods for the classification of MRS 
data. Finding the best general feature reduction procedure is a difficult issue, 
because it depends on the particular data used and the specific problem to be 
solved. Somorjai25 found that for the classification of thyroid neoplasms 
principal components analysis on the MR spectra gave similar results as 
picking peak heights or peak areas. In 26 it was observed that feature reduction 
with the use of selected frequency regions or peak quantitation resulted in 
worse classification results for brain tumors as compared to complete spectra. 
However, they used a support vector machine during classification which 
deals with the dimensionality problem. Furthermore, their results were based 
on long echo time (TE = 135 ms) spectra, while in this paper short echo time 
spectra are used. Long echo time spectra are less noisy, but also contain less 
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information. Feature reduction could be especially important in the selection 
of features from short echo time MRS data, because of the ability of most 
methods to separate information from noise. 
We have found that the feature reduction on the MRSI data did not have 
much effect on the classification result. The quantitation method produced the 
best result throughout all the investigations. The LCModel approach 
performed worst. This was not expected, since in theory this model would 
quantitate the important metabolites better than our simple quantitation 
approach. The principal component analysis was found to be slightly worse 
than the quantitation method. This method can be very interesting, since it is 
easily automated, user independent, and it doesnt need a priori information. 
Independent component analysis did not perform better than PCA and is 
more user dependent. Therefore it is not considered a better choice than PCA. 
Inter patient normalization on the metabolite MRSI data before feature 
reduction did not improve classification. However, inter patient normalization 
as well as intra normalization are an important issue. As shown in figure 7.4, 
the water image and metabolite images show non-uniformities in the 
excitation profile, especially at the borders. The lower signal at the borders is 
probably caused by the profile of the selective pulses of STEAM and the 
processing of data. These non-uniformities can be partially corrected27 by 
means of normalization, which should in principle improve classification. 
However, these intra-normalization requires a phantom-acquisition with the 
same spatial dimensions as the metabolite MRSI and was not performed. Inter 
patient normalization is very important if data from different sites, protocols 
and MR systems are used28. In our case, all data was acquired using the same 
protocol, site, operator and MR system, and therefore we were not surprised 
that normalization had no dramatic effect. We could however see 
improvements in the distribution of the water signals of the voxels in the 
different classes in the training set, as shown in figure 7.6. Therefore, the 
normalized water signals were used during combination of data sources. 
The classification results dramatically improved if the metabolite MRSI 
data were combined with the MR image information. To our knowledge this 
has not been described before in literature. Szabo de Edelenyi6 uses 
information from the T2-weighted image during classification, but did not 
compare the classification result with classification without MRI information. 
A comparison of figure 7.7a and b provides a good overview of the classes in 
multivariate space before and after introduction of the MRI information. All 
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classes are more isolated in multivariate space if MR image information is 
used. The CSF class, which was close to the grade II class is located far from 
all other classes if image information is added. This totally eliminates the α-
error (compare table 7.3 and 7.4) of CSF and therefore lowers the chance that 
a CSF voxel is wrongly assigned to the grade II (or other) class. The 
meningioma class is close to the grade IV class using only metabolite data 
(figure 7.7a, grade IV subplot). If also image data is used, the separation is 
better, and the classification result of meningioma increases dramatically (table 
7.4). An overlap between the grade II and III classes still occurs after addition 
of image information, but the results on the independent test set are better. 
Since the two classes originate from the same type of (glial) tumor, an overlap 
is always to be expected. 
We show that the classification result of brain tumors greatly improves if 
the combined power of MRSI and MRI data is used. The addition of image 
information increases the classification result on an independent data set from 
~ 78 % to ~ 92 %. Addition of the MRI information in classification proce-
dures seems to be unavoidable, since MR images obtained with different 
contrasts are always acquired during standard clinical investigations. 
Furthermore, it raises the question whether the addition of information from 
other sources of data, like position of the tumor, age and sex of the patient 
(clinical information) will further increase the classification results. This might 
be especially important if more tumor classes are considered at the same time. 
To use more sources of data however, a robust database of validated cases 
needs to be setup. Already some databases have been developed16, and they 
can be a source for the development of new procedures. 
Addition of water amplitude information as calculated from the 
unsuppressed MRSI data slightly improves classification, although no 
significant change was detected. However the box plots in figure 7.5 clearly 
show differences in the water signal for the classes. The use of the water signal 
has already been recognized long ago as a tumor marker29 and could 
contribute to a more accurate brain tumor classification. This also implies that 
normalization of a voxel with a water signal obtained from the same voxel is 
dangerous. For inter patient normalization it might be better to calculate a 
water normalization factor from multiple voxels selected from healthy tissue. 
Last, we have shown that the introduction of critical distances around the 
centroids of the classes in the training set can further improve the 
classification result. If we apply critical distances in our model, only 4 object of 
 Feature selection of MRS and MRI data 
161 
200 are misclassified. Of 10 objects a classification cannot be given. The 
classification result with use of an independent test set is 93%, and this is 
approaching the normally accepted 5% classification error in statistics. If 
critical distances are introduced, the classes within the feature space are 
defined by hypervolumes. A new object is only assigned to a class if it falls 
within its hypervolume. If it falls outside, it is considered to be an outlier, and 
thus unknown. This introduction of a class of unknown objects is 
important, since there are much more tumor types than most classifiers can 
deal with. In this way, a new object from a tumor the classifier cannot handle 
is not forced into an incorrect class. 
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Chemometric methods have been developed that use the combined power 
of proton MRSI data and MRI data, to aid in a more reliable and noninvasive 
brain tumor diagnosis. To obtain a reliable brain tumor classification, all steps 
in the classification strategy should be tuned and carefully executed. 
Therefore, it has been investigated what the necessary contributions to the 
total strategy could be. This has led to the development of chemometric 
methods which are necessary for the automated preprocessing of the data, for 
the feature reduction of the data and for the classification procedure. The 
classification procedure also provides probabilities of classification, which are 
important in the assessment of the reliability of the classification and might 
provide information regarding the heterogeneity of the tumor tissue.   
The developed chemometric methods have been tested and evaluated 
within a semi-automated classification system. This system provides an 
estimate of the location, type and grade of the tumor and can, for example, be 
used as a clinical tool to locate the best position for a brain tumor biopsy. We 
have found that the classification of glial tumors of three different grades, 
meningioma tumors, cerebro-spinal fluid and healthy brain tissue can be 
performed with an accuracy of up to 93%. 
Although feature reduction on the MRSI data is obligatory, the method of 
feature reduction is not a very crucial factor for successful classification. Four 
accepted methods of feature reduction (simple quantitation, principal 
component analysis, independent component analysis and LCModel) have 
been compared and they dont show dramatic differences. However, the 
automated preprocessing before the feature reduction is important! Most of 
the preprocessing procedures used in our models have originally been 
developed for use in single voxel spectroscopy. If applied automatically on a 
large set of MRSI spectra this causes problems, which are difficult to 
overcome. In this thesis a new filter is described to circumvent the occurrence 
of an artifact that may be introduced in MRSI spectra after Eddy current 
correction. Furthermore, other processing methods to automatically 
preprocess MRSI spectra should be developed. For example, the automation 
of baseline correction and first order phase correction of short echo time 
MRSI data are highly desirable. 
Next to preprocessing, the combination of features from MRI data and 
MRSI data greatly improves the classification accuracy. This raises the 
question whether the additional introduction of independently obtained data 
can further improve the classification result. For example, clinical information 
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like the age, gender and clinical symptoms can be introduced into the 
classification model. Radiologists find the approximate location of the brain 
tumor very important for the diagnosis. This location can be established in an 
early stage of the investigation and could be a good discriminator. 
Also the addition of spectroscopic data from other sources than proton 
MRSI may improve the classification. The addition of data from other 
magnetic resonance applications, like 31P-spectroscopy or functional imaging, 
might be worthwhile to investigate. As mentioned in the introduction, the use 
of 31P-MRS has been found important in studies of energy metabolism and 
intracellular pH. Thus, information obtained from 31P spectroscopy can be 
helpful in the improvement of brain tumor classification. However, 31P-MRS 
is time consuming and it requires specialized equipment, which is often found 
only in academic hospitals. Therefore, 31P-MRS in combination with proton 
MRSI might not be feasible.  
The combination of MR data with CT data and PET data is probably more 
interesting. At the moment, MRI, CT and PET are commonly applied during 
the investigation of a patient with a brain tumor. All three methods provide an 
image of the brain, and all with a different information content. Thus, it will 
be highly desirable to combine these data for brain tumor classification and 
chemometrics can play a role in the extraction of information of these 
combined data sources.  
In this thesis it has been shown that it is possible to get insight into the 
reliability of classification during the classification of brain tumors. This is 
performed by the calculation of a probability of classification for each 
individual voxel, or for a segment of multiple voxels. This is very important, 
since the clinician needs an indication of the reliability of the classification 
result as calculated by the model. Probabilities of classification in tumor 
diagnosis are rather new and other methods need to be investigated in the near 
future. A Bayesian approach could be considered, since this provides a way to 
incorporate prior knowledge into the system.  
Further investigations into the nature of the classification models is also an 
issue to consider. Presently, the spatial information in the maps and images is 
not used yet to improve the classification. Each voxel or pixel is treated as an 
independent source that needs to be classified. However, each voxel has 
several neighbors that have a high probability of belonging to the same class as 
the voxel under investigation. This information could be used by a 
classification model to obtain a more reliable/robust classification. 
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Also classification models that are of help in the follow up of patients can 
be developed. One could think of using MR data from several time instances 
to predict the development of the tumor after the patient has been treated. In 
the nearby future, time series of functional MRI in combination with 
chemometrics could be very important in the prediction of changes of brain 
function in the healthy brain tissue surrounding a brain tumor. At the 
moment, functional MRI is already used to investigate which parts of the brain 
have an important function during specific tasks like speech, vision and 
motoric actions. In this way, it is possible to map the function of the brain 
that surrounds a tumor. If there is loss of brain function in time, then this 
could be a reason to change the treatment of the patient. It is even better to 
predict the loss of brain function and to prevent it by changing the treatment.  
Another, completely different subject that needs attention, concerns the 
implementation of the classification software in a clinical environment. To do 
so, the development of a graphical user interface is highly desirable. The lay-
out of a desired user interface has been investigated by the INTERPRET 
consortium, but a practical implementation of the processing and classification 
models and the user interface has not been performed yet. Since most of the 
(pre)processing is automated, the system can be simply integrated in the clinic. 
However, some considerations have to be made. The classification software 
has to be robust, so further testing and removal of bugs are needed. It has to 
be investigated in what clinical environment the clinicians want to use the 
software. If it is desired, for example, to use the software real time during the 
investigation of the patient, then other specifications are needed than if the 
software is to be used after the investigations. In this context one should think 
of investigations into calculation times or accessibility of the software to the 
non-expert user.  
In future it is also highly desirable to link the software containing the 
classification strategy to a database that is independent and that contains a 
high number of cases sampled from all around the world. This database 
should be maintained by experts in the field of chemometrics, informatics and 
clinical diagnostics. Such a database will ensure that training sets with a large 
number of validated samples for several classes and a high quality are 
available. Furthermore, it avoids that non-experts change the local database of 
training sets. The INTERPRET consortium has made a start to setup such a 
database, but at the moment it does not contain a feature to directly link a 
processed training set to a classification algorithm. 
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Last, the best resolution of the classification maps should be investigated. 
Since MR images are obtained with a far higher spatial resolution than MRSI, 
rigorous processing is needed to equalize the two. Chemometrics can be of 
help in the development of better methods. Increasing the resolution to the 
MRI level preserves all the image information, and could therefore increase 
the classification result and reliability. It also results in classification maps with 
a high spatial resolution. However, an increase in resolution may also decrease 
the robustness and reliability of classification, since the spectroscopic 
information used for the classification of a voxel is acquired from a large 
volume around that voxel.  
I have written this thesis among other things because I am convinced that 
the use of chemometrics is very valuable for the diagnosis of patients with a 
brain tumor. Especially in future, since the number of specialized techniques 
in the clinic will only grow. The data that are generated by these techniques 
have to be presented to the clinician in the most informative way. To do so, 
new sophisticated methods have to be developed, that will be present during 
the whole trajectory of processing. The last four years I have been 
investigating such methods. I have created an user interface that offers the 
possibility to quickly process data. The filter described in chapter three is used 
during processing. With the interface, I have setup a large dataset which is 
used by several researchers who are developing methods to optimize tumor 
diagnosis. Furthermore, I have developed a classification model (chapter five) 
that provides excellent results. It is very well possible to classify tumors and to 
get information of the reliability of classification as well. 
I have also shown that the combination of MRI and MRSI data improves 
the classification of different tumor grades, healthy tissue and cerebro-spinal 
fluid. With this result, I hope to convince other researchers to combine data 
from different sources.  
The results of my work have been integrated into a demo. This demo is 
made to show the clinician how chemometrics can contribute to tumor 
diagnosis. I hope that this demo convinces clinicians that automated 
processing of MR data is essential for determination of the correct diagnosis 
of brain tumors.  
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Brain tumor diagnosis is a difficult challenge for the clinician, since it is 
rarely possible to decide upon the type and grade of the tumor with absolute 
certainty from the clinical history and classic radiological investigations. To 
improve the diagnosis of persons with a brain tumor, new radiological 
methods have been developed in the last decade. In the case of magnetic 
resonance, the classic magnetic resonance imaging (MRI) has, amongst others, 
been extended with functional MRI, diffusion weighted MRI and magnetic 
resonance spectroscopic imaging (MRSI). In the case of MRSI, a cross-section 
of the brain is measured, in which each pixel (called voxel) contains a 
spectrum. This spectrum has a very specific shape, which is defined by the 
tissue it is measured from. Therefore, MRSI could be very important in the 
investigation of brain lesions. 
However, due to the increased number of methods, an overwhelming 
amount of data is generated, which is not easily accessible by the clinician. 
Therefore, it is necessary to develop automated data processing and methods 
based on pattern recognition (chemometrics), that are able to objectively 
interpret the data. This would provide the clinician with tools to extract 
relevant information about the disease of the patient, without him spending to 
much time. Furthermore, methods that use pattern recognition are capable to 
obtain relevant information from data that would have been very difficult to 
recognize by the clinician. 
Chemometrics is a discipline that has the goal to obtain information and 
knowledge from data in the field of chemistry. The methods used in 
chemometrics are of a mathematical and statistical nature and are executed on 
a computer. These methods are often optimized for the interpretation of 
multivariate (multi-dimensional) data. The human eye is very good in the 
interpretations of one and two dimensional data. Often, this is best done on 
paper as a graph, figure or image. In the case of three dimensional data, the 
interpretation already becomes more difficult. If even more dimensions are 
available, then the human mind needs help from chemometrics to interpret 
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the data. Often, it is tried to extract the best information from the multivariate 
data and display it in a two dimensional image or graph. 
In this thesis, several chemometric methods are investigated, that could 
contribute to the automated interpretation of large data sets obtained with 
MRI and MRSI. The goal of the development of these methods is to extract as 
much relevant information about the type and grade of brain tumors. 
Eventually, these methods can be used in the construction of a decision 
support system for brain tumor diagnosis. This program could be used by 
clinicians to come to a more precise and less time consuming brain tumor 
diagnosis. This is very important, since the treatment of a brain tumor is very 
dependent on its type and grade. 
The development of chemometric methods that can be used to improve 
the diagnosis of patients with a brain tumor encompasses several challenges. 
The data preprocessing needs to be automated, quick, robust, and error 
propagation needs to be kept to a minimum. Classification models have to be 
developed to automatically locate and classify the tumor type of a brain tumor. 
The classification model should also provide an estimate of the reliability of 
the classification. This reliability of classification is especially important, since 
the clinicians who will use the system have to be convinced that the 
classification results are meaningful. Furthermore, the classification result 
should be spatially resolved and presented image-like, to facilitate an easy 
interpretation by clinicians in the clinic.  
The introduction of this thesis provides the reader with some background 
on tumor diagnosis. The tumor types investigated in this research are specified 
and the role of magnetic resonance imaging and spectroscopy in tumor 
diagnosis is briefly explained. This is followed by a short definition of 
chemometrics and the role it could play in the classification of brain tumors 
using MRI and MRS.  
In Chapter two an overview is given of the challenges for chemometrics in 
the analysis of MR images and spectra of brain tumors. The basic aspects of 
MRI and MRSI are outlined, as well as the processing of images and spectra. 
The main contributions of chemometrics to the analysis of MR data used for 
brain tumor classification are outlined. This involves the segmentation of MR 
images, the processing of spectroscopic data to compensate for instrumental 
imperfections and the development of classification models.  
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One of the steps in the preprocessing of MR spectra is called Eddy current 
correction. Eddy current correction normally improves the interpretation of 
the spectra, but in the case of MRSI spectra sometimes an artifact is 
introduced. This artifact can be circumvented by the application of a filter, 
which is described in Chapter three. 
After preprocessing of MRI data and MRSI data, similar voxels of a patient 
can be clustered to segment the brain in several regions, that have comparable 
metabolic and morphologic patterns. The development of such a semi-
automatic unsupervised clustering technique is described in Chapter four. 
The segments found during clustering can be classified using a new 
classification algorithm. This algorithm also calculates the probability of 
classification for each segment. Furthermore, the model can also calculate 
these values for each separate voxel. The results are presented image-wise and 
can be superimposed on high resolution MR images which provide relevant 
morphologic information. This is described in Chapter five.  
By visual comparison of the constructed probability of classification 
images, the clinician gets insight in the tumor morphology and type. The two 
classification images, one from the classified segments and one from the 
classified individual voxels, provide a consensus diagnosis of the tumor. 
Chapter six describes a new scientific decision support tool that uses both 
classification results and the probabilities of classification to aid the clinician in 
the diagnosis of a patient with a brain tumor. 
In Chapter seven, several feature reduction methods are compared in their 
ability to classify brain tumors of different type and grade, normal tissue and 
cerebro-spinal fluid. Also the combination of MRI data, MRSI data and 
information from the water signal is investigated. Although feature reduction 
is important, especially the combination of MRI and MRSI information is 
found to be important. 
I have written this thesis among other things because I am convinced that 
the use of chemometrics is necessary for the diagnosis of patients with a brain 
tumor. Especially in future, since the number of specialized techniques in the 
clinic will only grow. The data that is generated by these techniques has to be 
presented to the clinician in the most informative way. To do so, new 
sophisticated methods have to be developed, that will be present during the 
whole trajectory of processing. The last four years I have been investigating 
such methods. I have created an user interface that offers the possibility to 
construct a totally processed dataset. The filter described in chapter three is 
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among other things used in this user interface. Using the interface I have 
collected a large dataset, that is used by several researchers who are developing 
methods to optimize tumor diagnosis. Furthermore, I have developed a 
classification model (chapter five) that provides excellent results. It is very well 
possible to classify tumors and to get information of the reliability of 
classification as well. Next, I have investigated the influence of several feature 
selection methods on the classification result of different tumors, healthy 
tissue and cerebro-spinal fluid. About this topic, not much was yet published 
in the academic society. With the result, I hope to convince other researchers 
to combine data from different sources. Moreover, I hope that I have 
contributed to the awareness of clinicians that automated processing of MR 
data is very important for determination of the correct diagnosis in the clinic. 
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De diagnose van hersentumoren is een moeilijke taak voor de radioloog, 
omdat het vaak niet mogelijk is om met zekerheid het tumor-type en de graad 
vast te stellen op basis van de huidige diagnostiek. Om de diagnose van 
personen met een hersentumor te verbeteren, zijn er in de afgelopen tien jaar 
verscheidene nieuwe radiologische onderzoekstechnieken ontwikkeld. In het 
geval van magnetische resonantie imaging (MRI) is de klassieke MRI opname 
o.a. uitgebreid met functionele MRI, diffusie gewogen MRI en magnetische 
resonantie spectroscopie (MRSI). In het geval van MRSI wordt er een hersen-
scan uitgevoerd, waarin zich in elk pixel (voxel genoemd) een heel spectrum 
bevindt. Dit spectrum heeft een heel specifieke vorm, die wordt bepaald door 
het weefsel waaruit het is opgenomen. Daardoor kan MRSI dan ook zeer 
geschikt zijn om het type en de graad van hersentumoren te onderzoeken. 
Door het toenemen van het aantal onderzoekstechnieken ontstaat er echter 
een bijzonder grote hoeveelheid data, die niet altijd door de arts 
geïnterpreteerd kan worden. Daarom is het noodzakelijk om geautomatiseerde 
technieken te ontwikkelen die in staat zijn de data objectief te interpreteren. 
Deze methoden zijn gebaseerd op patroonherkenning (chemometrie). De 
automatische interpretatie van de grote hoeveelheid data stelt de arts in staat 
om de meest relevante informatie betreffende de ziekte van de patiënt te 
overzien, zonder dat hij daar veel tijd voor nodig heeft. Daarnaast zijn 
methoden die gebruik maken van patroonherkenning in staat om relevante 
informatie uit de data te verkrijgen die door de arts zeer moeilijk te herkennen 
zou zijn. 
Chemometrie is de discipline die als doel heeft zoveel mogelijk informatie 
en kennis te vergaren uit data die is opgenomen op het gebied van de chemie. 
De methoden die door de chemometrie gebruikt worden zijn wiskundig en 
statistisch van aard en worden uitgevoerd door een computer. Vaak zijn de 
chemometrische methoden geoptimaliseerd om te werken met multivariate 
(multivariabele) data. Het menselijk oog is prima in staat om data te 
interpreteren die uit een of twee variabelen bestaat. Vaak gaat het dan om 
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grafieken, figuren of plaatjes. In het geval van drie variabelen wordt de 
interpretatie al moeilijker. Onze wereld is driedimensionaal, maar het 
interpreteren van een driedimensionaal figuur op papier is al bijna onmogelijk. 
Als het om nog meer variabelen gaat, dan heeft de mens hulp nodig van onder 
andere de chemometrie om de data te interpreteren. Vaak wordt er 
geprobeerd om de multivariate data zodanig te bewerken dat het te 
projecteren is in een tweedimensionaal plaatje of figuur.  
In dit proefschrift worden verschillende chemometrische methoden 
beschreven die kunnen bijdragen aan de automatische interpretatie van grote 
datasets die zijn ontstaan door MRI en MRSI metingen. Het doel van de 
ontwikkeling van deze methoden is het verkrijgen van zoveel mogelijk 
relevante informatie over het type en de graad van hersentumoren. Uiteindelijk 
kunnen de ontwikkelde methoden worden gebruikt in de constructie van een 
beslissingssysteem, dat de arts helpt om in een korte tijd, maar met hoge 
nauwkeurigheid, de diagnose van een hersentumor vast te stellen. Dit is 
bijzonder belangrijk omdat de behandeling van patiënten met een 
hersentumor erg afhankelijk is van het type tumor en de graad van de tumor. 
De ontwikkeling van chemometrische methoden, die kunnen worden 
gebruikt om de diagnose van patiënten met een hersentumor te verbeteren, 
bevat meerdere uitdagingen. De voorbewerking van de ruwe data moet 
worden uitgevoerd met snelle, robuuste, geautomatiseerde software, die de 
opeenstapeling van fouten minimaliseert. Daarnaast moeten er classificatie-
modellen worden ontwikkeld die in staat zijn om de plaats van de tumor en 
het type en de graad te herkennen. Deze modellen moeten ook kunnen 
aangeven met welke maat van zekerheid de typering heeft plaatsgevonden. 
Deze maat van zekerheid is zeer belangrijk, omdat de arts overtuigd moet zijn 
van de kwaliteit van de classificatie. Verder moeten er methoden ontwikkeld 
worden die de gegevens als een plaatje aanleveren, zodat de resultaten 
eenvoudig door een arts te interpreteren zijn. 
De introductie van het proefschrift geeft de lezer een kort overzicht van 
tumordiagnose. De tumortypen die gebruikt worden in dit onderzoek worden 
gespecificeerd en de rol van magnetische resonantie imaging en spectroscopie 
in de tumordiagnose worden verklaard. Vervolgens wordt een samenvatting 
gegeven van de definitie van chemometrie en de rol die deze kan spelen in de 
classificatie van hersentumoren. 
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In hoofdstuk twee wordt ingegaan op de uitdagingen voor de chemometrie 
in de analyse van magnetische resonantie imaging en spectroscopie van 
hersentumoren. De basisaspecten van MRI en MRSI worden omschreven, net 
als een aantal voorbewerkingtechnieken. Voorts wordt de huidige bijdrage van 
de chemometrie in de analyse van MR data behandeld. Het betreft hier de 
segmentatie van MR images, de compensatie van artefacten geïnduceerd door 
de meetmethode en de ontwikkeling van classificatie modellen. 
Eén van de stappen in de voorbewerking van MR spectra wordt Eddy 
current correctie genoemd. Deze methode verbetert normaal gesproken de 
interpretatie van spectra, maar bij het gebruik in MRSI kan er soms een 
artefact geïnduceerd worden. Dit artefact kan worden geëlimineerd door het 
gebruik van een filter. Dit filter wordt beschreven in hoofdstuk drie. 
Na de voorbewerking van de MRI en MRSI data, kan deze gebruikt 
worden om een gesegmenteerd beeld van de hersenen te verkrijgen. De delen 
van de hersenen die gelijke metabole eigenschappen hebben, worden 
samengevoegd. De ontwikkeling van een segmentatie algoritme dat gestuurd 
wordt door een clusteranalyse, wordt beschreven in hoofdstuk vier. Het is een 
belangrijke stap in de condensatie van de data en het objectief indelen van de 
hersenen in regios met dezelfde metabole kenmerken. 
De segmenten die tijdens de clusteranalyse gevonden worden, kunnen 
worden geclassificeerd met gebruik van een nieuw ontwikkeld programma. Dit 
algoritme berekent ook de statistische betrouwbaarheid van classificatie voor 
elk segment. Daarnaast kan het model deze waarden ook voor elk los voxel in 
de MRSI plaatjes berekenen. De resultaten worden als classificatieplaatjes 
gepresenteerd en kunnen worden geprojecteerd op MR images die een hogere 
resolutie hebben. Dit wordt beschreven in hoofdstuk vijf. 
De twee classificatieplaatjes kunnen tezamen met de betrouwbaarheid van 
de classificatie gebruikt worden als een consensus diagnose. Wanneer een 
gebied in de hersenen in beide plaatjes hetzelfde wordt geclassificeerd, dan is 
de kans groot dat deze classificatie correct is. Als daarnaast ook de statistische 
betrouwbaarheid hoog is, dan geeft dit nog meer vertrouwen in een correcte 
weergave van de werkelijkheid. In hoofdstuk zes wordt een beslissingssysteem 
beschreven dat gebruik maakt van bovenstaande modellen. Dit systeem kan in 
de kliniek gebruikt worden om de arts te helpen bij de diagnose van patiënten 
met een hersentumor. 
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In hoofdstuk zeven wordt een aantal technische methoden met elkaar 
vergeleken die gebruikt kunnen worden om de meest relevante informatie uit 
een grote dataset te isoleren. De methoden worden getest in hun vermogen 
om drie verschillende typen hersentumoren, normaal hersenweefsel en 
hersenvloeistof te onderscheiden. Daarnaast wordt onderzocht of de 
combinatie van data, verkregen uit MRI én MRSI, leidt tot een verbetering van 
de classificatie. 
Deze thesis is mede tot stand gekomen omdat ik ervan overtuigd ben dat 
chemometrische methoden noodzakelijk zijn bij de diagnose van patiënten 
met een hersentumor. Zeker in de toekomst, aangezien het aantal technisch 
hoogstaande meettechnieken in de kliniek alleen maar zal toenemen. De data 
die door deze meetmethoden wordt gegenereerd, moet zo informatief 
mogelijk aan de arts worden aangeboden. Daarvoor zijn geavanceerde 
dataverwerkingstechnieken nodig. Deze technieken moeten aanwezig zijn in 
het gehele traject van de dataverwerking. De laatste vier jaar heb ik binnen dit 
traject onderzoek gedaan. Ik heb een user interface ontwikkeld die het 
mogelijk maakt om gemakkelijk een geheel verwerkte dataset te construeren. 
Daarvoor heb ik onder andere een filter ontwikkeld dat beschreven wordt in 
hoofdstuk drie. Een grote dataset die door mij is opgebouwd, wordt intussen 
gebruikt bij een aantal onderzoeken die als doel hebben tumordiagnose te 
optimaliseren. Daarnaast heb ik een classificatie model ontwikkeld (hoofdstuk 
vijf) dat tot goede resultaten leidt. Het is zeer wel mogelijk om tumoren te 
classificeren en daarnaast een beeld te krijgen van de betrouwbaarheid van 
classificatie. Daarnaast heb ik laten zien wat de invloed is van verschillende 
dataverwerkingstechnieken op het classificatieresultaat van verschillende 
groepen tumoren, gezond weefsel en hersenvloeistof. Hierover was in de 
academische wereld nog niet veel gepubliceerd. Met dit resultaat hoop ik 
andere wetenschappers te overtuigen om verschillende bronnen van data te 
combineren. Daarnaast hoop ik met mijn resultaten, die in de vorm van een 
demo toegankelijk zijn (zie hoofdstuk zes voor een voorbeeld), bij te dragen 
aan de bewustwording van de arts dat automatische MR informatieverwerking 
bijzonder belangrijk is bij het stellen van de juiste diagnose in de kliniek.  
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1H-MRSI proton magnetic resonance spectroscopic imaging 
2D  two-dimensional 
3D  three-dimensional 
AIC  akaikes information criterion 
ATP  adenosine triphosphate   
BIC  bayesian information criterion 
Cho  choline-containing compounds 
Cr  phosphocreatine plus creatine 
CSF  cerebro-spinal fluid 
CT  computed tomography 
ECC  Eddy current correction 
EM  expectation maximization 
FID  free induction decay 
FWHM full width at half maximum 
Gd-DTPA Gadolinium-DTPA 
GD-image Gd-DTPA enhanced image 
Glc  glucose 
Gln  glutamine 
Glu  glutamate 
HLSVD hankel lanczos singular value decomposition 
ICA  independent component analysis 
Ins  myo-inositol 
Lac  lactate 
LDA  lineair discriminant analysis 
Lip  lipids 
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MNG  meningioma 
MR  magnetic resonance 
MRI  magnetic resonance imaging 
MRS  magnetic resonance spectroscopy 
MRSI  magnetic resonance spectroscopic imaging 
NAA  N-acetylaspartate 
PCA  principal component analysis 
PC  principal component 
PD-image proton density weighted image 
PET  positron emission tomography 
rCBV  regional cerebral blood volume 
SVS  single voxel spectroscopy 
STEAM stimulated echo acquisition mode 
TE  echo time 
TM  mixing time 
TR  repetition time 
WHO  world health organization 
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Beste lezer. U kijkt waarschijnlijk in het dankwoord van dit proefschrift, 
omdat u graag wilt weten of uw naam ook wordt genoemd. Mocht dit niet zo 
zijn, wees dan gerust. Ik dank u bij deze alleen al omdat u de moeite heeft 
genomen mijn proefschrift door te bladeren. Over het algemeen is een 
proefschrift zo specialistisch dat de meeste mensen niet de vakkundigheid 
hebben om zich te verdiepen in de inhoud. Speciaal voor diegenen heb ik er 
alles aan gedaan om de samenvatting en introductie zo begrijpelijk mogelijk te 
houden. Probeert u ze eens te lezen! 
De hoofdstukken waarin het onderzoek van de laatste vier jaar wordt 
beschreven had ik niet tot stand kunnen brengen zonder de hulp van een 
groot aantal mensen. Deze wil ik dan ook graag persoonlijk noemen. 
Allereerst Lutgarde Buydens en Arend Heerschap: jullie wil ik speciaal 
bedanken voor het mogelijk maken van dit proefschrift. Binnen de structuur 
van jullie afdelingen heb ik ontzettend veel kunnen leren en is dit proefschrift 
gegroeid. Lutgarde, je hebt je enorm ingezet om mij academisch te scholen. 
Die ene keer dat ik onzin uitkraamde op een (belangrijke) vergadering werd 
mij vergeven. Maar ik moest er wel voor zorgen dat het niet weer gebeurde! 
Daarnaast wil ik alle collegas van de afdeling analytische chemie en de 
onderzoeksgroep van radiologie ontzettend bedanken. Brigitte, als secretaresse 
onverslaanbaar; mijn interpret maatjes Willem en Geert; Ron die altijd tijd 
had voor een vraag. Vooral ook Uwe en Jos. Met jullie heb ik een bijzonder 
leuke tijd gehad. En als je onderzoek doet, is dat belangrijk. Het zit namelijk 
niet altijd mee! Met jullie als mede AIOs, wist ik zeker dat het goed ging 
komen. Ook wil ik Marinette bedanken. Zij stond altijd voor mij klaar; zeer 
kritisch en altijd deskundig. Verder Dennis tennis, Mark en Yvonne die de 
spectro deden, Sjaak voor de Unix-les en alle ISMRM (Philidelphia-Denver-
Hawaï) gangers.....het was gezellig! 
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Naast de collegas op de afdelingen in Nijmegen, wil ik ook alle personen 
bedanken waarmee ik heb samengewerkt in het Europese interpret project. 
Vooral Chantal, Joshua, Leentje, Sabine, Carles en Christoph wil ik persoonlijk 
bedanken. Door deze mensen en het project heb ik vele mooie plekken mogen 
bezoeken, heb ik veel geleerd en heb ik nu een leuke baan in Frankrijk. 
Tot slot wil ik mijn familie bedanken. Alhoewel mijn ouders niet altijd 
begrepen waar het nu precies over ging, toonden ze altijd belangstelling en 
waren ze bezorgd over de voortgang! Dat was fijn. Bedankt Pa en Ma!  
Karijn, we hebben ons samen door het schrijven van het proefschrift heen 
geslagen. Zeker de laatste maanden, toen de laatste loodjes het spreekwoord 
eer aandeden, heb ik haar tekort gedaan. Wou ze met mij iets leuks gaan doen, 
moest ik weer werken! En dat terwijl buiten de bergen en de sneeuw ons 
toelachten! Nu hebben we weer meer tijd om er samen op uit te trekken. En 
dat zullen we nog vele jaren blijven doen. 
 
Gegroet en tot wederziens, 
Arjan  
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